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SUMMARY
Three areas of reproductive toxicology have been investigated in this 
thesis: the development of in vitro reproductive systems, the importance of 
male-mediated adverse effects on reproduction, and the action of reactive 
oxygen species and antioxidants in reproductive systems.
In  vitro reproductive techniques allow the separate observation of the 
functions of individual cell and tissue types and also give control over 
chemical treatment and measurement of toxicity. All those techniques used 
gave insight into some of the toxicological hazards for reproductive functions 
and also have value in initial assessments of toxicity. Separation of the 
maternal and embryonic components in embryotoxicity and protection was 
achieved through the use of post-implantation rat embryo cultures. The 
actions of a number of chemicals known to be toxic to the Sertoli cell were 
examined in an in vitro system, incorporating hepatocytes in a dual­
compartment culture assembly to give the system metabolizing potential. 
The model was used to show that various chemicals required metabolism 
before toxicity to Sertoli cells became apparent. The effects of ethanol on 
the in vitro fertilizing capacity of mouse sperm were investigated following 
exposure to different dose regimens. None of those used showed an adverse 
effect of ethanol on fertilizing ability, implicating another aspect of the 
reproductive process.
Infertility or testicular damage may result if the male reproductive 
system is disrupted by xenobiotics. It is being recognized increasingly that 
the offspring may be affected by chemical exposure of the male, as well as 
the female, to certain chemicals. The frequency of tumours, malformations 
and karyotype anomalies in the adult offspring has been investigated in rats 
after paternal exposure to cyclophosphamide. A small positive effect was 
observed, which could have implications for the exposure of human males 
to chemicals.
Many chemicals known to have adverse effects on reproduction have 
the capacity to produce reactive oxygen species. The use of the xanthine/ 
xanthine oxidase radical-generating system in vitro has shown that reactive 
oxygen species may have a role in mediating reproductive toxicity. Cultured 
post-implantation embryos and cultured Sertoli cells were both adversely 
affected by this radical-generating system and protection was afforded by L- 
ascorbic acid (in embryos and Sertoli cells) and by DL-a-tocopherol (in 
embryos only).
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CHAPTER 1
INTRODUCTION
There is increasing pressure on experimental biologists to reduce the 
number of animals used. It is, therefore, essential that in vitro systems are 
developed and utilized. In this thesis, three such systems have been 
investigated in the field of reproductive toxicology. The procedure for 
culturing post-implantation rat embryos is well-established and allows 
discrimination between maternally-mediated and direct embryotoxicity. In 
vitro fertilization procedures have been developed for the treatment of 
human infertility, but may also be used in toxicological investigations since 
they enable the effects of chemicals on the fertilization process itself to be 
ascertained. The resulting pre-implantation embryos can be grown in 
culture so that treatment-induced growth inhibition or embryolethality may 
be observed.
The supporting cells of the reproductive system are also susceptible 
to chemical insult an the culture of separate testicular cell types permits 
identification of the target sites involved. Procedures for growing Sertoli 
cells in vitro have been developed for physiological investigations and are 
also appropriate for studies of toxicity. One of the limitations of using in 
vitro systems is the lack of the normal processes of metabolism which occur 
in vivo. The use of a dual-compartment system, in which Sertoli/germ cells 
are grown in the inner compartment and treatment is carried out in the 
outer compartment containing hepatocytes, is one approach to overcoming 
this problem.
Recognition of the importance of the male in reproductive toxicology 
is becoming more widespread. In addition to effects on fertility and 
testicular damage, it is possible that mutations may be inherited by
offspring via the male germ cells. Whilst this is most likely to cause embryo 
lethality, the persistence of such mutations in adult offspring is of greater
concern since they could lead to tumours and other malformations. This has 
been studied in rats after treatment with cyclophosphamide (CP*).
The effects of chemicals on reproductive systems have been 
investigated for many years. Oxygen radicals are known to be implicated in 
the action of many toxins and antioxidant vitamins are known to offer 
protection. In vitro methods have been used to elucidate the mechanisms 
of such action. It is of interest to know how oxygen radicals and 
antioxidants act in reproductive toxicity and this has been investigated in 
vitro using post-implantation embryos and Sertoli/germ cells.
1.1 REPRODUCTIVE PROCESSES
Any of the reproductive processes in the male or the female may be 
targets for toxicity. The developing embryo is also susceptible to the action 
of toxic chemicals.
Inter-relationship  
b etw een  aspects o f reproduction
Fig. 1.1 illustrates the stages of the reproductive process.
Damaging events occurring at a particular stage in the reproductive 
process may not become evident until a later stage: for example, damage to
the testis may lead to infertility; damage to spermatozoa may lead to mal­
formations in the offspring.
abbreviations used in this thesis are listed on page x
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Fig. 1.1 Targets for reproductive toxicity
Hormones
Testis/Ovary
Accessory organs
Mitosis
Meiosis OogenesisSpermatogenesis
Maturation
OocytesSpermatozoa
Mating
Fertilization’
Implantation
Pre-imp­
lantation
embryo^
Post-imp­
lantation
embryo^Development
Offspring
perinatally
Offspring
as adults'^
Male
Reproductive
Tract^
Female
Reproductive
Tract
numbers indicate experimental chapters in which these targets are discussed
It is impossible to consider any aspect of reproductive toxicology in 
isolation from other aspects since these form a continuous sequence of 
events. Only some of these aspects may be studied in vitro: for example, al­
though effects may be detected on pre- or post-implantation embryos in 
vitro, effects on the crucial step of implantation can, at present, only be 
investigated in vivo; similarly, various testicular cell types can be maintained 
in culture but spermatogenesis does not occur. The genetic aspects of 
reproductive toxicology are easier to study in the male since effects specific 
to certain stages of gametogenesis can be compared and the confounding 
effects which are possible through maternal toxicity are not present.
T estis and sperm atogenesis
The function of the testis is the production of sperm; additionally, the 
testes form part of the endocrine system (Amann, 1989).
Testis
A  description of the location and functions of the various cell types in 
the testis is shown in fig. 1.2. The seminiferous tubules of the testis are 
enclosed within the interstitial tissue containing the Leydig cells, blood 
vessels, nerves and lymphatic vessels. Within these tubules are the Sertoli 
cells and the developing germ cells, which are described in more detail in 
section 5.1.
Structural support for the seminiferous tubule is provided by the 
peritubular cells. These are mesenchymal somatic cells (fibroblasts and 
myoid cells) which form a close association with the Sertoli cells on either 
side of the basal lamina (Dym & Fawcett, 1970). Spermatogonia undergo 
mitosis, ultimately producing pre-leptotene and leptotene (primary) 
spermatocytes, on the inside of the basal lamina. Subsequent spermatocyte
stages (primary (zygotene, pachytene) and secondary) are physically enclosed 
within the Sertoli cell cytoplasm (Ritzén et al, 1989) and undergo meiosis 
(see below). The resulting spermatids move through the cytoplasm of the 
Sertoli cell as they undergo spermiogenesis (see below) (Ritzén et al, 1989). 
During spermiation, immature (immotile) spermatozoa are released into the 
lumen and they collect in the rete testis tubules at the ends of the 
seminiferous tubules. They leave the testis via the efferent ducts, undergo 
maturation in the caput and corpus epididymis (when motility and fertility 
are acquired) and are stored in the cauda epididymis.
Fig. 1.2 Cell types in the testis
Section of testis Cell type Functions
Interstitial tissue Leydig cells Release testosterone and 
oestradiol; under LH control
Seminiferous
tubule
On basal 
lamina
Peritubular
cells
Structural support; release P- 
Mod-S
Sertoli cells Under testosterone & FSH 
control; release ABP & inhibin; 
enclose spermatocytes and 
spermatids
Spermatogonia Undergoing mitosis & 
differentiation
Middle layer Spermatocytes Undergoing
meiosis
Within Sertoli 
cells
Inner layer Spermatids Undergoing
spermiogenesis
Lumen Spermatozoa Immature; progressing to rete 
testis and epididymis
LH, leutinizing hormone; P-Mod-S, peritubular factor modulating Sertoli cells; 
FSH, follicle stimulating hormone; ABP, androgen binding protein;
The blood-testis barrier regulates the passage of substances from the
interstitial compartment of the testis into the lumen of the seminiferous 
tubule and is formed by the joining of Sertoli cells to each other via tight 
junctions (Tindall e( uZ, 1985). Sertoli cells and germ cells are joined by gap
junctions (allowing communication) and desmosomes (providing adherence) 
(McGinley et al, 1979). The germ cells are joined by intercellular bridges 
forming a syncitium (Amann, 1989).
Spermatogenesis
The stages of spermatogenesis are outlined in fig. 1.3.
Fig. 1.3 Stages of germ cell development
Stage Action Time^ (weeks)
Mouse Rat
Spermatogene­
sis
Mitosis Spermatogonia proliferate 6 - 8 7 - 9
Meiosis Spermatocytes divide 4 - 5 5 - 6
Spermio­
genesis
Spermatids develop through 
condensation of DNA and 
cytoplasmic changes
2 - 3 3 - 4
Maturation Spermatozoa mature in the 
epididymis
1 1 - 2
stages indicated will be affected if treatment is carried out at the specified 
number of weeks before observation; from Trasler et al, 1985; Oakberg, 1957
Spermatogonia are the diploid stem cells from which the male germ 
cells are derived. (In addition, there is a population of reserve spermato­
gonia which generally do not divide.) The process of spermatogenesis begins 
with the synchronous division of a population of A-spermatogonia, through 
intermediate- and B-spermatogonia, into diploid primary spermatocytes 
which undergo meiosis. The first reduction division produces secondary 
spermatocytes each of which contains one homologue of each chromosome 
pair. The second reduction division results in the production of four haploid 
spermatids. Spermiogenesis is the process of morphological change by which 
round spermatids become spermatozoa with a head (containing highly 
condensed DNA), a tail and minimal cytoplasm.
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At a given timepoint, there will be several populations of germ cells 
(each population at a different stage of development) in a particular zone of 
the seminiferous epithelium. A defined number of such zones exists for 
which the pattern of germ cell stages is characteristic. The time difference 
between the germ cell stages within a zone corresponds to the cycle of the 
seminiferous epithelium; the time for the completion of spermatogenesis 
(spermatogonia to spermatozoa) is four to five times the length of this cycle. 
[Amann, 1989; Parvinen, 1982]
Hormones
The testis is involved in the endocrine system, being controlled by, 
and controlling through, the action of hormones.
Leydig cell function is under the control of leutinizing hormone (LH), 
which is secreted by the anterior pituitary in response to gonadotrophin 
releasing hormone (GnRH) from the hypothalamus. Both testosterone and 
oestradiol produced by the Leydig cells act upon both the hypothalamus and 
the anterior pituitary in negative feedback loops.
The junctions between the Sertoli cells which form the blood-testis 
barrier give these cells the property of polarity. Secretions may, therefore, 
be made either into the lumen of the seminiferous tubule or into the inter­
stitial compartment. Communication with the rest of the body via hor­
mones is made through this interface. Sertoli cell function is under the con­
trol of follicle-stimulating hormone (FSH) from the anterior pituitary and 
testosterone from the Leydig cells. Both these hormones are required for 
spermatogenesis and are controlled by inhibin, produced by the Sertoli cells, 
which acts upon the anterior pituitary in a negative feedback loop, and 
activin, which acts in a stimulatory manner.
In addition, there are many local controls which operate between the 
different cell types in the testis, some of which are described in section 5.1. 
[Amann, 1989]
F ertilization
Aspects of mating behaviour which may be affected by xenobiotics are 
beyond the scope of this thesis. The process of fertilization is dealt with in 
section 3.1.
E m bryogenesis
The process of embryogenesis can be divided into two phases: pre- and 
post-implantation. The stages of embryogenesis are outlined in fig. 1.4.
Pre-implantation development
Immediately after fertilization, the two haploid genomes are 
‘reprogrammed’ and replicated (under oocyte control) in preparation for the 
first cleavage division, a process which takes 24 h (twice the normal cell- 
cycle time) in mouse embryos. In the 2-cell embryo, the embryonic genes 
take over the control of cell division. After the first three cell divisions, the 
8-cell embryo becomes polarized prior to differentiation and the formation 
of the blastocyst. Differentiation begins as the blastocyst forms: it comprises 
a trophectoderm, which becomes the placenta, and an inner cell mass, which 
becomes the organism itself, after implantation. [Pratt, 1989]
During the pre-implantation period, the susceptibility of the embryo 
to chemicals is such that they will either be able to repair damage or will 
die, hence the likelihood of inducing malformations is low (but see section 
1.2).
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Post-implantation development
A few days after implantation, organogenesis (days 8 - 15 in rats) 
begins at the egg cylinder stage with the formation of the primitive streak 
and head fold. The first somites appear prior to the commencement of the 
yolk-sac and allantoic circulation, and the hind limb buds form (at day 12 in 
rats). The final sequence of events is the formation of the limbs, tail and 
digits. Throughout organogenesis there is a substantial growth in embryo­
nic size.
All systems undergo a crucial stage of development during the 
organogenesis period and hence, susceptibility to toxic insult is high at this 
time with the likely outcome being major morphological defects.
Subsequent to the initiation of the major systems, further growth and 
development continues (particularly of the central nervous system in 
humans) up until birth. During this latter stage, embryos are less 
susceptible to the action of toxic chemicals and the likely outcome of such 
exposure would be physiological or minor morphological defects. [New, 1978; 
Harbison, 1978]
Fig. 1.4 Stages of embryogenesis
Stage Time (days)
Mouse Eat Human
Feitilization 1 1 1
Implantation 4 5 6
Organogenesis 6 -  12 8 - 15 15 - 43
Birth 19 21 267
from New, 1983
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1.2 REPRODUCTIVE TOXINS
Chemicals may mediate their effects on the reproductive system in 
various ways. Some will require metabolic activation and the sequence of 
events which ensues will be dependent upon the particular target site.
M ediators o f tox ic  action
There are many ways in which toxins may act on the reproductive 
system. Of particular relevance here are the mechanisms by which oxygen 
radicals may be produced and may act, the induction of membrane damage 
and the effects this may have, and genotoxic events which may be mediated 
by chromosomal mutation.
Oxygen radicals
The cells of aerobic organisms require oxygen, by definition. The 
reduction of molecular oxygen normally results in the production of water, 
but some enzymes allow its divalent reduction to hydrogen peroxide (HgOg) 
(Fridovich, 1989; Halliwell, 1978). Superoxide anion radicals (Og"') may also 
be generated during the metabolism of oxygen by univalent reduction, or 
from the electron transport chain or autoxidation (Halliwell, 1984; Fridovich, 
1989). The reaction of certain oxidases may also result in the production of 
oxygen radicals as in the conversion of xanthine (X) to uric acid by xanthine 
oxidase (XO) (see fig. 1.5) (Phillips eZ uZ, 1984). There are two pathways by 
which XO may oxidize X (Fridovich, 1970). The one involving the divalent 
reduction of oxygen, resulting in the production of HgOg, predominates under 
physiological conditions; approximately 20 % of the oxidation occurs by the 
univalent reduction of oxygen producing Og " (Fridovich, 1970).
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Fig. 1.5 Oxygen radical reactions
xanthine
oxidase
xanthine — »• uric acid
Oj-
superoxide
dismutase
O g"' +  O 2"' + 2 H+ —  ^ HgOg +  O2
+ O 2"' +  H2O2 — + O2 +  OH' +  H2O
Haber-Weiss reaction
from Halliwell, 1984; Phillips et al, 1984
Many toxins are known to produce their effects through the action of 
free radicals, which are highly reactive due to their possession of an 
unpaired electron (Slater, 1984), although not all xenobiotics which generate 
oxygen radicals mediate their toxic effects through them (Halliwell & 
Gutteridge, 1988). This high reactivity gives them great potential for 
damaging biological systems: they are known to react with lipids, DNA and 
proteins, thereby causing membrane damage, mutation and enzyme 
inhibition (Slater, 1984). The interaction of oxygen radicals with DNA can 
cause cytotoxicity in addition to mutation (Halliwell & Grooteveld, 1987). 
This may lead to a series of other radical-mediated reactions, including lipid 
peroxidation (Halhwell & Gutteridge, 1988).
One mechanism for the toxicity of ethanol, depending upon the 
pattern of exposure and the metabolic route, is by the production of oxygen 
radicals (Cederbaum, 1989; Fridovich, 1989). This could occur through
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depletion of glutathione, via cytochrome P-450 oxidation producing free rad­
icals or by cytochrome P450IIE1 catalysis of the Haber-Weiss reaction 
(Cederbaum, 1989). Alternatively, ethanol may be metabolized by alcohol 
dehydrogenase (ADH) or by cytochrome P-450 monooxygenases to produce 
acetaldehyde (Fridovich, 1989). Acetaldehyde may then be oxidized, giving 
rise to oxygen radicals in a reaction catalysed by XO or aldehyde oxidase 
(Fridovich, 1989).
Some chemicals may be reduced to form free radicals, as catalysed by 
XO or nicotinamide adenine dinucleotide phosphate (reduced form) 
(NADPH)-cytochrome P-450 reductase, during the process of redox cycling 
(Juchau et al, 1985). Og " may subsequently be produced through the 
reaction of oxygen with these free radicals. Reduced glutathione may 
thereby be depleted (through its glutathione peroxidase-catalysed reaction 
with hydrogen peroxide; Halliwell, 1984), lipid peroxidation initiated and 
hydroxyl radicals (OH*) produced via HgOg (Halliwell & Gutteridge, 1988).
Og’* is a relatively long-lived radical (Halliwell, 1978) and is not as 
reactive as OH*; it is the latter which is believed to be responsible for many 
of the toxic effects of oxygen (Halliwell & Gutteridge, 1984b). The Haber- 
Weiss reaction occurs between Og“* and HgOg, resulting in the production of 
OH*, a reaction which is dependent upon the presence of metal ions as a 
catalyst (see fig. 1.5) (Halliwell & Gutteridge, 1984b) [but see below under 
‘Metabolism’ In  situ’].
Some disease states are associated with an increase in lipid peroxid- 
ation (Halliwell & Gutteridge, 1984a), which is initiated by the removal of 
a hydrogen atom from a lipid by a free radical (e.g. OH*; Halliwell, 1984) 
(Halliwell & Gutteridge, 1984b). Subsequently, the resulting lipid radical 
reacts with molecular oxygen producing a hydroperoxy radical, which is itself 
capable of removing a hydrogen atom from a lipid (Halliwell & Gutteridge,
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1984b). Further reactions result in the production of lipid hydroperoxides 
(Halliwell & Gutteridge, 1984b). Polyunsaturated fatty acids (i.e. those with 
many double bonds) are the most susceptible to lipid peroxidation 
(Rosenblum et al, 1989).
Lipid peroxidation occurs at a high rate in the testis (Kornbrust & 
Mavis, 1980) and may be increased by ethanol (Anderson & Wilhs, 1981). 
Damage to the Leydig cells (e.g. by ethanol) may disrupt reproductive 
function through a decrease in testosterone production (Rosenblum et al, 
1989).
Human sperm produce Og'* and HgOg through the action of an 
NADPH-oxidase bound to the sperm membrane (Aitken & Clarkson, 1988). 
The high lipid content of sperm renders them susceptible to lipid 
peroxidation (Abel & Lee, 1988; Jones & Mann, 1977a,b) and HgOg has been 
found to disrupt sperm motility and fertilizing ability (Aitken & Clarkson,
1988). If a treatment kills a large number of sperm, the release of free 
radicals as they degrade may prevent fertilization by the surviving sperm 
(Moore, 1988).
Og’* has been reported to kill and induce mutations in Chinese 
hamster ovary (CHO) cells in culture (Cunningham & Lokesh, 1983) and 
also to induce chromosome aberrations and sister chromatid exchanges 
(SCEs) in human lymphocytes (Emerit uZ, 1982). However, Phillips aZ 
(1984) found that although Og"* was directly responsible for the chromosome 
aberrations induced in CHO cells, its conversion to HgOg was necessary for 
the induction of SCE or mutation.
Membrane formation occurs at a high rate in the developing embryo 
(lannaccone, 1986). Each cleavage division of the pre-implantation embryo
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requires substantial synthesis of cell membrane since surface area increases 
by one third each time (Pratt, 1989). The high lipid (unsaturated fatty acid) 
content of membranes means that they are susceptible to the initiation of 
lipid peroxidation through the interaction of oxygen radicals produced by 
various toxins (see above; Rosenblum et al, 1989; Halliwell & Gutteridge,
1988). Thus, lipid peroxidation is one possible mechanism for 
embryotoxicity (lannaccone, 1986).
Rosenblum et al (1989) have suggested that ethanol promotes lipid 
peroxidation in the membranes of cells of both liver and testis (Leydig cells). 
The pathological effects observed in the testes of animals treated chronically 
with ethanol could be attributed to such effects on membranes (Rosenblum 
et al, 1989). In the liver, acetaldehyde-induced lipid peroxidation may be 
responsible for the membrane damage observed after ethanol treatment 
(Lauterberg & Bilzer, 1988; Brunt, 1988).
The membrane is an important spermatozoal feature enabling it to 
undergo the acrosome reaction and fusion with the zona pellucida (Bleil & 
Wassarman, 1983). Sperm membranes have a high lipid content in order to 
maximize fluidity (Aitken, 1989a). Lipid peroxidation in sperm may make 
a significant contribution, through membrane damage, to male infertility 
(Aitken, 1989a).
The ability of a chemical to cross membranes has an influence on its 
ability to cause cell damage (Juchau et al, 1985).
CAro/noso/Tic da/Tzage
In humans, chromosome anomalies may theoretically be studied in 
newborns, spontaneous abortions, blastocysts or gametes (Houghton & 
Tomkins, 1982). It has been reported that up to 50 % of human conceptuses 
and 0.5 % of live births carry a chromosome anomaly (Holden, 1982). In one 
of the chromosome deletion syndromes known in humans (Prader-Willi
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syndrome) it is the paternal chromosome which is usually broken and it is 
possible that this may be associated with chemical exposure (Cassidy et al, 
1989).
The most frequent cause of embryolethality in experimental animals 
is a chromosomal abnormality (Auroux & Dulioust, 1985) and it has been 
shown that chemically-induced post-implantation loss may be caused by 
chromosome aberrations (Brewen et al, 1975). Only cells carrying minor 
chromosomal abnormalities could be expected to complete meiosis, therefore 
any chromosome aberrations which are found in offspring must either be 
slight or have resulted from post-meiotic exposure. Alternatively, dominant 
gene mutations of incomplete penetrance may be observed (Lyon & 
Renshaw, 1988), and it is possible that such mutations may contribute to 
pleiotropic phenotypes (such as size or intelligence) which may only be 
measurable in a population, rather than an individual.
Meiosis may be impaired through chromosome pairing failure in cells 
which carry a translocation (Setterfield et al, 1988), a fact that is used in the 
heritable translocation test in which male sterility is the endpoint measured 
(UKEMS, 1990; Lyon & Meredith, 1966). Different translocations have 
different impacts on meiotic breakdown, and male and female gametogenesis 
may not respond in the same way (Setterfield et al, 1988). Germ cells 
containing numerical or large structural chromosome aberrations will 
probably have originated during, rather than before, meiosis since the 
division process would be expected to eliminate them. Ethanol was found 
to cause numerical chromosome aberrations in spermatogonia, primary 
spermatocytes (Alvarez, 1985) and secondary spermatocytes (Hunt, 1987).
Many chromosome mutations may be missed by the dominant lethal 
test but can be detected by chromosomal analysis of the first cleavage 
metaphase (Matsuda eZ aZ, 1989c). DNA-damaging agents, such as X-rays, 
which act upon male gametes may induce chromosome aberrations that can
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be visualized in the pronucleus after in vitro fertilization (Matsuda et al, 
1989a). Ornaghi & Giavini (1989) have found that micronuclei can be 
induced in pre-implantation embryos by CP. It has been shown that 
methylmethane sulphonate (MMS) induces post-meiotic chromosome 
damage in mice which results in chromatid aberrations in 1-cell embryos and 
correlates with the observed increase in dominant lethality (Brewen et al, 
1975).
M etabolism
Metabohc activation is necessary in order for the toxic potential of 
most chemicals to be realized; this often involves the formation of free 
radicals (Slater, 1984). Such free radicals may arise as intermediates in 
reactions catalysed by cytochromes P-450 and NADPH found in the hver and 
other organs (Slater, 1984).
In situ
The site of metabolism of a xenobiotic compound has a role in 
determining the site of toxicity. Many chemicals are metabolized in the 
liver, indeed this organ is the major site of metabolism, and such 
metabolism may give rise to toxic products. Their toxicity at an 
extrahepatic target site is then dependent upon transport. By contrast, 
chemicals which are metabolized by the cells of the target organ are already 
in a position to exert their toxicity. Such metabolism may be different, since 
a different array of enzymes may be present (Juchau uZ, 1985).
The metabolic capacity of Sertoli cells is known to be important in the 
energy requirement of germ cells since the latter utilize lactate produced 
from glucose by the former (Grootegoed uZ, 1989). In the antioxidant 
defence of germ cells, synthesis of glutathione by Sertoli cells may be
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important since the former have a high glutathione content but a low 
capacity for its synthesis (Grootegoed et al, 1989). Thus, since Sertoli cells 
are known to have metabolic capability, it is possible that toxic action may 
be mediated in situ (Foster et al, 1987).
Reactive metabolites generated in the liver are unlikely to reach the 
testis (Working, 1989), whereas those generated in the Sertoli cell are 
immediately available to cause the observed toxicity (Foster et al, 1987). In 
the case of 1,3-dinitrobenzene (1,3-DNB), it was not the ultimate products 
of nitroreduction that proved to be toxic, but intermediates of the pathway: 
thus, in situ metabolism was essential for toxicity (Foster et al, 1987). It is 
possible that oxidation of ethanol in the testis (Anderson et al, 1985) 
increases its damaging effect over that which would be expected from 
measurements of its penetration into the tubules (Salonen & Eriksson,
1989).
In the testis, benzo[a]pyrene and 7,12-dimethylbenz(a)anthracene 
may be metabolized via a cytochrome P-450 mechanism present in the 
microsomes (Georgellis et al, 1988). This system may result in the 
production of Og'* within the testis (Georgellis et al, 1987) and testosterone 
production has been shown to be inhibited by free radicals in Leydig cells in 
vitro (Myers & Abney, 1988).
Acrolein, one of the metabolites of CP, has been reported to have had 
a contrasting effect on rat post-implantation embryos in culture: when added 
directly to the medium it was harmless but when generated through 
embryonic metabolic activity it was embryotoxic (Mirkes nZ, 1984). The 
transformation of chemicals into toxic metabolites within the embryo itself 
means that its susceptible targets are much more likely to be affected (Filler 
& Lew, 1981).
Since their high reactivity means that they do not diffuse far (Slater,
1984), generation of oxygen radicals Z/i sZZi/ greatly increases their damaging
17
capacity (e.g. Og’* generated in membranes, Halliwell & Gutteridge, 1984b; 
HgOg in sperm membranes, Aitken, 1989).
Cytochrome P-450s
The cytochrome P-450 system provides the terminal oxidase of 
microsomal mixed-function oxygenase reactions and performs bioactivation 
(Connors, 1978). There are numerous families of cytochrome P-450 
enzymes, which may perform oxidations of xenobiotics (Parke, 1987; Juchau 
et al, 1991). Many of the cytochromes of the P-450I family produce reactive 
metabolites leading to toxicity whilst many of the P-450IIB family produce 
metabolites with oxygen in an accessible position leading to detoxication 
through conjugation (loannides et al, 1984). Activation, but not detoxication, 
may also be performed by flavoprotein monooxygenases (Parke, 1987).
The involvement of P-450 in the metabolism of ethanol is a possible 
source of oxygen radicals, and indeed such metabolism has been 
demonstrated to occur in a particular strain of deermouse which has a 
deficiency of ADH (Knecht et al, 1990). Cytochrome P-450 is involved in the 
initial step in the metabolism of CP, producing hydroxy-CP (Mirkes et al,
1981). CP is bioactivated to its toxic metabolites by a P-450-dependent 
monooxygenase system (Hales, 1982).
Cytochrome P450IIE1 is a hepatic P-450 protein induced by ethanol 
and known to have a high oxidase activity (Tindberg & Ingelman-Sundberg,
1989). It is therefore probable that it will be involved in lipid peroxidation, 
since it is known that the toxicity of oxygen may be mediated through an 
increase in the oxidase activities of cytochromes P-450 and by an increased 
level of P-450s (Tindberg & Ingelman-Sundberg, 1989).
The majority of cytochrome P-450 is hepatic, although most tissues 
have some (in Slater, 1984). Cytochromes P-450 act as monooxygenases and 
also convert oxygen to water in mixed function oxidase reactions in
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conjunction with NADPH (Tindberg & Ingelman-Sundberg, 1989). Such 
activity is capable of producing Og'* and initiating lipid peroxidation 
(Ekstrom & Ingelman-Sundberg, 1984).
Maternal and embryonic
The metabolic capability of the embryo plays an important role in the 
mediation of toxicity in utero (Filler & Lew, 1981). Post-implantation 
embryos are known to have the capacity for such metabolic transformation, 
involving cytochrome P-450, although at a much lower rate than in adult 
animals (Juchau et al, 1985), and pre-implantation embryos have also been 
shown to have this capability (Filler & Lew, 1981). The mixed-function 
oxidase system is known to have become active in mouse blastocysts, since 
benzo[a]pyrene metabolites were identified in their culture medium (Filler 
& Lew, 1981). Cytochrome P-450-dependent metabolism of benzo[a]pyrene 
occurs in mouse embryos at day IV2 and the extent to which this occurs is 
dependent upon the genetic constitution of the embryo (Galloway et al, 
1980).
Fantel et al (1985) showed that cultured rat embryos were able to 
bioactivate adriamycin to a certain extent and (not surprisingly) that this 
activation could be greatly increased by the addition of a metabolizing 
system to the culture. Phenytoin was found to be teratogenic to cultured 
mouse post-implantation embryos: again there was an involvement of 
embryonic cytochrome P-450 metabolism, and an increased effect was 
observed in the presence of an exogenous source of cytochrome P-450 
(Shanks et al, 1989). Similarly, both CP and 2-acetylaminofluorene (AAF) 
did not have a damaging effect on embryos unless a cytochrome P-450- 
dependent monooxygenase system was provided either maternally or with 
S-9 (the post-mitochondrial 9000 g supernatant of a rat liver homogenate),
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induced by phénobarbital or 3-methylcholanthrene respecitvely, in the 
culture medium (Juchau et al, 1985; Faustman-Watts et al, 1986).
In contrast to the reports of a lack of effect of certain chemicals on 
embryos in vitro, that are known to have an effect in vivo, Khera (1989) 
found that ethylene thiourea induced malformations in day 10 rat embryos 
in vitro but not in vivo, a discrepancy that may be due to a lack of maternal 
detoxication. Pre-implantation embryos, whilst being capable of metabolic 
activation, may lack detoxication systems (Filler & Lew, 1981). 
Embryogenesis generally mirrors evolution in that the activation systems (P- 
4501) become functional before the detoxication systems (P-450IIB) (Lum et 
al, 1989; Parke, 1984). Juchau et al (1991) have shown that cytochrome 
P450IA1 was active in rat embryos during organogenesis and brough about 
embryotoxicity through metabolism of AAF.
In vitro
In order for the toxicity of certain chemicals to be mediated in vitro, 
it is essential that a metabolizing system is present in the culture medium. 
Alternative approaches include the incorporation of S-9 or hepatocytes in the 
culture system (Kasper et al, 1990). This permits the investigation of the 
effects of metabolic activation (or detoxication) with any potential xenobiotic. 
In order to determine which metabolite mediates the toxic effect, it is 
sometimes possible to test the pre-synthesized, known metabolites 
individually in vitro (Moore, 1986).
Foster eZ uZ (1987) tested a series of known Z/i uZuo metabolites of 1,3- 
DNB in Sertoli cell cultures. The fact that these had no toxic effect, 
whereas the addition of the parent compound caused germ cell detachment 
was taken by Foster et al (1987) to indicate that it was the process of 
metabolism itself which had the damaging effect, although Working (1989) 
concluded that it was the parent compound itself that was toxic (see section
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5.4). Other systems for which this approach has been described are mono- 
(2-ethylhexyl) phthalate (MEHP) metabolites in Sertoli cell cultures, none 
of which were as toxic as the parent compound (Gray, 1986), and CP 
metabolites in cultured post-implantation embryos (Mirkes et al, 1981) (see 
section 2.1).
Toxic effects
It would be expected that cells that are rapidly dividing would be 
particularly susceptible to the toxicity of exogenous agents since many 
complex processes are occurring, the disruption of any one of which would 
result in disorganization. Thus, embryos and male germ cells provide 
obvious targets for toxicity.
Teratogenic effects
A teratogenic event is one which causes the malformation of an 
embryo. It may occur through damage to a key population of embryonic 
cells, leading to the disruption of a particular developmental sequence. 
Cytotoxicity may cause teratogenicity even when the xenobiotic is a 
mutagen (Brent & Beckman, 1990). A threshold exposure would be 
expected for this type of event, below which there is no risk of teratogenicity 
(Giavini, 1988; Brent & Beckman, 1990).
The effect of a chemical on an embryo is dependent upon the time at 
which the embryo is exposed (Harbison, 1978). Teratogens may act 
specifically at a particular stage of embryonic development, with 
organogenesis generally considered to be the most sensitive period (Brown,
1985). This is illustrated by the increased incidence of neural tube defects 
elicited by 7-hydroxy-2-AAF or valproic acid in early compared with late 
post-implantation embryos (Harris uZ, 1988). Brown aZ (1979) have
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suggested that growth inhibition at organogenesis is responsible for the mal­
formations induced in embryos by maternal ethanol consumption.
A rapid transfer of both CP (or its metabolites) and methylnitrosourea 
(MNU) into pre-implantation embryos has been demonstrated (Vogel & 
Spielmann, 1989; Vogel et al, 1989). Gaylor et al (1988) have suggested that 
the earlier in embryonic life a teratogen acts, the more likely it is that an 
effect on a single cell will be teratogenic. However, it is generally believed 
that the pre-implantation embryo is a less sensitive target for teratogenicity 
than the post-implantation embryo (Brown, 1985). If a moderate number 
of cells are killed (by CP or MNU) in the (mouse) pre-implantation embryo, 
these may be replaced at the next cell cycle; the killing of a large number 
will result in embryolethality (Vogel et al, 1989). The growth of mouse 
embryos exposed in utero to mitomycin C prior to organogenesis was 
inhibited but full recovery, in terms of size, was possible by day 14 of 
gestation (Snow, 1983).
In one of the few studies in which teratogenicity has been induced by 
treatment of pre-implantation embryos, Spielmann et al (1989) found that 
the teratogenic dose of MNU required was ten times higher at the pre- than 
at the post-implantation stage (although still much lower than that required 
to produce toxicity in adult animals). Conversely, Zusman et al (1989) 
observed that cultured pre-implantation embryos were more sensitive than 
early post-implantation embryos to the inhibition of development and 
differentiation by ‘serum factors’ present in the serum from diabetic 
patients.
It is to be expected that toxicity at a particular stage of organogenesis,
when a particular organ(s) is undergoing development, will result in a 
characteristic malformation(s) (Spielmann et al, 1989). However, earlier in 
embryogenesis, before differentiation of cells (i.e. in the pre-implantation
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embryo), the pattern of embryotoxicity and/or malformation will be less 
predictable (Spielmann et al, 1989).
Damage to the yolk-sac, rather than direct damage, may cause 
embryotoxicity (Juchau et al, 1985). This could occur with chemicals that 
are unable to cross cell membranes.
Ge/zeZZc
Certain aspects of reproductive toxicology overlap with aspects of 
genetic toxicology. Although no chemical has been found which can mutate 
germ cells exclusively (Adler & Ashby, 1989), it is still considered important 
to investigate this possibility since, in the human population, the 
consequences would be serious.
A genetic effect may be manifested at any stage of the reproductive 
cycle, thereby causing infertility, pre-implantation loss, malformation in post­
implantation embryos or abnormalities in the offspring. Genetic damage can 
be induced as late in the development of male germ cells as epididymal 
maturation (when sperm DNA is highly compact). Trasler et al (1985) found 
that CP caused an increase in post-implantation loss in rats just one week 
after treatment began.
The relationship between genotoxic and teratogenic events has been 
investigated by Novotna & Jelinek (1990) using chick embryos. They have 
shown that genotoxic damage caused by CP treatment (and measured as 
chromosome aberrations) can lead to developmental defects through cell 
cycle delay and cell death. CP is mutagenic through the alkylating action 
of one of its metabolites, phosphoramide mustard, on DNA: it is possible 
that a similar mechanism induces its teratogenic effects (Mirkes eZ uZ, 1984).
Direct chemical teratogenicity may be influenced by the genotype of 
the embryos, for example, benzo[n]pyrene induced different developmental 
defects in two different strains of mice (Russell, 1979). Auroux eZ aZ (1990)
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have suggested that particular systems (e.g. the nervous system) may have 
an increased likelihood of being affected by mutations.
Mutation may result from an effect on a single cell; the risk of a 
mutation occurring in an organism decreases with exposure level, but is 
always present (Brent & Beckman, 1990). However, it is conceivable that 
mutagenic events also have a threshold dose, since protective mechanisms 
have a certain limited capacity (Gaylor et al, 1988).
The induction of minor effects in many offspring is perhaps more 
likely than the induction of major effects in a few offspring (e.g. Auroux et 
al, 1990; CP in rats). Many phenotypic features (e.g. size) are determined 
by the interaction of many genetic and environmental factors and a 
mutation in one of these genes would not necessarily be immediately 
obvious. Experimental evidence for the induction of minor effects is more 
difficult to obtain than for the induction of major effects. An example of 
such a study is that carried out by Johnson et al (1990) in which detailed 
measurements of individual bones of the offspring of mice after paternal 
ethylnitrosourea treatment, revealed an increased incidence of variants 
which may have been due to this type of mutation.
Rqorodf/cZZæ e/yècZs
Other manifestations of reproductive toxicity include testicular 
dysfunction and reduction in fertilizing ability. Although infertility may 
result from genetic events it may also arise through toxicity at other stages.
Spermatogenesis may be disrupted through the indirect action of a 
toxin on one of its control processes. The testis may be affected directly or 
indirectly through the disruption of hormonal action (Chapin & Phelps,
1990). Spermatogenesis may be disrupted in such a way that sperm 
production is decreased or damaged sperm are produced (Amann, 1989).
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Ethanol exerts its effect initially on Leydig cells (Rosenblum et al, 
1989), thus causing hormonal disruption, before damage to sperm (Anderson 
et al, 1980b). Acetaldehyde was found to have no effect on sperm 
morphology or sperm number in mice (Lahdetie, 1988). Disruption of 
energy metabolism by uncoupling oxidative phosphorylation is caused by 
gossypol and causes its antifertility effect (Reyes et al, 1986).
1.3 OBJECTIVES
Three main areas of investigation in reproductive toxicology have 
been covered.
In vitro system s
In vitro systems have been developed in reproductive toxicology in 
order to better understand mechanisms of action and to attempt to reduce 
animal distress. Post-implantation embryos have been cultured from rats 
and treated in vitro (chapter 2). Fertilization and pre-implantation embryo 
development have been observed in mice in response to ethanol treatm ent 
Z/i uZuo or uZZro (chapter 3). Sertoli/germ cell cultures have been set up 
from rats and treated uZZro in a dual-compartment system incorporating 
hepatocytes to provide metabolic activation (chapter 5).
M ale-m ediated effects
Many toxic chemicals are known to affect the male reproductive 
system (Bernstein, 1984). in  uZZro fertilization techniques have been used
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to study the action of ethanol in inducing male infertility (chapter 3). An in 
vivo study was required in order to investigate the induction of mutations 
in germ cells. The offspring of CP-treated male rats were examined as 
adults for tumours, malformations and chromosome anomalies (chapter 4). 
The effects of phthalate esters, antifertility drugs and oxygen radicals have 
been measured in Sertoli/germ cells in a dual-compartment culture system 
(chapter 5).
O xygen rad icals  
and an tioxidan ts
Many toxins are known to produce their effects through the action of 
active oxygen species and in vitro systems may be used to investigate their 
action. The X/XO system has been used to generate in cultures of post- 
implantation rat embryos (chapter 2) and cultured rat Sertoli/germ cells 
(chapter 5). The protective effects of L-ascorbic acid and DL-a-tocopherol 
have also been investigated in these systems.
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CHAPTER 2
PROTECTION OF CULTURED POST­
IMPLANTATION RAT EMBRYOS FROM 
THE ACTION OF XANTHINE AND 
XANTHINE OXIDASE USING L-ASCORBIC 
ACID AND DL « TOCOPHEROL
2.1 INTRODUCTION
The human foetus in utero is one of the most widely recognized 
targets in reproductive toxicology with foetal alcohol syndrome being, 
perhaps, the best known example (Lancet, 1983). The development of in 
vitro procedures is an important area in toxicological research, allowing 
direct treatment with toxic chemicals and close examination of the 
mechanisms by which they may act. This chapter deals with the use of 
post-implantation rat embryo culture as a means of investigating mechan­
isms of teratogenesis.
The post-im plantation  em bryo  
as a  target for tox ic ity
Animal models are used for toxicity testing and research in the field 
of teratogenicity: pregnant females are treated with the chemical under 
investigation and their embryos examined for teratogenic effects. Brent & 
Beckman (1990) concluded that since it is unlikely that a ‘placental barrier’ 
will be present in one species and not in another, with respect to a 
particular chemical, the use of such animal models provides useful data for 
the assessment of risk to humans. However, there are exceptions to this 
‘rule’ (e.g. thalidomide; Anderson, 1988) and the magnitude of teratogenic 
effect may be species-dependent (Harbison, 1978; Wilson, 1977).
New (1983) has pointed out that the potential for the utilization of 
embryo culture techniques lies in the possibility for both manipulation of 
the environment and close observation of the embryo.
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Maternal effects
Chemicals acting on post-implantation embryos in utero have been 
transported across the placenta via the maternal blood stream. Chemicals 
vary in their ability to cross the placenta, according to their molecular 
weight, lipid affinity, polarity and protein binding (Brent & Beckman, 1990). 
A chemical’s teratogenic potential may either have been increased or 
decreased by maternal metabolism by the time it reaches the embryo. Any 
study in which the effects of chemicals on post-implantation embryos in 
vitro are to be measured, therefore requires knowledge of the metabolites 
which are likely to be formed.
Faustman et al (1989) found that while the developmental toxicity of 
various alkylating agents was qualitatively similar in vivo and in vitro, their 
relative potency was different. The teratogenic effects of cyclophosphamide 
(CP) in vivo are dependent upon bioactivation through maternal cytochrome 
P-450: this chemical induced teratogenic effects in vitro only if an exogenous 
source of cytochrome P-450 was added to the culture medium (Greenaway 
et al, 1982). Direct treatment with the toxic metabolite of CP, phosphor­
amide mustard, produced similar in vitro teratogenicity to that produced by 
CP with cytochrome P-450 from S-9 (Mirkes et al, 1984; Greenaway et al,
1982).
Although the teratogenicity of phenytoin was found to require an 
exogenous source of cytochrome P-450 (maternally in vivo or added to the 
culture medium in vitro), some activation of the compound was found to 
occur by the embryos themselves leading to growth inhibition (Shanks eZ 
al, 1989). Dimethoxyethyl phthalate is teratogenic in rats in vivo due to its 
metabolism to methoxyacetic acid in the maternal compartment (Yonemoto 
et al, 1984). In vitro treatment with dimethoxyethyl phthalate had no 
effect, whereas treatment with the secondary metabolite, methoxyacetic
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acid, caused a similar teratogenic effect to that seen in vivo with 
dimethoxyethyl phthalate (Yonemoto et al, 1984).
However, embryos in utero may be indirectly affected by maternal 
toxicity, whereas embryos in vitro can only be affected directly by the agents 
added to the culture medium.
Reproductive toxicology
The flowchart in fig. 1.1 shows the inter-relationship between targets 
for reproductive toxicity. The development of the post-implantation embryo 
can be affected by events earlier in the reproductive process (which may be 
genetic effects mediated by mutation), or by the direct action of toxins on 
the embryo.
In the latter case, a genetic predisposition may influence the response 
of an embryo as has been seen in the differential ethanol embryotoxicity 
between two strains of mice (Gilliam et al, 1989). Seller & Perkins-Cole 
(1987) found a sex difference in the rate of embryonic development of 
untreated mice. This may indicate that sex-linked genetic control exists and 
could lead to differential sensitivity to teratogens.
Essentially, however, the teratogenic effects observed after the direct 
action of toxins on the embryo can be considered ‘reproductive’ rather than 
‘genetic’, as discussed in section 1.2. This is an important area for research 
and testing since, although the cause of most human birth defects (60 - 70 
%) remains unknown, few of the remainder are found to have a genetic 
origin, with factors such as maternal exposure to drugs and chemicals, and 
maternal infections and diseases making a meyor contribution (Brent & 
Beckman, 1990).
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O xygen rad icals as 
m ediators o f tox ic  in su lt
As discussed in section 1.2, many chemicals mediate their toxic effects 
via the production of active oxygen species. It is feasible that oxygen 
radicals may be generated during embryonic metabolism.
In vivo teratogens
Using an animal model of foetal alcohol syndrome, exposure of 
pregnant rats to ethanol has been shown to cause neural tube defects in 
embryos (Ross & Persaud, 1989). The toxicity of ethanol may be mediated 
through increased lipid peroxidation and the production of active oxygen 
species (Cederbaum, 1989). Ionizing radiation is known to cause the 
production of oxygen radicals (Slater, 1984) and exposure of pregnant rats 
to X-rays has been shown to cause embryolethality and malformations and 
to inhibit embryonic growth (Brent, 1971). It is also possible that the 
clastogenic effects observed in mouse pre-implantation embryos 
transplacentally-treated with CP are mediated by oxygen radicals (Kola et 
nZ, 1989).
In vitro teratogens
Direct exposure of cultured rat embryos to ethanol results in a 
reduction of growth and differentiation (Brown et al, 1979). Mutoh et al 
(1990) have shown that damage to cultured rat mucosal cells by ethanol is 
brought about by the action of oxygen radicals. It is, therefore, possible that 
its embryotoxicity is mediated via the same action. Free radical metabolites 
of 2-acetylamino fluorene (AAF) were shown to cause certain types of 
embryonic malformation in rat embryos in vitro (Faustman-Watts et al,
1986). The direct action of peroxides on chick embryos in vitro has been
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examined by Korhonen et al (1984). They found malformations and 
embryolethality at a moderate frequency after exposure to these free 
radicals. Oxygen radicals formed by the action of xanthine (X)/xanthine 
oxidase (XO) have been shown to have teratogenic effects on post-implant­
ation rat embryos in vitro (Jenkinson et al, 1986).
A natural defence mechanism has been shown to exist in rat embryos 
in that deliberate modulation of the glutathione concentration altered the 
response to teratogens in vitro (Harris et al, 1988) (see section 6.3).
The p rotective e ffects  
o f v itam ins
Vitamin supplementation during pregnancy is an aspect of human 
reproductive medicine which is receiving increasing attention (Smithells et 
al, 1983; Rhoads & Mills, 1986; MRC Vitamin Study Research Group, 1991). 
Several vitamins can act as antioxidants (Machlin & Benedich, 1987).
Vitamin supplementation during pregnancy
Vogel & Spielmann (1989) and Kola et al (1989) found that L-ascorbic 
acid reduced the frequency of chromosome aberrations (but not sister 
chromatid exchanges (SCEs)) and increased viability in pre-implantation 
mouse embryos maternally treated with CP. This action was presumed to 
occur via the antioxidant action of L-ascorbic acid (Kola et al, 1989) 
inhibiting the formation of toxic intermediates (Vogel & Spielmann, 1989). 
No adverse effects were elicited by L-ascorbic acid alone, even at a level of 
1.6 g kg^ (Vogel & Spielmann, 1989). It is only Z/z uZZro that L-ascorbic acid 
has been found to have genotoxic and cytotoxic effects, presumably because 
of the protective mechanisms available in vivo.
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The incidence of orofacial clefts in humans has been shown to be 
reduced by periconceptional supplementation with ‘Spofavit’ (which includes 
vitamins A, B, C and E) plus folic acid (Tolarova, 1982; MRC Vitamin Study 
Research Group, 1991). An increase in DL-a-tocopherol in rat embryos 
subjected to ischaemic distress corresponded to a decrease in Hpid peroxide 
levels in the embryonic tissues, showing that lipid peroxidation had been 
inhibited by DL-a-tocopherol (Iwasa et al, 1990).
Vitamins in vitro
Faustman-Watts et al (1986) found L-ascorbic acid to have a protective 
effect against the abnormalities of flexure (induced by the metabolites of 
AAF) through its action as a radical-trapping agent.
The death of cultured post-implantation rat embryos explanted from 
females fed on a vitamin E-deficient diet was prevented by the addition of 
DL-a-tocopherol to the culture medium (Steele et al, 1974). This confirmed 
a similar effect in vivo and suggested that the vitamin can act directly on 
the embryo without modification by maternal metabolism.
Kinking of the neural tube and abnormal turning was observed in 
embryos cultured in vitro in folic acid-deficient serum (Miller et al, 1989) 
showing that this vitamin is essential for their normal development.
The cu lture system
The method used for the culture of post-implantation rat embryos is 
a modification of that developed by New (1978) and is described in detail in
section 2.2.
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Culture conditions
The culture medium used comprised 75% rat serum and 25% tissue 
culture medium, cultures were supplied with oxygen and rotated during 
incubation: these conditions provided an environment which closely 
mimicked that found in vivo (New, 1978). The gassing regimen provided 
oxygen which diffused through to the embiyo. It has been found that there 
is an optimum oxygen level at each stage of development and that 
teratogenicity can result from too much or too little (Miki et al, 1988). The 
O2/CO2/N 2 mixtures used were administered to all culture bottles 
simultaneously through a multi-outlet tubing system thus reducing the 
possibility of the production of false positives.
Experimental design
Experimental design was such that the possibility of bias due to the 
litter of origin of the embryos was eliminated. Embryos were evenly 
assigned to the various treatment groups; random assignment could, by 
chance, have resulted in an unbalanced distribution.
The results of several experiments were pooled for the final analysis, 
so it was ensured that a negative control (X only) and a positive control 
(X/XO) were included in each experiment.
Scoring
The scoring system used was a simplified version of that described by 
Brown & Fabro (1981): growth parameters were measured (in order to 
ascertain developmental progress) and morphological changes noted (in 
order to assess the induction of malformations). Morphological scoring in 
the study presented in this chapter was performed by classifying 
abnormalities of the neural suture into categories according to their severity. 
This scheme followed the logic, though not the detail, of the morphological
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scoring system described by Brown & Fabro (1981) in that it aimed for 
objectivity and definition in the assessment of a continuously variable 
parameter. Their scheme was more complex in that it also incorporated the 
classification of many other organs and systems of the embryo according to 
precise morphology, which indicated the developmental stage. Since scoring 
of the morphological features can be somewhat subjective, all scoring was 
done without knowledge of treatment through coding of the culture bottles 
by a technician who was not involved in the scoring process. Each of the 
estimates of embryonic growth used was completely objective since it was 
made either by direct measurement or counting.
Objectives
Superoxide anion radicals (O2"*) can be generated in culture medium 
by the addition of X/XO (see section 1.2). The work presented in this 
chapter has examined the effects of this radical-generating system on 
cultured post-implantation rat embryos and the protective effects of L- 
ascorbic acid (vitamin C) and DL-a-tocopherol (vitamin E). Preliminary 
experiments were conducted to establish the appropriate concentration of 
enzyme and substrate and thus validate the system.
2.2 METHODS
M aterials
The materials used in the work presented in this chapter were as
follows:-
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L-ascorbic acid,
(vitamin C) free acid, 20 - 200 mesh
Coomassie brilliant blue, 
protein reagent G-250
Culture bottles.
Pyrex, 50 ml
Diet pellets,
rat & mouse no. 3 (modified)
Dissecting microscope.
Model SZ
Eagle’s minimal essential medium, 
with Earle’s salts w/o L-glutamine
Sigma Chemical Co. Ltd., 
Poole, UK
Sigma Chemical Co. Ltd., 
Poole, UK
J. Bibby Science Products Ltd. 
Stone, UK
Special Diet Services, 
Waltham, UK
Olympus,
through CMS, London, UK
Gibco BRL Ltd.,
Uxbridge, UK
Ethanol,
absolute
Eyepiece graticule.
L-glutamine,
200 mM (lOOx)
Incubator,
37 °C, containing roller 
Incubator,
37 °C, for treatment of post-implantation 
embryos
O2 /N 2 /CO 2  mixtures
Orthophosphoric acid,
AnalaR
Penicillin and streptomycin,
solution, 10 000 lU ml penicillin, 
10 000 /ug ml'^ streptomycin
Petri dish,
plastic, 60 mm diameter, sterile
Phosphate buffered saline, 
solution A, Dulbecco’s, pH 7.3
Rat,
Sprague Dawley
Rat serum,
heat inactivated
Rocker/roller apparatus
Sodium carbonate, 
anhydrous
FSA Laboratory Supplies, 
Loughborough, UK
Graticules Ltd., 
Tonbridge, UK
Gibco BRL Ltd.,
Uxbridge, UK
LTE Ltd.
ICN Flow,
High Wycombe, UK
British Oxygen Company Ltd., 
London, UK
FSA Laboratory Supplies, 
Loughborough, UK
Gibco BRL Ltd,
Uxbridge, UK
Sterilin Ltd.,
Hounslow, Middlesex, UK 
Oxoid,
Unipath Ltd., Basingstoke, UK
Charles River,
Margate, UK
In house by the method of 
New (1978),
BIBRA
Denley Instruments,
Luckham, Billingshurst, UK
FSA Laboratory Supplies, 
Loughborough, UK
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Sonicator,
model Soniprep 150
Spectrophotometer,
nKdel&CRS2000
DL-a-tocopherol, 
(vitamin E) approx. 95
Watchmakers forceps
Xanthine,
(2,6-dihydroxypnrine) grade V, 99 
100 %, crystalline
Xanthine oxidase, 
grade III from buttermilk
MSE Scientific Instruments, 
Crawley, UK
Cecil,
Cambridge, UK
Sigma Chemical Co. Ltd., 
Poole, UK
A. Dumont & Fils, 
Switzerland
Sigma Chemical Co. Ltd., 
Poole, UK
Sigma Chemical Co. Ltd., 
Poole, UK
G eneral M ethods
For a diagrammatic representation of the method see fig. 2.1.
General animal husbandry
Animals were housed in polypropylene cages with stainless steel tops 
and grid floors. These were suspended on racks over paper for removal of 
excreta. Conditions in the room in which the animals were housed were 
closely controlled: temperature = 19-24 °C; relative humidity = 45-70 %; 
lighting = 12 h light, 12 h dark; air changes = 15 per hour with no 
recirculation using high efficiency Alters.
Tap water was supplied in plastic bottles and pelleted diet through a 
depression in the top of the cage. Observations were made daily for signs 
of ill-health. All animals were acclimatized for 10 days before use for 
experimental purposes.
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Fig. 2.1 Method for 
Dost-implantation rat embryo culture
day 0
9.6 days 
gestation
pregnant
females
rats mated Embiyos
exphnted
60mm dishes 
PBS
up to 16 up to 16 up to 16
embryos embryos embryos
60mm dishes 
EMEM 
37°C 
5% COg
Ih
50ml Pyrex
bottles
EMEM/
rat serum
37°C
40 rpm
Og/Ng/COg
44h
treat­
ment 
B
treat­
ment 
C
treat-
ment 
D
treat 
ment 
A
Females kflled 
& uteri removed 
Embryos dissected
Rdcheifs
membranes
removed
Undamped 
embiyos 
allocated 
to treat­
ment groups
Treatment
\ / \ / \ / \ /
up to 6 up to 6 up to 6 up to 6
embryos embiyos embryos embryos
^  coding and scoring ^
Culture
Assessmait
PBS, phosphate bufTered saline; EMEM, Eagle's minimal essential medium; 
rpm, revolutions per minute
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Explanting post-implantation rat embryos
Sexually mature female Sprague-Dawley rats were mated to sexually 
mature stud males of the same strain. Females were housed individually 
and matings were confirmed by the presence of a vaginal plug beneath the 
cage. The day the plug was found was designated day 0 of gestation.
On day nine of gestation, females were killed and their uteri removed. 
Decidua were carefully removed and all those from each female placed in 
separate sterile 60 mm plastic petri dishes containing approximately 5 ml 
sterile phosphate buffered saline, solution A, pH 7.3.
Under a dissecting microscope, two pairs of watchmakers forceps were 
used to dissect the embryos from the decidua and to remove the Reichert’s 
membrane. When all embryos had been dissected, they were checked for 
accidental damage and those which were intact were evenly assigned to the 
different treatment groups, i.e. some embryos from each female were placed 
in each group. Embryos were assumed to be 9.5 days old, as mating had 
probably occurred during the dark cycle at the beginning of day 0.
Treatment
Treatment was carried out in sterile 60 mm plastic petri dishes 
containing 10 ml Eagle’s minimal essential medium supplemented with L- 
glutamine (2 mM) and penicillin (20 lU mU) and streptomycin (20 pg mU). 
Embryos were transferred to the treatment dishes (see below) using a 
sterile plastic pipette and bulb (Pastet) and incubated for 1 h at 37°C in 5% 
CO2 in air.
At the end of the treatment period, embryos were transferred, using 
a Pastet, to 50 ml Pyrex culture bottles containing 3 ml rat serum and 1 ml 
Eagle’s minimal essential medium supplemented with L-glutamine, penicillin
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and streptomycin (as above). Air above the cultures was replaced with an 
O2/N 2/CO2 mixture in the proportions 5:90:5 by blowing in a gentle stream 
of gas for 5 min. Bottles were sealed tightly and incubated at 37°C on a 
rocker/roller apparatus at 40 revolutions per minute before scoring (see 
below).
Scoring
Eighteen hours after the start of the incubation, cultures were gassed 
with O2/N 2/CO2 at 20:75:5 and after a further 6 h with O2/N 2/CO2 at 40:55:5. 
After a total of 44 h in culture, embryos were transferred to a 60 mm plastic 
petri dish (containing approximately 5 ml phosphate buffered saline) for 
evaluation.
Scoring was done without knowledge of treatment; the scoring system 
used was as follows:
■ assessment of blood circulation - observation of the blood 
vessels of the yolk-sac indicated whether the embryo was alive 
or dead
■ measurement of yolk-sac diameter - using an eyepiece 
graticule, in mm
■ measurement of crown-rump length
■ measurement of head length
■ counting of somites - the embryo was turned so that its back 
was uppermost and somites were counted from somite 14 
(identified as being opposite the posterior end of the fore-limb 
bud)
■ general inspection for abnormalities - in particular, 
abnormahties of the neural suture. These were graded as
follows:
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0 = no abnormality
1 = mild abnormality (small deviation from the normal
straight line)
2 = moderate abnormality (one or more sharp kinks)
3 = severe abnormahty (incomplete closure of the neural
suture at the site of sharp kinks)
4 = turning failure (incomplete change from dorsal to
ventral concave flexure which should occur at 10.5 days)
5 = poor development (this score was assigned to embryos
which had no circulation and poor growth and 
development of both yolk sac and embryo - the growth 
parameters defined above could not be measured as 
development had not continued for the full 44 h)
measurement of protein content - embryos were stored at -20°C 
until the protein determination. This was carried out by the 
method of Bradford (1976) using embryos sonicated with 4 x 1  
s bursts at amplitude 1 with low power. Absorbence at 595 nm 
was measured in a spectrophotometer after reaction of 0.5 ml 
each sonicated embryo with 5 ml Coomassie brilliant blue G- 
250 protein reagent (lOOmg dissolved in 50 ml 90 % ethanol + 
100 ml orthophosphoric acid, made up to 11 with water) for 2 - 
30 min
T reatm ents w ith  xan th in e, xan th in e oxidase, 
L-aseorbic acid  and DL-a-tocopherol
Post-implantation rat embryo cultures were set up as described above. 
Up to six pregnant females were used in any one experiment giving a total 
of up to 42 embryos. The treatment options given to groups of two to six 
embryos are shown in table 2.1.
The required chemicals were added to 60 mm plastic petri dishes 
containing Eagle’s minimal essential medium, supplemented with L- 
glutamine, penicillin and streptomycin as above, to give a total volume of 10 
ml. XO was thouroughly re-mixed and the appropriate volume for a given 
concentration was added. This varied according to the activity of the 
particular batch. X was made up at 1 mg mU in 0.5 % sodium carbonate and 
added as a 100 or 200 jul volume. L-ascorbic acid was made up at 10 mM in 
phosphate buffered saline and added as a 10 jLtl, 100 /il or 1 ml volume. DL-
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a-tocopherol was suspended at 0.95 mg ml^ in phosphate buffered saline by 
sonication for 5 min in 5 s bursts at amplitude 3 with medium power and 
added as a 1, 2 or 3 ml volume (used within 2 h).
Table 2.1 Treatments of cultured post-implantation rat embryos with xanthine, 
xanthine oxidase, L-ascorbic acid and DL-a-tocopherol
Treat­ Xanthine Xanthine L-ascorbic acid DL-a-tocopherol
ment oxidase
ipM) (mU ml'^) (pM) (pg ml'^)
65 129 25 40 80 10 100 1000 95 190 285
A /
B /
C / /
D / /
E / /
E / /
G / /
H / /
I /
J / /
K / /
L / /
M / / /
N / / /
O / /
P / / /
Q / / /
R / / /
S / / /
T / / /
U / /
A positive and a negative control was included in each individual 
experiment, i.e. one group was treated with X only and another with X/XO.
41
S tatistica l A nalysis
Severity of neural suture abnormalities
The various grades of neural suture abnormality were given scores 
according to their severity; the dependence of the trend of these scores on 
treatment was tested by the Cochran Armitage trend test (Snedecor & 
Cochran, 1968a).
Growth parameters
Homogeneity of variance within each growth parameter for the 
various treatments within a set of experiments was measured by Bartlett’s 
test (Snedecor & Cochran, 1968b). Differences between treatments were 
tested using analysis of variance (ANOVA) (Snedecor & Cochran, 1968c) and, 
where Bartlett’s statistic was non-significant, variances were pooled and 
differences from control (X only) or X/XO-treated embryos tested by the 
least significant difference test (Snedecor & Cochran, 1968d). Where 
Bartlett’s statistic was significant for a growth parameter, differences 
between treatments were tested using a pooled or two-sample Student’s t- 
test (Snedecor & Cochran, 1968e) according to whether variances for a 
particular comparison were equal.
2.3 RESULTS
N eural suture abnorm alities  
and  grow th param eters
The most obvious effect of treatment of post-implantation rat 
embryos with X/XO was the development of abnormalities of the neural
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suture. The results are presented as tables showing the frequency of each 
grade of severity of abnormality (0 to 5) for each treatment. The Cochran- 
Armitage trend test was used to compare the linear trend of the distribution 
of these frequencies against the distribution found in either the control (X 
only) or the X/XO treated embryos. The values for chi-squared calculated 
by this test are presented in the tables together with a significance rating.
The means and standard deviations are presented for the five growth 
parameters measured.
V alidation  E xperim ents
Neural suture abnormalities
The results are shown in table 2.2.
The distribution of neural suture abnormalities was altered by 
treatment with X/XO in a dose-related manner compared with control 
embryos treated with X only at the same concentration. There was a 
significant linear trend (p < 0.05) towards increasingly severe abnormalities 
only at the higher concentration of X (129 pM) with 25 m il ml \  The higher 
levels of XO (40 or 80 m il ml ') produced a significant linear trend (p < 0.05) 
towards increasingly severe abnormalities with both concentrations of X (65 
or 129 pM). XO at 80 m il ml ' completely inhibited growth and development 
of the embryos and they were all given an abnormality score of 5.
The results are shown in table 2.3.
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Bartlett’s statistic for homogeneity of variance was not significant for 
yolk-sac diameter for cultures with 65 ijlM X (p > 0.05) and ANOVA was 
significant (p < 0.001). Bartlett’s test and ANOVA were not performed for 
crown-rump length, head length, somite number or protein content for 
cultures with 65 pM X, since there were only two groups (0 and 25 mU ml^ 
XO). For cultures with 129 pM X, Bartlett’s statistic was not significant for 
any of the five growth parameters (p > 0.05). ANOVA was significant for 
yolk-sac diameter (p < 0.001), not significant for crown-rump length, head 
length or somite number (p > 0.05) and significant for protein content (p < 
0.05).
For each of the parameters, values for each X/XO-treated group were 
compared against the appropriate X-treated group. Least significant 
difference tests were carried out for all sets of data in which there was more 
than one group (as listed above) since Bartlett’s test was not significant on 
any occasion. Student’s t-test was carried out with pooled variances for 
those sets of data in which there were only two groups.
Treatment with the two different concentrations of X (65 fiM or 129 
pM) did not significantly alter any of the growth parameters except protein 
content (p < 0.05) (table 2.3, lines 1 & 2). Treatment with X at 65 pM and 
XO at 25 m il ml ' XO significantly decreased head length (p < 0.01) (table 
2.3, lines 1 & 3), whilst treatment with X at 129 pM and XO at 40 mU ml ' 
XO significantly increased protein content (table 2.3, lines 2 & 6). Yolk-sac 
diameter was significantly decreased (p < 0.001) by treatment with X and 
higher levels of XO (40 or 80 mU ml') (table 2.3, lines 1, 5 & 7 and lines 2 
& 8).
Many parameters could not be measured after treatment with X and 
40 or 80 mU ml' XO due to the extremely poor development which had 
occurred during the culture period.
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L-ascorbic acid
Neural suture abnormalities
The results are shown in table 2.4.
Table 2.4 Effects of L-ascorbic acid on neural suture abnormalities 
induced in cultured rat embryos treated with xanthine or 
xanthine/xanthine oxidase
Treatment No.
of
emb­
ryos
Neural suture abnormalities and severity 
scores
Cochran 
Armitage 
trend test 
(chi-squared 
values)
None Mild Mod­
erate
Severe Turn­
ing
failure
vs.
X
vs.
X/XO
0 1 2 3 4
X 13 9 4 0 0 0 - 14.1
***
X/XO 22 3 5 5 7 2 14.1
***
-
X/XO
AA 10 pM.
13 3 3 1 2 4 9.4 0.0
ns
X/XO 
AA 100 pM
10 0 4 3 1 2 12.3
***
0.0
ns
X/XO 
AA 1 mM
10 7 3 0 0 0 0.0
ns
11.8
***
X
AA 10 /iM
12 9 1 2 0 0 0.2
ns
11.3
***
X
AA 100 /jM
14 8 4 1 1 0 1.4
ns
9.6
**
X
AA 1 mM
10 7 3 0 0 0 0.0
ns
11.8
X, xanthine, 129 juM; XO, xanthine oxidase, 25 mU ml" ; AA, L-ascorbic acid; 
ns, not significantly different, p > 0.05; **, significantly different, p  < 0.01; 
***, significantly different, p < 0.001
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The distribution of neural suture abnormalities was altered by 
treatment with X/XO {i.e. xanthine 129 pM and xanthine oxidase 25 mU 
ml ‘) compared with control embryos (X, i.e. xanthine 129 pM, only); there 
was a significant linear trend (p < 0,001) towards increasingly severe 
abnormalities (table 2.4, line 2 vs. line 1). This trend was not abolished by 
the addition of 10 pM or 100 fiM L-ascorbic acid to cultures containing 
X/XO; the trend was still significantly towards increasingly severe 
abnormalities (p < 0.01 and p < 0.001 respectively) compared with control 
embryos (X only) (table 2.4, lines 3 and 4 respectively vs. line 1). Embryos 
from these two treatments showed a linear trend in neural suture 
abnormahties which was not significantly different (p > 0.05) from embryos 
treated with X/XO (table 2.4, lines 3 and 4 respectively vs. line 2). 
However, the effect was abolished by the addition of 1 mM L-ascorbic acid 
to cultures containing X/XO. This treatment caused a linear trend which 
was not significantly different {p > 0.05) from that in control embryos (X 
only) (table 2.4, line 5 vs. line 1); there was a significant linear trend ip < 
0.001) towards decreasingly severe neural suture abnormalities compared 
with embryos treated with X/XO (table 2.4, line 5 vs. line 2).
The addition of 10 pM, 100 pM or 1 mM L-ascorbic acid to embryos 
treated with X only caused a linear trend in severity of neural suture 
abnormalities which was not significantly different ip > 0.05) from that in 
control (X only) (table 2.4, lines 6, 7 and 8 respectively vs. line 1); there was 
a significant linear trend (p < 0.001, p < 0.01 and p < 0.001 respectively) 
towards decreasingly severe neural suture abnormalities compared with 
embiyos treated with X/XO (table 2.4, lines 6, 7 and 8 respectively i/s. line 
2).
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Growth parameters
The results are shown in table 2.5.
Bartlett’s statistic for homogeneity of variance was not significant for 
yolk-sac diameter, crown-rump length, head length or somite number ip > 
0.05); it was significant for protein content (p < 0.05) which meant that the 
power of the ANOVA may have been reduced i.e. there was a possibility of 
overlooking a significant result.
ANOVA was significant for yolk-sac diameter ip < 0.05), crown-rump 
length ip < 0.05) and protein content ip < 0.001) (this, despite a significant 
Bartlett’s statistic), showing that differences existed between the treatment 
groups for these three parameters. It was not significant for head length or 
somite number ip > 0.05) showing that there was no treatment-related 
difference in either of these two parameters.
For each of the parameters, values for each treatment group were 
compared against either control (X only) or X/XO treatments. Least 
significant difference tests were carried out using pooled variances for yolk- 
sac diameter, crown-rump length, head length and somite number (i.e. 
where Bartlett’s statistic was not significant). Student’s t-test was carried 
out for protein content; this was either pooled or two-sample according to 
the equality of variance in the particular pair of values being compared.
Treatment with X/XO or X/XO/L-ascorbic acid (at any of the three 
concentrations of L-ascorbic acid used) did not cause a significant difference 
ip > 0.05) in any of the five parameters measured compared with control 
embryos (X only) (table 2.5 lines 2, 3, 4 and 5 respectively z/s. line 1).
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However, treatment with X/L-ascorbic acid 10 /xM did cause a 
significant increase in yolk-sac diameter (p < 0.05) and in protein content ip 
< 0.001), but not in the other parameters ip > 0.05), when compared with 
control embryos (X only) (table 2.5, line 6 vs. line 1). Treatment with X/L- 
ascorbic acid 100 pM or 1 mM had no significant effect on any of the 
parameters ip > 0.05) in this comparison (table 2.5 lines 7 and 8 respectively 
vs. line 1).
In comparison with the X/XO group, treatment with X/XO/L-ascorbic 
acid caused a significant difference in some parameters at some 
concentrations (table 2.5 lines 3, 4 and 5 vs. line 2). Yolk-sac diameter was 
significantly different ip < 0.05) in embryos treated with X/XO/L-ascorbic 
acid 100 /xM but not 10 pM or 1 mM ip > 0.05). Crown-rump length was 
significantly different ip < 0.05) in embryos treated with X/XO/L-ascorbic 
acid at all three concentrations used (10 /xM, 100 pM or 1 mM). The 
significant differences ip < 0.05) found for head length and somite number 
for X/XO/L-ascorbic acid 10 pM and for head length only for X/XO/L- 
ascorbic acid 100 pM are of reduced importance since they did not generate 
a significant ANOVA. Protein content was not significantly different ip > 
0.05) from X/XO-treated embryos for X/XO/L-ascorbic acid at any 
concentration.
Significant differences were found in all parameters between embryos 
treated with X/L-ascorbic acid 10 pM and those treated with X/XO (table 
2.5 line 6 vs. line 2). The differences in yolk-sac diameter and crown-rump 
length were significant with p < 0.01 and in protein content with p < 0.001. 
As explained for the other treatments above, the differences in head length 
and somite number (p < 0.05) were not considered to be important. 
Treatment with X/L-ascorbic acid 100 pM or 1 mM produced no significant 
differences (p > 0.05) when compared with X/XO-treated embryos (table 2.5
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lines 7 and 8 respectively us. line 2) with the exception of somite number (p 
< 0.05) for which ANOVA was not significant.
DL-a-Tocopherol
Neural suture abnormalities
Two series of experiments were carried out involving DL-a-tocopherol; 
the results with XO at 25 mU ml^ are shown in table 2.6 and with XO at 40 
mU ml^ in table 2.7.
As in the L-ascorbic acid series, the distribution of neural suture 
abnormalities was altered by treatment with X/XO compared with control 
embryos; there was a significant linear trend (p < 0.001) towards 
increasingly severe abnormalities (table 2.6, line 2 vs. line 1). None of the 
three levels of DL-a-tocopherol (95, 190 and 285 pg mlO which were added 
to cultures containing X/XO abolished this trend (table 2.6, lines 3, 4 and 5 
respectively vs. line 1). However, higher levels (190 and 285 pg mlO 
reduced the significance of this trend, with 190 pg ml^ being slightly more 
effective. Embryos treated with X/XO and DL-a-tocopherol at 95 or 285 pg 
ml ' showed a linear trend in severity of neural suture abnormalities that 
was not significantly different ip > 0.05) from X/XO treated embryos (table
2.6, lines 3 and 5 respectively vs. line 2). DL-a-tocopherol at 190 pg ml \  
however, caused a significant linear trend ip < 0.05) towards decreasingly 
severe neural suture abnormalities compared with embryos treated with 
X/XO (table 2.6, line 4 vs. line 2).
The addition of 285 pg ml^ DL-a-tocopherol to cultures treated with 
X only caused a linear trend in severity of neural suture abnormalities which 
was not significantly different ip > 0.05) from that in control (X only) (table
2.6, line 6 vs. line 1); there was a significant linear trend ip < 0.001) towards
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decreasingly severe neural suture abnormalities compared with embryos 
treated with X/XO (table 2.6, line 6 vs. line 2).
Table 2.6 Effects of DL-g-tocopheroI on neural suture abnormalities induced in 
cultured rat embryos treated with xanthine 
or xanthine/xanthine oxidase.
Treatment No.
of
emb­
ryos
Neural suture abnormalities 
and severity score
Cochran 
Armitage 
trend test 
(chi-squared 
values)
None Mild Mod­
erate
Sev­
ere
Turn­
ing
fail­
ure
vs.
X
vs
X/XO
0 1 2 3 4
X 18 13 4 0 0 1 - 19.7
***
X/XO 16 1 2 1 2 10 19.7
***
-
X/XO
AT 95 pg ml'^
14 2 1 1 1 9 15.3
***
0.1
ns
X/XO
AT 190 pg mT^
8 3 0 2 2 1 5.7
*
4.4
X/XO
AT 285 pg ml'^
7 3 0 0 0 4 7.3
**
1.3
ns
X
AT 285 pg mT^
10 7 3 0 0 0 0.3
ns
16.2
***
X, xanthine, 129 pM; XO, xanthine oxidase, 25 mU ml-^; AT, DL-a -
tocopherol; ns, not significantly different, p  > 0.05; *, significantly different, 
p  < 0.05; **, significantly different, p  < 0.01; ***, significantly different, p < 
0.001
The second series of experiments involving DL-a-tocopherol used a 
higher level of XO. Treatment with X/XO (i.e. xanthine 129 and 
xanthine oxidase 40 mU ml') considerably inhibited the growth and 
development of the embryos, necessitating the introduction of a further 
abnormality score of 5 (see section 2.2).
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Table 2.7 Effects of DL-g-tocopherol on neural suture abnormalities induced in 
cultured rat embryos treated with xanthine or xanthine and 
a high level of xanthine oxidase.
Treatment No.
of
emb­
ryos
Neural suture abnormalities 
and severity scores
Poor
dev­
elop­
ment
Cochran 
Armitage 
trend test 
(chi-squared 
values)
None Mild Mod­
er­
ate
Sev­
ere
TF vs. X vs.
X/
XO
0 1 2 3 4 5
X 18 16 1 0 0 1 0 " 30.3
***
X/XO 18 0 1 1 0 0 16 30.3 -
X/XO
AT 95 pg mf^
19 0 1 0 0 6 12 30.9
***
0.2
ns
X/XO
AT 190 pg mf^
12 0 3 0 2 2 5 18.5 4.3
*
X/XO
AT 285 pg ml'^
8 2 0 0 2 2 2 12.6 5.8
TF, turning failure; X, xanthine, 129 /iM; XO, xanthine oxidase, 40 mU ml'^; 
AT, DL-a-tocopherol; ns, not significantly different, p  > 0.05; *, significantly 
different, < 0.05; ***, significantly different, p  < 0.001
As in the first series, treatment with X/XO caused a significant linear 
trend (p < 0.001) towards increasingly severe abnormalities (table 2.7, line 2 
vs. line 1). Again, none of the three levels of DL-a-tocopherol (95, 190 and 
285 Mg ml O which were added to cultures containing X/XO abolished this 
trend which remained significantly different (p < 0.001) from controls (X only) 
although chi-squared did decrease with increasing DL-a-tocopherol level 
(table 2.7, lines 3, 4 and 5 respectively us. line 1). Embryos treated with 
X/XO and DL-a-tocopherol at 95 pg ml * showed a linear trend in severity of 
neural suture abnormalities which was not significantly different (p > 0.05) 
from X/XO treated embryos (table 2.7, line 3 us. line 2). However, the 
addition of DL-a-tocopherol at 190 and 285 pg ml ’ to cultures treated with
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X/XO caused a significant linear trend ip < 0.05) towards decreasingly severe 
neural suture abnormalities compared with embryos treated with X/XO (table
2.7, lines 4 and 5 respectively vs. line 2).
Growth parameters
The results are shown in table 2.8.
Bartlett’s statistic for homogeneity of variance was not significant for 
yolk-sac diameter, head length, somite number or protein content ip > 0.05); 
it was significant for crown-rump length ip < 0.05) (see above).
ANOVA was significant only for yolk-sac diameter ip < 0.01), showing 
that differences existed between the treatment groups for this parameter. 
It was not significant for crown-rump length (although a significant Bartlett’s 
statistic would have reduced the significance in the ANOVA), head length, 
somite number or protein content ip > 0.05) showing that there was no 
treatment-related difference in any of these parameters.
For each of the parameters, values for each treatment group were 
compared against either control (X only) or X/XO treatments. Least 
significant difference tests were carried out using a pooled variance for yolk- 
sac diameter, head length, somite number and protein content (i.e. where 
Bartlett’s statistic was not significant). Student’s t-test was carried out for 
crown-rump length; this was either pooled or two-sample according to the 
equality of variance in the particular pair of values being compared.
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Treatment with X/XO did not cause a significant difference (p > 
0.05) in yolk-sac diameter, crown-rump length, head length or protein 
content compared with control embryos (X only) (table 2.8 line 2 us. line 1). 
There was a significant difference (p < 0.01) for somite number but, as this 
did not generate a significant difference in ANOVA, its importance is 
reduced. Treatment with X/XO/DL-a-tocopherol 95 or 285 pg ml^ did not 
cause a significant increase in any of the five parameters measured (p > 
0.05) when compared either with control embryos (X only) or X/XO treated 
embryos (table 2.8, line 3 and 5 respectively vs. lines 1 and 2 respectively). 
Treatment with X/XO/DL-a-tocopherol 190 pg ml^ did not cause a 
significant difference in yolk-sac diameter, crown-rump length, head length 
or protein content. There was a significant difference (p < 0.05) in somite 
number but, as this did not generate a significant difference in ANOVA, its 
importance is reduced. Treatment with X/DL-a-tocopherol 285 pg ml^ 
caused a significant difference in yolk-sac diameter when compared with 
control embryos (X only) (p < 0.05) or with X/XO treated embryos (p < 0.01) 
(table 2.8 line 6 vs. lines 1 and 2 respectively). It did not cause a significant 
difference in any of the other parameters.
2.4 DISCUSSION
The dam aging effects o f  
oxygen  rad icals
The results presented in this chapter show that teratogenic effects 
were observed when post-implantation rat embryos were exposed to X/XO 
i/z and confirm the findings of Jenkinson er aZ (1986). The assessment 
of neural suture abnormalities provided a very sensitive index of each of the
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different treatments in this system. The distribution of neural suture 
abnormalities within groups showed a highly significant difference between 
control embryos and those exposed to X/XO in all three sets of experiments 
using the concentrations of X and XO determined by the validation 
experiments.
The growth parameters measured in the embryos did not show any 
consistent differences between treated and untreated embryos and thus did 
not provide a very sensitive index of the extent of teratogenicity. In nine of 
the ten comparisons of growth parameters between X/XO-treated and 
control embryos there was no significant difference. In the DL-a-tocopherol 
set of experiments there was a statistically significant reduction in somite 
number with X/XO treatment but the biological importance of this finding 
is questionable since the actual difference was only 1.5 somites.
As discussed in section 1.2, many in vitro studies have been carried 
out in which genetic and toxic effects have been observed in response to 
agents which are known to act through the production of active oxygen 
species. Identification of the type of oxygen radical involved can be made by 
the addition of radical scavengers or antioxidants to the culture medium 
which may cause a reduction in the damaging effect (Phillips et al, 1984). 
Either hydroxyl radicals (OH") or hydrogen peroxide (H^ Og) are thought to 
have been responsible for the abnormalities of the neural suture seen here, 
since the effect was decreased by the addition of high levels of glutathione 
and abolished by the addition of catalase, but unaffected by additions of 
superoxide dismutase or desferrioxamine (Jenkinson aZ, 1986). The 
flexure abnormalities observed in the cultured embryos of Faustman-Watts 
uZ (1986) were believed to have been caused by free radicals (produced 
during the metabolism of AAF) since they were eliminated by radical- 
trapping agents.
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P rotection  again st th e  effects  
o f oxygen  rad icals
The antioxidants L-ascorbic acid and DL-a-tocopherol have been 
shown in this study to abolish or reduce the embryotoxic effects of X/XO in 
cultured rat embryos respectively.
L-Ascorbic acid
L-ascorbic acid at 1 mM had a strongly protective effect, as indicated 
by the complete abolition of the neural suture abnormalities induced by 
X/XO, but the lower concentrations of L-ascorbic acid (10 or 100 pM) did not 
give this protection. Although L-ascorbic acid can act as either an 
antioxidant (through the prevention of peroxidation) or a pro-oxidant 
(through the production of hydrogen peroxide and free radicals by 
autoxidation) (Shamberger, 1984), the results presented in this chapter did 
not indicate any teratogenic effect of L-ascorbic acid alone nor any 
enhancement of the teratogenic effect of X/XO. Thus, L-ascorbic acid acted 
as an antioxidant in this system.
There was a statistically significant increase in yolk-sac size and 
protein content in embryos treated with 10 pM L-ascorbic acid. Since higher 
levels of L-ascorbic acid did not have this effect, this was not considered to 
be biologically important. Other growth parameters were unaffected and 
other treatments were without effect.
Humans (and guinea-pigs) differ from most other mammals in that 
they have an obligatory requirement for L-ascorbic acid since they are 
unable to synthesize it (reviewed by Ginter, 1989). The question of 
recommended dietary allowance (RDA) for pregnant women is still open to 
debate with regard to whether it should be increased above the 30 - 60 mg 
level recommended in the UK for healthy adults (Ginter, 1989). Schofield
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et al (1989) have shown that healthy offspring can be produced by women 
whose diets fall below the RDA for L-ascorbic acid and other vitamins but 
other studies have suggested that an increase would be advisable. For 
example, Habibzadeh et al (1986) showed that dietary supplementation of 
pregnant guinea pigs with L-ascorbic acid during organogenesis increased 
the size of embryos in relation to dose consumed. The in vitro results 
presented in this chapter would seem to support this view.
Human placental tissue fragments in vitro have been found to reverse 
the process of L-ascorbic acid oxidation providing a mechanism whereby the 
reduced form is available to the embryo for use as an antioxidant (Choi & 
Rose, 1989).
Embryos were presumably protected from the neural suture-damaging 
effects of the X/XO-generated oxygen radicals by reactions occurring 
extracellularly (van Rensburg et al, 1989). As discussed in section 6.3, the 
protective role of L-ascorbic acid against X/XO-derived oxygen radicals in 
this embryo culture system correlates with the results of some workers but 
not with the results of others, a situation which is presumably due to the 
different actions of L-ascorbic acid under different conditions as discussed 
above.
DL- a~tocopherol
DL-a-tocopherol at 190 or 285 pg ml ' had a protective effect against 
the damage induced by X/XO, as indicated by a reduction in the severity of 
neural suture abnormalities, but at 95 pg ml^ it did not have this effect. It 
was not expected that DL-a-tocopherol would induce teratogenic effects 
itself (Martin & Hurley, 1977) and, indeed, no damage was induced by the 
addition of DL-a-tocopherol at 285 pg ml^ to the culture medium.
The protective effect of DL-a-tocopherol in the study presented in this 
chapter was not found to be as strong as the protective effect of L-ascorbic
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acid. Steele et al (1974) pointed out that the preparation of DL-a-tocopherol 
as a suspension would leave a large proportion of it biologically unavailable 
since it is present as a micellar suspension. This necessitated the use of 
higher concentrations in vitro (95,190 & 285 /xg ml^ in the study presented 
in this chapter) than would be achieved in vivo (5 /xg ml^; Steele et al, 1974) 
to compensate for this. Weitberg et al (1985) found that DL-a-tocopherol- 
succinate only protected against the induction of SCEs in Chinese hamster 
ovary (CHO) cells by hypoxanthine/XO if cultures were pre-incubated with 
the antioxidant for 72 h; no acute effect was seen. The protective effect 
observed in the cultured embryos may have been potentiated had a system 
been developed in which such a pre-incubation was possible (in the system 
used, embryos were treated for just 1 h immediately after explanting). The 
fact that the protective effect of DL-a-tocopherol found here was not 
concentration-dependent may also be explained by its method of preparation. 
DL-a-tocopherol-succinate (82 /xg ml O was not found to protect against the 
embryotoxic effects of AAF-metabohtes presumably because the toxic actions 
of these metabolites did not take place intracellularly (Faustman-Watts et 
oZ, 1986).
There was a statistically significant increase in yolk-sac size in 
embryos treated with 285 /xg ml^ DL-a-tocopherol. It is possible that 
subsequent growth of the embryo may be enhanced by such an effect (Snow, 
1983). A level of 95 /xg ml ' DL-a-tocopherol increased the viability of 
embryos in culture (Steele et al, 1974) so it is possible that this effect was 
treatment related. Other growth parameters were unaffected and other 
treatments were without effect.
The level of vitamin E in post-implantation rat embryos m i/iuo is 
approximately 10 % of the maternal level showing that it does not readily 
pass across the placenta (Iwasa aZ, 1990; Martin & Hurley, 1977). 
However, it was possible to increase the level in the embryo through an
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increase in the DL-a-tocopherol-acetate content of the maternal diet and 
thus enable antioxidant protection to occur (Iwasa et al, 1990).
M echanism  o f action  o f teratogen s
The mechanism by which the kinks of the neural suture developed 
is thought to be by restorative growth after damage (Snow, 1985). This 
involves the acceleration of cell division at areas of cytotoxicity regardless 
of the timing of cell proliferation in adjacent cells (Snow, 1983).
As described in section 1.2, embryos have been found to contain a 
cytochrome P-450-dependent monooxygenase system which contributes to 
the metabolism of compounds to toxic intermediates to a greater extent 
than previously thought (Juchau et al, 1985). Cytochrome P-450 can be 
induced in mouse embryos in a manner which is under genetic control as 
illustrated by the strain differences observed in the in vitro teratogenicity 
of benzo[a]pyrene measured by frequency of SCEs (Galloway et al, 1980). 
AAF, for example, is metabolized to an embryotoxic intermediate by such a 
system through transplacental induction (Juchau et al, 1985). The lack of 
ability of rat embryos to metabolize CP to toxic intermediates themselves 
may also imply a lack of ability to inactivate maternally metabolized toxins, 
thus increasing the susceptibility of the embryo to toxic insult (Greenaway 
nZ, 1982).
The p oten tia l for th e  u se o f post-im plantation  em bryo  
cu lture in  tox ieo log ica l in vestigation
As discussed in section 6.1, there are several advantages to the use of 
ÎAX uZ^ ro systems. Post-implantation embiyos in culture may be used to gain 
an insight into the mechanisms of embryotoxicity. Also, they may provide
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a means of selecting toxins which require further studies to be performed 
in vivo (Anderson, 1988).
Using ethylenethiourea, an established direct-acting teratogen, Khera
(1989) found differences between the malformations induced in rat embryos 
in vivo and in vitro. This discrepancy in severity and type of abnormality 
was explained by differential levels of exposure at different stages of 
development. Maternal metabolism will gradually degrade a chemical, a 
factor which is not present in vitro (Khera, 1989). Other differences 
between in vivo and in vitro embryonic environments include pressure 
exerted by the uterus which would tend to retain any swellings, thus 
allowing more severe manifestations of this type of effect in vitro, and the 
various handling disadvantages (mechanical, temperature, oxygen 
availability, etc.) which may render in vitro embryos ‘weaker’ and thereby 
more susceptible to chemical injury (Khera, 1989).
New (1978) has shown that rat embryos cultured in vitro from 9(6 to 
IIV2 days developed at virtually the same rate as embryos in vivo. Using CP 
as the test substance, Greenaway et al (1982) found remarkably similar 
changes in in vitro- and in vivo-exposed rat embryos. Whilst they accepted 
that compensation had to be made for the growth delay seen in vitro by 
measuring these embryos after a slightly longer time, taking the values for 
protein content as percentages gave a very good correlation between in vivo 
and Z/i exposure.
C onclusions and future p ossib ilities
It is concluded that Z/x uZ^ ro embryo systems do have a role in the 
investigation of teratogenic effects but that allowance must be made for the 
differences known to exist compared with the Z/x uZuo situation, particularly 
with respect to certain types of abnormality. Even chemicals which are
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known to require bioactivation should be tested both with and without an 
exogenous metabolizing system in order to measure the embryonic 
contribution to toxicity. The work presented here has shown that L-ascorbic 
acid and DL-a-tocopherol had a protective effect on cultured post­
implantation embryos treated with X/XO through their action as 
antioxidants.
Future work might include the investigation of antioxidant protection 
against embryotoxicity induced by xenobiotic chemicals, thus elucidating the 
role of oxygen radicals in this action. The relative roles of embryonic and 
maternal metabolism with respect to the generation of oxygen radicals could 
be studied through the incorporation of a suitable metabolizing system in 
the cultures.
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CHAPTERS
DEVELOPMENT OF THE USE OF IN VITRO 
FERTILIZATION TECHNIQUES IN MICE 
FOR REPRODUCTIVE TOXICOLOGY 
USING ETHANOL AS A MODEL 
COMPOUND
3.1 INTRODUCTION
There are many functions of the male reproductive system whose 
impairment results in infertility. In this chapter, an in vitro mouse system 
has been used in order to gain an insight into specific effects on the fertiliz­
ation process itself and on early embryogenesis. Ethanol has been used as 
a model compound since its adverse effects on male reproduction are well 
established (reviewed by Anderson & Willis, 1981).
F ertilization
Process
The process of fertilization commences once the sperm have 
penetrated the female reproductive tract and are present in the vicinity of 
the oocyte. It comprises the penetration of an oocyte by a spermatozoon, 
through the cumulus cells, zona pellucida and plasma membrane 
(Wassarman, 1987). Sperm capacitation is a prerequisite for this event 
(Austin, 1951; Chang, 1951) and involves the removal of several inhibitory 
factors which are present in the seminal plasma (Reddy et al, 1982; Fraser, 
1985; Fraser et al, 1990).
A further condition for fertihzation is the completion of the acrosome 
reaction (Wassarman, 1987), during which hyaluronidase, which degrades 
the hyaluronic acid present in the cumulus cells surrounding the oocytes, is 
released. This would suggest that the acrosome reaction occurs at the start 
of the penetration process (Wassarman, 1987), but one of the three surface 
glycoproteins of the zo/m peZZz/cZda (ZP3) is required for the induction of the 
acrosome reaction in mice (Bleil & Wassarman, 1980a,b, 1983; Florman &
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Storey, 1982) suggesting that the initial stages of penetration occur before 
commencement of the acrosome reaction.
Once an oocyte has been penetrated by a spermatozoon it is rendered 
unrecognizable to further sperm and therefore not available for fertilization 
(Bleil & Wassarman, 1983). This is brought about through the cortical 
reaction in which changes in ZP3, which is also required for recognition and 
binding, are induced (Bleil & Wassarman, 1980a,b; Wassarman, 1987).
Both sperm and oocyte must be mature in order for fertihzation to 
progress: human sperm are unable to penetrate the zona pellucida before 
the oocyte has begun the second metaphase of meiosis (Tesafik et al, 1988). 
This maturation process was found to be dependent upon the presence of 
cumulus cells in rat oocytes in vitro (Vanderhyden & Armstrong, 1989). 
Specific factors are provided by the epithelial cells of the epididymis which 
are required for sperm maturation, as shown in the hamster by Moore & 
Smith (1988).
In vitro models
Since Thibault et al (1954) first successfully carried out in vitro 
fertilization in the rabbit, progress has been made in using the technique in 
other species. One of the most important uses is in human infertihty 
diagnosis and treatment.
In vitro fertilization using human gametes has been successfully 
employed as a treatment for some types of infertility (Edwards aZ, 1980). 
Research into various aspects of human fertilization has utilized oocytes 
generated for, and subsequently rejected from, such a fertility treatment 
programme (Liu aZ, 1988; Tesafik, 1989). Although this system has the 
obvious advantage that the characteristics of the human zozm peZZzxcZdn are 
retained, it is possible to use zonn-ffee golden hamster ova for this type of 
study since, uniquely, these can be penetrated by sperm from other species
(Yanagimachi, 1984). This system provides the opportunity for a fertihty 
test for any species in which ova are not readily available i.e. humans 
(Yanagimachi et al, 1976) and farm animals (Creighton & Houghton, 1987). 
In the presence of suitable control fertilizations, a negative result indicates 
that the sperm lack the ability to undergo certain functions (capacitation, 
acrosome reaction) and can be taken as meaningful. Conversely, a positive 
result does not necessarily indicate that fertilization will proceed in vivo 
since other functions (e.g. sperm-zona binding) are not tested (Yanagimachi 
et al, 1976). In addition, zona-îree golden hamster ova may be used to facil­
itate the examination of human sperm chromosomes, providing a method for 
the assessment of heritable damage (Yanagimachi, 1984).
It has been recognized that utilization of the techniques of in vitro 
fertilization in laboratory animals could provide a basis for toxicity studies 
(Brackett, 1978; Moore, 1986). Areas in which the assessment of a reduction 
in fertilizing ability brought about by toxic chemicals would be useful include 
the development of male contraceptives and the assessment of potential 
environmental, occupational, food or drug exposure (Brackett, 1978; 
Holloway et al, 1990a; Moore, 1989). Measurement of in vitro fertilizing 
ability can be combined with the evaluation of other sperm parameters 
(Holloway et al, 1990a,b), thus providing an insight into the mechanism of 
the induced infertility.
Many of the findings relating to the mechanisms and processes of 
fertilization have been made using in vitro fertilization systems. For 
example, the mouse in vitro fertilization system has been used by Reddy et 
al (1982) and Fraser et al (1990) in order to elucidate the nature of a 
decapacitation factor. Breeding programmes using in vitro fertilization 
techniques have been developed for some farm, laboratory and zoo animals.
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T he pre-im plantation  em bryo as 
a target for tox icity
Embryolethality
Since chromosome aberrations are known to occur with high 
frequency in human spontaneous abortions (Holden, 1982), some of which 
are presumably chemically-induced, this could provide an explanation for the 
high incidence of dead post-implantation embryos often seen in experimental 
animals treated early in pregnancy (Ornaghi & Giavini, 1989). Such genetic 
damage after maternal cyclophosphamide (CP) treatment was measured as 
an increase in micronucleus frequency in rat pre-implantation embryos 
(Ornaghi & Giavini, 1989) and as an increase in chromosome aberration and 
sister chromatid exchange (SCE) frequency in mouse pre-implantation 
embryos (Vogel & Spielmann, 1989). Chromosome damage has been 
measured in 2-cell mouse embryos as an increase in micronucleus frequency 
caused by X-irradiation of sperm in vitro (Pampfer et al, 1989). Also, 
treatment of mice at fertilization with the microtubule inhibitor nocodazole 
caused alterations in ploidy, which caused embryolethality at around the 
time of implantation (Generoso et al, 1989).
In vitro exposure of mouse pre-implantation embryos to an exogenous 
source of oxygen radicals has been shown to be lethal (lannaccone, 1986). 
This was found to be due to the disruption of membrane organization 
(lannaccone, 1986), which would be expected to be highly damaging since 
there is a significant requirement for membrane synthesis during 
embryogenesis (see section 1.2).
In an investigation in humans into the relationship between exposure 
to anaesthetics in the workplace and spontaneous abortion, Warren aZ
(1990) used cultured pre-implantation mouse embryos to show that the 
effect on further cleavage was dependent on the stage of development at
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which the embryos were exposed. This was believed to be due to the 
difference in the synchrony of cell division at different pre-implantation 
stages, with the Gg-specific effects of nitrous oxide causing greater damage 
at the stage of greatest synchrony (i.e. the 2-cell stage) (Warren et al, 1990). 
This stage specificity with respect to pre-implantation embryotoxicity was 
also found by Weissenborn & Streffer (1989). They showed that irradiation 
of 2-cell embryos with X-rays produced fewer chromosome aberrations than 
irradiation of 1-cell embryos, a finding they attributed to differences in 
chromosome structure in pre-implantation embryos at different stages. 
Sensitivity was also found to be dependent on developmental stage in vitro: 
the growth of rabbit pre-implantation embryos was inhibited by light at the 
2-cell stage and by room temperature at the 8-cell stage (Schumacher & 
Fischer, 1988).
Teratogenicity
Although embryolethality is a commonly observed effect of pre­
implantation embryo exposure to toxins, teratogenic effects are much less 
likely (Ornaghi & Giavini, 1989), in contrast to the situation with post­
implantation embryos (see section 1.2). CP was found not to induce 
malformations if mouse embryos were exposed in utero at day 3, although 
embryolethahty and inhibited development were observed (Spielmann et al, 
1977; Vogel & Spielmann, 1989).
These studies support the generally held view that teratogenic effects 
are not induced before implantation, toxic effects being manifested as 
spontaneous abortion (Vogel & Spielmann, 1989; Vogel nZ, 1989). An 
exception to this ‘rule’ is the finding by Takeuchi (1984), confirmed by 
Spielmann nZ (1989), that methylnitrosourea (MNU) induced malform­
ations in mouse embryos exposed on day 2 of gestation. The effects of MNU 
can be seen in the pre-implantation embryos themselves, expressed as an
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increased frequency of SCEs (Vogel aZ, 1989). In addition, it is possible to
induce teratogenicity through exposure of parental germ cells, as discussed 
in chapter 4.
E thanol as a reproductive tox in
Infertility
Infertility can be caused hormonally through a decrease in free 
testosterone, as observed in human male alcoholics, leading to impotence 
and reduced libido (Farnsworth et al, 1978). The toxic action of ethanol on 
the liver involves enzyme changes which affect the ability to metabolize 
reproductive hormones (Anderson & Willis, 1981). Alternatively there may 
be effects on the fertilization process itself, namely alterations in sperm 
fertilizing capacity (Anderson et al, 1983). These two mechanisms can be 
differentiated through the use of an in vitro fertilization system (Anderson 
et al, 1983).
In addition to the hormonal effects of ethanol which may contribute 
to infertility, depletion of zinc and vitamin A are frequently observed in 
alcoholics and lipid peroxidation may be increased, thus leading to sperm 
damage (Anderson & Willis, 1981). Metabolism of ethanol by alcohol 
dehydrogenase (ADH) may reduce the capacity for retinol metabolism which 
is required for spermatogenesis (van Thiel et al, 1974). Vitamin A 
supplementation has been found to have a protective effect in rats against 
ethanol-induced germ cell damage (Rosenblum nZ, 1989; van Thiel eZ aZ, 
1974).
Ethanol has been shown to have a genotoxic effect in both germ cells 
and somatic cells (Adler & Ashby, 1989). Both acute and chronic treatments
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have been found to reduce litter size through the induction of dominant 
lethal mutations (Badr & Badr, 1976; Klassen & Persaud, 1976, 1978). In a 
series of experiments in which male mice were treated chronically with 
ethanol in a liquid diet, Anderson et al (1978) found that although pregnancy 
rate was unaffected, litter size and offspring survival were reduced. In 
humans, an association between paternal ethanol consumption and reduced 
birthweight has been found, although the mechanism for this effect is not 
known (Little & Sing, 1987) (see section 4.1).
Ethanol was found to disrupt meiotic chromosome segregation in 
oocytes when given to mice acutely at around the time of fertilization 
(Kaufman & Bain, 1984a). The resulting aneuploid embryos went through 
the first few cleavage divisions but had died by the early post-implantation 
period, although some triploid embryos remained alive, but malformed, at 
day 10 of gestation (Kaufman & Bain, 1984b). Aneuploidy has been induced 
in mouse primary spermatocytes and spermatogonia by ethanol consumed 
at a similar level to human drinking (Alvarez, 1985), presumably resulting 
in the production of some aneuploid sperm (Hunt, 1987).
E xperim ental system
Fertilization can be influenced by events occurring earlier in the 
reproductive process (see fig. 1.1) but it is also possible that the events of 
fertilization itself may be disrupted. The use of an Z/z uZZro system allows 
close control and observation of these events (Moore, 1986), as discussed in 
section 6.1.
Tre(%Z/?%enZ u/ZzA Zo%Z/is
Since the desired concentration of ethanol could be satisfactorily 
administered via the drinking water (M. Festing, personal communication),
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it was felt unnecessary to use the liquid diet treatment regimen of Anderson 
et al (1980b, 1982, 1983). The use of pair-fed controls eliminated the 
possibility that effects due to under-nutrition would be seen.
There are several opportunities for the treatment of sperm in vitro: 
during the initial dispersal stage in the culture medium, during all or part 
of the capacitation stage or during fertihzation. The simplest of these, 
technically, is to treat during dispersal and this approach has been employed 
in the study presented this chapter.
In vitro fertilization and pre-implantation embryo culture
The culture requirements of embryos of the F, hybrid C57B1 x CBA 
had already been established (M. Wood, personal communication), so this 
strain was chosen for these in vitro fertilization studies, despite the fact that 
it was less readily available than others. Chatot et al (1990) have shown 
that different strains of mouse have different requirements with respect to 
culture medium for their embryos in vitro. It might have been possible to 
use some of the random-bred and inbred strains since alteration of the levels 
of various medium components (including glutamine and glucose) from those 
used for the culture of F, hybrid embryos, could enable these embryos to 
overcome the 2-cell block (Chatot et al, 1990).
For a given strain, culture medium components were found to have 
little effect on mouse pre-implantation embryo development, although 
metabolism has been shown to be modulated (Gardner & Leese, 1990). 
Considerable care was taken to reduce the variability between different 
batches of media; the osmolarity was always checked and kept within a 
narrow range.
The use of hyaluronidase in the culture medium allowed the dispersal 
of the cumulus cells and enabled the oocytes to be distributed amongst the 
various treatm ent groups to avoid the possibility of bias introduced by the
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female of origin. Cumulus masses were pooled from all the females used for 
one in vitro fertilization. These were treated with hyaluronidase and groups 
of individual oocytes were transferred to separate fertilization dishes 
containing sperm that had been subjected to different treatments.
Scoring and selection o f endpoints
Early work in the field of in vitro fertilization aimed at producing live 
young after embryo transfer (Thibault et al, 1954). This would still be a 
possible endpoint when using in vitro fertilization as a toxicity screen 
(Brackett, 1978).
Different workers have used different criteria for the assessment of 
fertilization in vitro. Holloway et al (1990a,b) scored as fertilized, those 
oocytes in which the decondensing sperm head and the sperm midpiece 
could be seen in the cytoplasm and the sperm tail in the pre-vitelline space 
after 24 h. Anderson et al (1980b) scored as fertilized, those oocytes which 
had undergone the first cleavage division or those in which the decondensed 
male pronucleus could be seen, when fixed and stained after 26 h.
In the studies presented in this chapter, fertilization rate was 
calculated as the proportion of embryos which had reached the 2-cell stage 
24 h after mixing sperm and ova. This may have resulted in slightly lower 
rates, but indicated successful fertilizations and had the advantage of being 
quick and easy to score (Pampfer et al, 1989). Development was followed to 
the blastocyst stage in order to establish whether a toxic effect may be 
manifested in the pre-implantation embryo.
The aim of the work presented in this chapter was to measure the
effect of ethanol on male fertilizing ability. Initially, control levels were 
established with respect to the routine procedures utilized.
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Two approaches to the measurement of toxicity were used: in vivo 
treatment followed by in vitro assessment of sperm; in vitro treatm ent and 
assessment. The resulting embryos were maintained in culture for the 
whole of the pre-implantation period in order to detect the mediation of 
‘infertility’ through embryolethality at this stage.
3.2 METHODS
M aterials
The materials used in the work presented in this chapter were as
follows:
7X,
phosphate-free laboratory detergent
Bovine serum albumin, 
fraction V, 96 - 99 %
Calcium chloride,
AnalaR
Diet pellets,
rat & mouse no. 3 (modified)
Disodium hydrogen orthophosphate, 
dodecahydrate, AnalaR
Dissecting microscope,
Model SZ
Embiyological watchglass,
30 mm diameter
Ethanol,
absolute, 99.5 % w/w 
with < 0.01 % methanol
Formalin,
10 % buffered, made from 10 
mM; GPR), 10 % Na^HPO^ (353 mM; GPR)
10 % formaldehyde solution (37 - 41 %; GPR)
KHgPO^ (224
ICN Flow,
High Wycombe, UK
Sigma Chemical Co. Ltd., 
Poole, UK
BDH Chemicals Ltd., 
Poole, UK
Special Diet Services, 
Waltham, UK
BDH Chemicals Ltd., 
Poole, UK
Olympus,
London, UK
Raymond A. Lamb, 
London, UK
FSA Laboratory Supplies, 
Loughborough, UK
Made in house using reagents 
supplied by BDH Chemicals Ltd. 
Poole. UK
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D-glucose,
AnalaR
Haemacytometer,
counting chamber, improved Neubauer 
HEPES,
(N-2 -hydro3iyethylpiperazine-N’-2 -ethane- 
sulfonic acid) free acid, Ultrol® grade
Hotplate,
Techne Dri-Block® DB-3
Human chorionic gonadotrophin, 
Chorulon®, Organon
Hyaluronidase,
type 1 -S: from bovine testes, lyophilized 
powder (300 U mg'^)
Incubator,
37 °C
Industrial methylated spirits
Lipsol,
Mquid concentrate, phosphate-free, 
biodegradable
Magnesium chloride, 
hexahydrate, AnalaR
Magnesium sulphate, 
heptahydrate, AnalaR
Mouse,
F2 hybrid CBA? x C57d; either Fq animals 
purchased, and mated at BIBRA; or F  ^ hybrids 
purchased directly
Mouthpiece,
haematology
Osmometer,
semi-micro
Paraffin oil,
liquid, colourless, light GPR
Pasteur pipette, 
glass, long-form, 230 mm
Penicillin,
Crystapen®
Petri dish,
plastic, 60 mm diameter, sterile
pH colour standards,
from M KH2P0^ (acid) and M
NagHPO^ (alkali)
BDH Chemicals Ltd., 
Poole, UK
Weber Scientific 
International Ltd., 
Lancing, UK
Calbiochem-Boehring, 
Cambridge Biosciences, 
Cambridge, UK
FSA Laboratory Supplies, 
Loughborough, UK
Intervet,
Cambridge, UK
Sigma Chemical Co. Ltd., 
Poole. UK
ICN Flow,
High Wycombe, UK
Infrakem Ltd.,
Wigan, UK
Lip,
Shipley, UK
BDH Chemicals Ltd., 
Poole, UK
BDH Chemicals Ltd., 
Poole, UK
Harlan Olac Ltd. 
Bicester, UK
Arnold R. Horwell, 
London, UK
Knauer,
Berlin, Germany
BDH Chemicals Ltd., 
Poole, UK
John Poulten Ltd., 
Barking, UK
Glaxo Pharmaceuticals 
Uxbridge, UK
Becton Dickinson (Falcon), 
Oxford, UK
Made in house,
BIBRA
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Phenol red,
0.5 % solution
Phosphate buffered saline, 
solution A, Dulhecco’s, pH 7.3
Pipette,
1 0  ml, plastic
Potassium chloride,
AnalaR
Potassium dihydrogen orthophosphate, 
AnalaR
Pregnant mares’ serum gonadotrophin, 
Folligon®, Organon
Sodium chloride,
AnalaR
Sodium hydrogen carbonate,
AnalaR
Sodium hydroxide, 
pellets, AnalaR
Sodium lactate,
DL-lactic acid, sodium salt, 60 % aqueous 
solution
Sodium pyruvate,
pyruvic acid (a-ketopropionic acid;
2 -oxopropanoic acid) sodium salt, type 1 1 ,
crystalline
Streptomycin, 
sulphate BP for injection
Sucrose,
(1-0-a-D-glucopyrano^l-B-D-fructofuranoside; 
saccharose; cane sugar) grade II
Watchmakers forceps
ICN Flow,
High Wycombe, UK
Oxoid,
Unipath Ltd., Basingstoke, UK
Becton Dickinson (Falcon), 
Oxford, UK
BDH Chemicals Ltd.,
Poole, UK
BDH Chemicals Ltd.,
Poole, UK
Intervet,
Cambridge, UK
BDH Chemicals Ltd.,
Poole, UK
BDH Chemicals Ltd.,
Poole, UK
BDH Chemicals Ltd.,
Poole, UK
Sigma Chemical Co. Ltd., 
Poole, UK
Sigma Chemical Co. Ltd., 
Poole, UK
Evans Medical Ltd., 
Horsham, UK
Sigma Chemical Co. Ltd., 
Poole, UK
A. Dumont & Fils, 
Switzerland
G eneral M ethods
For a diagrammatic representation of the method see fig. 3.1.
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Fig. 3.1 Method for in vitro fertilization and 
pre-implantation embryo culture
superovulation
Sperm prepared
males
killed
13 - 16 h
Sperm
released
from
epididy­
mides
T6
dish
epididymides
Sperm
dispersal
30 min
Sperm con­
centration 
adjusted
sperm
count
females
kiHed
90 minCompletion of 
capacitation
M2
dish oviducts
r hyalur-> 
onidase 
treatm ent
< 6  min
T6+BSA
dish sperm & ova
4 h
M16+BSA
dish
up to 1 0  embryos
per drop of medium
1 - 5 days
scoring
Females injected 
withPMSG&48h
later with hCG
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Cumulus
masses
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CKa
dispersal
FertOization
Culture
Scoring
see table 3.1 for description of culture media T6, M16 and M2; ESA, bovine 
serum albumin; hCG, human chorionic gonadotrophin; PMSG, pregnant 
mares’ serum gonadotrophin
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Culture media and dishes
Culture media T6, Ml 6 and M2 (see table 3.1) were prepared from 
concentrated stocks (see tables 3.2 and 3.3). Medium was added to 30 mm 
diameter glass embryological watchglasses or 60 mm diameter plastic petri 
dishes (see table 3.1) and overlaid with paraffin oil to prevent evaporation. 
Dishes containing media for sperm collection and dispersal, ova collection, 
ova dispersal, 1-cell embryo washing and for embryo culture (see table 3.1) 
were incubated at 37 °C and 5 % COg in air overnight before use. Media for 
ova washing and for fertilization (see table 3.1) were left in the same 
incubator overnight and adjusted to pH 7.6, using 0.1 M NaOH and 
comparing with pH colour standards, before adding to the dishes on the day 
of use. All dishes were kept in the incubator until required and on a 37 °C 
hotplate or the warm stage of a dissecting microscope when in use.
Preparation of sperm
Two sexually mature male mice were used for each in vitro 
fertilization assay. These were hybrids of CBÂ9 x C57cf. Animals were 
maintained as described in section 2.2.
Males were killed by cervical dislocation and the two cauda 
epididymides removed from each. One epididymis from each male was 
placed in each of two sperm collection and dispersal dishes (see table 3.1). 
Under the dissecting microscope, watchmakers forceps were used to pierce 
and squeeze the epididymides to release the sperm. The epididymal tissue 
was removed and the dishes placed in the incubator for 30 min to allow the 
sperm to disperse. The dish with the best-dispersed sperm was used for the 
in vitro fertilization assay and the other discarded. A 40 jul sample of sperm 
suspension was added to 10 % buffered formalin (400 /il) and the sperm 
counted using a haemacytometer. An aliquot of sperm suspension (40 /il, 
ac^usted as required with T6 culture medium) was added to the 400 jitl drop
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of medium in the fertilization dish (see table 3.1) to give a final 
concentration of 10® sperm ml \  The fertilization dish was returned to the 
incubator until 2 h after the initial dissection of the males, to allow 
capacitation to be completed.
Table 3.1 Culture media used for 
in vitro fertilization
Use of dish Culture medium® Type of dish Contents of dish
Sperm collection 
and dispersal
T6 30 mm 
embryological 
watchglass with 
coverslip
1  ml medium, 
overlaid with 
paraffin oil
Ova collection M2+BSA^ 30 mm 
embryological 
watchglass with 
coverslip
1  ml medium,
overlaid with 
paraffin oil
Ova dispersal M2 +BSA^-H
hyaluronidase^
30 mm
embryological watch- 
glass with coverslip
1  ml medium, 
overlaid with 
paraffin oil
Ova washing T6 +BSA(^ 30 mm
embryological watch- 
glass with coverslip
1  ml medium, 
overlaid with 
paraffin oil
Fertilization T6 +BSA^ 60 mm plastic petri 
dish
1 0 0  yï medium 
surrounded by 
paraffin oil, 300 yl 
medium placed on 
top, overlaid with 
paraffin oil
One-cell embryo 
washing
M16+BSA^ 30 mm
embryological watch- 
glass with coverslip
1  ml medium, 
overlaid with 
paraffin oil
Embryo culture M16+BSA^ 60 mm plastic petri 
dish
2 1  separate drops 
of medium 
pipetted in rows 
under 1 0  ml 
paraffin oil
BSA, bovine serum albumin; ^  see table 3.2 for details of culture media; 
BSA at 4 mg ml'^; hyaluronidase at 300 U ml'^; BSA at 15 mg ml'^
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Preparation of ova
To achieve high rates of in vitro fertilization and the development of 
as high a percentage of embryos as possible beyond the 2-cell stage (up to 
blastocyst), Fj hybrids of C BA 9 x C57cf mice were used. Animals were kept 
as described in section 2.2, but were not acclimatized for 10 days before use. 
Two to four immature, 3-week-old females per in vitro fertilization assay 
were superovulated by intraperitoneal (IP) injection with 7.5 lU pregnant 
mares’ serum gonadotrophin in 0.3 ml phosphate buffered saline followed 
after 48 h by injection with 6.0 lU human chorionic gonadotrophin (hCG) in
0.3 ml water.
Table 3.2 Culture media made from concentrated stocks 
for use in in vitro fertilization
Medium Stock solutions 
for type M or 
type T media®
Volume of 
stock required
Total volume^ Maximum 
storage time
M2 A(M) 1 0 . 0  ml 1 0 0  ml 2  weeks
B (M) 1 . 6  ml
C (M) 1 . 0  ml
D (M) 1 . 0  ml
E(M ) 8.4 ml
M16 A(M) 1 0 . 0  ml 1 0 0  ml 2  weeks
B(M) 1 0 . 0  ml
C (M) 1 . 0  ml
D (M) 1 . 0  ml
T6 A(T) 1 0 . 0  ml 1 0 0  ml 2  weeks
B (T) 1 0 . 0  ml
c m 1 . 0  ml
D (T) 1 . 0  ml
®, see table 3.3 for description of stock solutions; balance made up with 
double-distilled water
80
Table 3.3 Components of concentrated stocks used for culture media 
for in vitro fertilization
Stock® Chemical g 1 0 0  mT^ Maximum
storage
time
Osmol­
arity,
mOsmol
kg^
M® stocks T® stocks
A N a a 5.53 5.72 3 months 243^
KCl 0.36 0 . 1 1
KH2 PO4 0.16 0
MgSO^.THgO 0.29 0
MgCl2 .6 H 2 0 0 0 . 1 0
Na^HPO^.lZHgO 0 0.13
Na lactate 4.35 4.65
Glucose 1 . 0 0 1 . 0 0
Penicillin 0.06 0.06
Streptomycin 0.05 0.05
B NaHCO^ 2 . 1 0 2 . 1 0 2  weeks 430
Phenol red 2  ml 2  ml
C Na pyruvate 0.36 0.52 2  weeks 62(M)
93(T)
D CaClg-gHgO 2.52 2.62 3 months 447
E HEPES 5.96 - 3 months 360^
Phenol red 2  ml -
HEPES, (N-[2-Hydroxyethyl]piperazine-N’-[2-ethanesulfonic acid]); ®, see 
table 3.2 for details of use of M and T stocks; , osmolarity measured in 10 % 
dilution of A stocks; pH 7.4
Thirteen to sixteen hours after hCG injection, females were killed by 
cervical dislocation. The two oviducts, together with the ends of the uterine 
horns, were removed from each and placed in the ova collection dish (see 
table 3.1). Under the dissecting microscope, two pairs of watchmakers 
forceps were used to pierce the oviducts and release the cumulus masses. 
The oviduct and uterine tissue were removed and the cumulus masses were 
transferred to the ova dispersal dish containing 300 U ml^ hyaluronidase 
(see table 3.1). After approximately 5 min treatment, during which the
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cumulus cells were dispersed, the ova were transferred by pipette to the 
first ova washing dish (see table 3.1), then to the second, and finally to the 
fertilization dish (see table 3.1) containing capacitated sperm (see above). 
The zona pellucida remained intact.
The fertilization dish, containing sperm and ova, was returned to the 
incubator for 4 h to allow fertilization to take place.
Culture and scoring o f pre-implantation embryos
After fertilization, all the presumptive 1-cell embryos were removed 
from the fertilization dish by pipette and passed through two 1-cell embryo 
washing dishes (see table 3.1). Up to ten embryos were placed in each drop 
of medium in the embryo culture dish (see table 3.1) using as many drops 
as necessary. Under the dissecting microscope the 1-cell embryos were 
scored for the presence or absence of the second polar body (see fig. 3.2), and 
the embryo culture dish returned to the incubator. Embryos were scored 
for progression to 2 cells on day two, 3 - 4 cells on day three, 5 -1 6  cells on 
day four and blastocyst on day five, as shown in fig. 3.2.
Glassware and plastics
Glassware was soaked overnight in industrial methylated spirits to 
remove oil where necessary, soaked in 2 % Lipsol® overnight, washed in 
2 % 7X® and rinsed ten times in tap water, five times in single distilled 
water and three times in double-distilled water. Culture dishes were 
checked under the dissecting microscope for cleanliness and were then oven 
sterilised.
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Fig. 3.2 Scoring system for pre-implantation 
mouse embryos
Day of 
culture
Appearance of embryo^ Notes
1
2 nd polar body
1 st polar body sometimes visible; 
orientation may mean that 2 nd 
polar body cannot be seen
2
Q
2 -cell embryo
Cells visibly smaller so 2-cell 
embiyos can be recognised whatever
their orientation
3
4-cell embryo
3- to 4-cell embryos scored
4
8 -cell embryo
5- to 16-cell embryos scored; ball of 
cells which cannot easily be counted
5 #
blastocyst
Hollow structure; cells not 
distinguishable; sometimes hatching 
out of the zona peZZnczda
the table shows the stage of development which can be reached after the 
particular number of days in culture
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In order to ensure the highest possible rates of in vitro fertilization 
and pre-implantation embryo development, all plastics were purchased from 
Becton Dickinson (Falcon) since these are known to be of a suitable quality 
(M. Wood, personal communication). Pasteur pipettes were heated in a 
flame and pulled out to make narrow-bore pipettes which were controlled 
via a mouthpiece.
V alidation  exp erim en ts
The time interval between injection of hCG and collection of ova was 
believed to affect the number of ova collected. The correlation between the 
two was determined.
Hyaluronidase treatment of ova
Two experiments (HI & H2) were carried out in order to investigate 
the effect of hyaluronidase treatment on the rate of in vitro fertilization and 
subsequent development of pre-implantation embryos. In each experiment 
half the cumulus masses were processed using the method described above, 
i.e. they were placed in the ova dispersal dish (containing 300 U ml' 
hyaluronidase) for up to 6 min, washed twice and transferred, using a 
pipette, to a fertilization dish containing sperm. The other half were not 
dispersed and, after washing twice, were transferred as intact cumulus 
masses, using watchmakers forceps, to a second fertilization dish containing 
sperm. Fertilization and development was scored over a five day culture 
period, as described above.
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Sperm number
Four experiments (SI, S2, S3 & S4) were carried out in order to 
investigate the effect of a reduction in sperm number on in vitro fertilization 
frequency. As described above, the standard sperm concentration used was 
10® ml ‘ and in each of these four experiments, reduced sperm concentrations 
of 5 X 10® ml \  10® ml^ and 5 x 10* ml ' were also used. Pooled sperm from 
two animals were used for all four dilutions and in vitro fertilization rate 
determined (as described above) using pooled ova from 3 or 4 females. 
Fertilization and development were scored over a five day culture period, as 
described above.
T reatm ent w ith  eth an ol in vivo
Experiment 1
Nine Fj hybrid male mice (CBÂ9 x C57cf) were used at age 7 weeks. 
Males from different litters were evenly distributed amongst the three 
treatment groups and given 19.0 % or 11.4 % volumeivolume ratio (v/v) 
ethanol in drinking water (high and low treatment groups) or 157 g 1' 
sucrose in drinking water (control group; equicaloric to low level ethanol). 
Liquid consumption was measured twice weekly and bodyweight at post 
mortem examination. Bodyweights were not measured at the start of the 
study but males were evenly assigned to the different treatment groups and 
significant differences would not have been expected between them.
After 6 and 12 weeks m fertilizing ability was measured using 
the method described above. One in fertilization assay was carried out 
after 6 weeks, using one male from each group, and two m fertilization 
assays after 12 weeks, each using one male from each group. Three female 
mice (CBA9 x C57cf) were used for each m fertilization assay at age 3
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to 4 weeks. Fertilization and development was scored over a five day 
culture period, as described above.
Experiment 2
Sixteen Fj hybrid males (CBA9 x C57cf) were used at age 9-10 weeks. 
The males were divided into four groups, individually housed and given 
ethanol and/or sucrose in drinking water as shown in tables 3.4 & 3.5. 
Bodyweights of all animals were measured before treatment began and 
twice weekly during the 16-week treatment period.
The four individuals in group 1 (high level ethanol, 20 % v/v) received 
drinking water containing 5 % (v/v) and 10 % (v/v) ethanol for the first two 
weeks respectively, and thereafter 20 % (v/v). Individual food and water 
intakes were measured daily in group 1 in order to calculate the amount to 
be given to the pair-fed animals in groups 2 and 3.
Animals in group 2 (low level ethanol, 10 % v/v) and group 3 
(equicaloric sucrose control, 275 g 1') were pair-fed to specific individuals in 
group 1 during the 2-week build-up time and the final 14-week treatment,
i.e. the amounts consumed in one day by animals in group 1 were given to 
the corresponding animals in groups 2 and 3 on the following day.
Animals in group 4 received food and water ad libitum and the 
amounts of each consumed were recorded daily.
At the end of treatment, one male from each group was weighed and 
tested for in ui^ro fertilizing ability (using the method described above) on 
each of four successive days. Four to five female mice (CBA9 x C57cf) were 
used per in vitro fertilization at age 3 to 5 weeks. Fertilization and 
development were scored over a five day culture period, as described above.
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Table 3.4 Ethanol and sucrose treatments given to mice in 
drinking water in experiment 2
Treatment Treatment group®
week
1 2 3 4
High dose 
ethanol 
( 2 0  % v/v)
Low dose 
ethanol 
(pair-fed^ to 
group 1 ;
1 0  % v/v)
Equicaloric 
sucrose 
(pair-fed^ to 
group 1 )
Normal 
feeding 
(Le. water ad 
libitum)
Week 1 e e b a
Week 2 f f c a
Week 8  - 16 h _______ g_______ d a
one sperm collection and dispersal dish, immediately prior to addition of the 
epididymides, to give a final concentration of 174 mM, 435 mM or 870 mM. 
In each in vitro fertilization experiment there was one control dish and one 
dish containing one of these concentrations of ethanol.
In vitro fertilizing ability was measured using the method described 
above. Two female mice (C B A 9 x C57cf) were used per in vitro fertilization 
at age 3 to 6 weeks. Fertilization and development was scored over a five 
day culture period, as described above.
S ta tistica l analysis
A correlation coefficient was calculated for the number of ova 
collected with respect to the time between hCG injection and ova collection 
(Snedecor & Cochran, 1968f). The proportion of 2-cell embryos in different 
treatment groups was compared using a Fisher’s exact test (Siegel, 1956a).
For bodyweights and water consumptions, homogeneity of variance 
was measured by Bartlett’s test (Snedecor & Cochran, 1968b). Differences 
between treatments were tested using analysis of variance (ANOVA) 
(Snedecor & Cochran, 1968c) and, where Bartlett’s statistic was non­
significant, variances were pooled and differences from control (food and 
water ad libitum) or pair-fed sucrose control tested by the least significant 
difference test (Snedecor & Cochran, 1968d). Where Bartlett’s statistic was 
significant, differences between treatments were tested by Student’s t-test 
(Snedecor & Cochran, 1968e).
3.3 RESULTS
A ssessm en t o f fertiliza tion  rate  
and pre-im plan tation  em bryo develop m en t
Embryos were scored (see fig. 3.2) for the presence of the second polar 
body (indicating the penetration of ova by sperm) immediately after their 
transfer to the embryo culture dish on day one. Depending on the 
orientation of the 1-cell embryos, the second polar body was not always 
easily visible and misclassification of 1-cell embryos as unfertilized ova was 
possible. The movement of the tails of sperm attached to the zonapellucida 
caused movement of the embryos/ova and brought some previously hidden 
second polar bodies into view. However, the need to return the embryos to 
the incubator as soon as possible made it inappropriate to spend too long in 
scoring at this stage. Thus, the estimation of fertilization rate from the 
presence of the second polar body on day one was often low, despite the fact 
that occasionally the first polar body was visible, since the polar bodies could 
be distinguished by their size and appearance.
On day two, embryos were scored for the completion of the first 
cleavage division, after which they had reached the 2-cell stage. Depending 
on the orientation of the embryo, the two cells were not always visible side- 
by-side and were no longer turned by attached sperm. However, each of the 
two new cells was smaller than the original ovum so that 2-cell embryos 
could be distinguished whatever their orientation. The measurement of the 
fertihzation rate was very accurate if measured by the number of 2-cell 
embryos on day two and was nearly always higher than the rate measured 
by the presence of the second polar body on day one.
Embryos were scored for the completion of the second cleavage 
division in one or both cells on day three, when they reached the easily
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identifiable 3- to 4-cell stage. There were usually fewer 3- to 4-cell embryos 
on day three than there were 2-cell embryos on day two, presumably due to 
the fact that the in vitro conditions were not ideal for normal development.
On day four, normally-dividing embryos had completed the third, and 
sometimes the fourth, cleavage division producing a ball of between 5 and 
16 cells. It became very difficult to identify individual cells as their number 
increased and the embryos started to compact. Developing embryos were 
identified as balls of cells and had to be distinguished from fragmentation 
occurring as cells broke up in dead or dying embryos. (These may have been 
encountered earlier in the culture period.)
The completion of the fifth cleavage division (32 cells) or more, and 
development of the blastocoel cavity forming a blastocyst, had occurred in 
normally-dividing embryos by day five. Blastocysts were slightly larger in 
diameter than the balls of cells seen on day four, the cells were completely 
indistinguishable giving a smooth appearance and the embryos were hollow. 
Occasionally blastocysts had begun to hatch as the zona pellucida thinned. 
At this stage in vivo embryos would begin to implant into the uterine wall 
and cultures were therefore terminated on day five. There were usually 
very few blastocysts on day five and the number of fragmenting embryos 
was normally high.
Taking into account the scoring rates at different stages of in vitro 
development discussed above, the number of 2-cell embryos on day two was 
considered to be the most accurate measure of fertilization rate. A 
successful in vitro fertilization was deemed to be one in which 80 to 100 % 
of the ova incubated with sperm from control animals produced 2-cell 
embryos on day two.
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V alidation  exp erim en ts
Timing o f superovulation
The scatter diagram in fig. 3.3 shows the distribution of the number 
of ova collected with respect to the time between hCG injection and 
collection of ova in 39 preliminary experiments. The correlation coefficient 
was 0.24, which was not significant. Generally, very low values for the 
number of ova collected per female were obtained with the longest times 
after hCG injection.
Fig. 3.3 Correlation between time after human chorionic gonadotrophin 
injection and number of ova collected
m e a n  n o .  o f  o v a  p e r  f e m a l e
6 0
5 0  -
4 0  -
3 0  -
2 0  -
1 5 : 3 0 1 6 :0 0 1 7 : 0 01 5 : 0 0 1 6 : 3 0
t i m e  a f t e r  h CG  I n j e c t i o n ,  h a n d  mi n
hCG, human chorionic gonadotrophin
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Hyaluronidase treatment
The effect of hyaluronidase treatment on in vitro fertihzation rate and 
pre-implantation embryo development was evaluated in experiments HI and 
H2. The results are shown in table 3.6.
Table 3.6 The effect of hyaluronidase treatment of ova on in vitro fertilization 
rate and pre-implantation embryo development
Day
of
cul­
ture
Stage of 
develop­
ment®
Experiment H I Experiment H2
Without
hyaluronidase
With
hyaluronidase
Without
hyaluronidase
With
hyaluronidase
No. % No. % No. % No. %
1 2nd PB 29 97 36 95 35 70 58 82
2 2-cell 29 97 3 8 ^ 100 44 88 69^ ® 97
3 3- to 4-ceU 14 47 22 58 44 88 66 93
4 5- to 16-cell 0 0 11 29 36 72 61 86
5 Blastocyst 1 3 0 0 13 26 35 49
Total number of 
embryos
30 38 50 71
2 Fragment­
ing^
0 0 0 0 1 2 1 1
3 9 30 10 26 3 6 1 1
4 29 97 27 71 14 28 11 15
5 29 97 38 100 26 52 27 38
the number of embryos and the percentage of the total are shown at each stage 
of development; ^  developmental stage scored as shown in fig. 3.2; ,
fragmenting embryos occurred as cells broke up in dead or dying embryos; PB, 
polar body; not significantly different,p  > 0.05, from corresponding embryos
without hyaluronidase
Fertilization rate (measured by the proportion of 2-cell embryos on 
day two; table 3.6 line 2) was not decreased by the use of hyaluronidase in 
either experiment ip > 0.05). Subsequent development (table 3.6 lines 3, 
4 & 5) was not adversely affected by hyaluronidase treatment but progressed 
further in a greater proportion of embryos in experiment H2 than in 
experiment HI. Fragmentation (table 3.6 lines 7, 8, 9 & 10) did not occur
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at a higher rate in embryos from ova exposed to hyaluronidase but the rate 
was lower in experiment H2 than in experiment HI.
Sperm concentration
The effect of sperm concentration on in vitro fertihzation rate and 
pre-implantation embryo development was determined in experiments SI, 
S2, S3 and 84. The results are shown in table 3.7.
Table 3.7 The effect of sperm concentration on in vitro fertilization 
rate and pre-implantation embryo development
Day
of
cul­
ture
Stage of 
develop­
ment®
Sperm concentration
10® ml'^ 5 X 10® ml'^ 10® ml*^ 5 X lO'^  mP^
No. % No. % No. % No. %
1 2nd PB 51 76 54 68 34 50 16 26
2 2-cell 59 88 56** 71 28*** 41 14*** 23
3 3- to 4-cell 53 79 48 61 18 26 10 16
4 5- to 16-cell 46 69 43 54 15 22 8 13
5 Blastocyst 16 24 15 19 2 3 3 5
Total number of 
embryos
67 79 68 61
2 Fragment­
ing
1 1 3 4 2 3 1 2
3 1 1 9 11 5 7 8 13
4 15 22 27 34 44 65 50 82
5 49 73 62 78 66 97 58 95
pooled results for four experiments SI, S2, S3, S4; the number of embryos 
and the percentage of the total are shown at each stage of development; ®, 
developmental stage scored as shown in fig. 3.2; fragmenting embryos 
occurred as cells broke up in dead or dying embryos; PB, polar body; , 
significantly lower, p  < 0.01; , significantly lower, p  < 0.001, than cultures
using 10® sperm ml'^
A reduction in fertilization rate (measured by the proportion of 2-cell 
embryos on day two; table 3.7 line 2) was observed with the reduction in
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sperm concentration. With the standard concentration of 10® sperm ml^ 
there was a fertilization rate of 88 % which was reduced to 71 % with 5x10® 
ml^ (p < 0.01), to 41 % with 10® ml * (p < 0.001) and to 23 % with 5 x 10^  ml^ 
(p < 0.001). Similar reductions were seen at the subsequent stages of 
development (table 3.7 lines 3, 4 & 5). Fragmentation rate was low (1 %) 
after each of the first two days in cultures where 10® ml^ sperm 
concentration had been used and was higher (up to 13 %) in the three 
cultures where lower sperm concentrations had been used (table 3.7 lines 
7 & 8). There was a large increase in the proportion of fragmenting 
embryos after four and five days in culture in all sets (table 3.7 lines 9 & 10) 
with cultures showing a higher fragmentation rate with lower initial sperm 
concentration.
The effects o f in vivo treatm ent o f m ale m ice w ith  
eth an ol on in vitro fertiliza tion  rate and  
pre-im plantation  em bryo developm ent
Experiment 1
Table 3.8 shows the bodyweights and drinking water consumptions 
for the three groups of animals treated with high level ethanol (19.0 % v/v), 
low level ethanol (11.4 % v/v) or sucrose (157 g 1‘) in drinking water. 
Bodyweights were similar after 6 weeks treatment (table 3.8, column 1, hnes 
1, 3 & 5) but after 12 weeks treatment, mean bodyweight in both the 
ethanol-treated groups was significantly lower (p < 0.05) than that in control 
group (table 3.8, column 1, lines 2, 4 & 6). Mean daily liquid consumption 
in both the ethanol-treated groups was less than half that in the control 
(table 3.8, column 2). Mean daily ethanol consumption was 17.8 g kg ' in the 
high level group and 10.6 g kg' in the low level group (table 3.8, column 3).
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Table 3.8 Bodyweights and drinking water consumption for male 
mice treated with ethanol or sucrose in experiment 1 (without pair feeding)
Treatment Weeks of 
treatment
No. of 
male mice 
treated
Bodyweight,
g
mean ± SD
Daily consumption
liquid, 
ml kg*
Ethanol,
gkg'^
Sucrose 
(equicaloric 
to 19.0 % 
ethanol)
6 1 30.2 342 0.00
12 2 38.9 ± 0.78 327 ± 50 0.00
Ethanol 
(11.4 % v/v)
6 1 31.7 114 10.1
12 2 33.1* ± 1.06 123^^± 0 10.9
Ethanol 
(19.0 % v/v)
6 1 30.6 110 16.5
12 2 31.3**± 1.27 123*± 3 18.5
SD, standard deviation; not significantly different, p  > 0.05; , significantly 
different, p < 0.05; , significantly different, p  < 0.01, compared with
corresponding value for 12-week sucrose control; least significant difference 
test used for bodyweights; Student’s t-test used for daily liquid consumption
The effects of ethanol treatment on fertilization rate and subsequent 
pre-implantation embryo development are shown in table 3.9. Fertilization 
rate (measured by the proportion of 2-cell embryos on day two; table 3.9, 
line 2) was lower in both the ethanol-treated groups after 6 weeks 
treatment but this difference was significant ip < 0.05) in the low level 
group and was not significant ip > 0.05) in the high level group. After 12 
weeks treatment there was little difference in fertilization rate between the 
groups ip > 0.05). No treatment-related differences were seen in either the 
subsequent development of the pre-implantation embryos (table 3.9, lines 
3, 4 & 5) or the fragmentation rate (table 3.9, lines 7, 8, 9 & 10).
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Experiment 2
Table 3.10 shows the bodyweights and drinking water consumptions 
for the four groups of animals treated with high level ethanol (20 % v/v), 
low level ethanol (10 % v/v + 137 g 1^  sucrose) and sucrose (275 g V) in 
drinking water, and control (food and water ad libitum).
Table 3.10 Bodyweights and drinking water consumption for male mice treated 
with ethanol or sucrose in experiment 2 (incorporating pair feeding)
Treatment No.
of
male
mice
Bodyweight, mean ± SD Dmly consumption
At
start, g
At
end, g
Gain,
%
Liquid, 
ml kg'^
Ethanol,
gkg"^
Control 
(food and 
water ad 
libitum)
4 32.0 
± 3.6
36.4 
± 3.3
1 2 . 1  
± 2.5
104.6 
± 9.0
0 . 0 0
Sucrose 
(274gl-l 
equicaloric 
to 20% 
ethanol)
4 28.3*
± 1.0
32.9^
± 1.0
14.1^^ 
± 2.7
91.7^^ 
± 2 . 6
0 . 0 0
Ethanol 
( 1 0  % v/v 
+ 137 g 
sucrose)
4 3 0  3 ns [ns] 
± 1.5
3 5  ^ns [ns] 
± 2 . 8
1 3  gns [ns] 
± 3.9
9 5 .0 “® 
± 1 2 . 2
7.50
Ethanol 
(20 % v/v)
4 33.3^ ^^  
± 1.9
36.8^ [*]
± 2.4
9  gns [ns]
± 2.9
96.0“'* 
± 7.5
15.18
SD, standard deviation; not significantly different, p  > 0.05; significantly
different, p  < 0.05, compared with untreated control; iiot significantly 
different, p > 0.05; significantly different, p  < 0.05; significantly 
different, p  < 0.01, compared with sucrose control
The percentage gain in weight was not significantly different (p > 
0.05) in any of the three pair-fed groups compared with the control group 
nor in either of the ethanol-treated groups compared with the sucrose 
control (table 3.10, column 3). Mean bodyweights at the start or at the end 
of treatment did vary but not in relation to treatment (table 3.10, columns
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1 & 2). Mean daily liquid consumption was lower in each of the three pair- 
fed groups compared to the control group but these differences were not 
significant (p > 0.05) (table 3.10, column 4). There was no significant 
difference (p > 0.05) between either of the ethanol-treated groups and the 
sucrose control (table 3.10, column 4). Mean daily ethanol consumption was 
15.18 g kg^ in the high level group and 7.50 g kg' in the low level group 
(table 3.10, column 5). Food consumptions were not subjected to statistical 
analysis, but they appeared to be similar between groups.
The effects of ethanol treatment on fertilization rate and subsequent 
pre-implantation embryo development are shown in table 3.11.
Fertilization rate (measured by the proportion of 2-cell embryos on 
day two; table 3.11, line 2) was lower in all three pair-fed groups (high level 
ethanol, low level ethanol and sucrose) but the differences were significant 
(p < 0.01) for the sucrose group and the low level ethanol group ip < 0.05) 
and not significant for the high level ethanol group ip > 0.05). No 
treatment-related differences were seen in either the subsequent 
development of the pre-implantation embryos (table 3.11, lines 3, 4 & 5) or 
the fragmentation rate (table 3.11, lines 7, 8, 9 & 10).
The e ffects  o f in vitro treatm en t o f  sperm  w ith  
eth an ol on  in vitro fertiliza tion  rate and  
pre-im plantation  em bryo developm ent
The effect on in vitro fertilization rate and pre-implantation embryo 
development of treatment of sperm with ethanol in the sperm collection and 
dispersal dish was measured. The results are shown in table 3.12.
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Table 3.11 The effect of ethanol treatment of male mice in vivo on in vitro fertilization rate
and pre-implantation embryo development in experiment 2 (with pair feeding)
Day
of
cul­
ture
Stage of 
develop­
ment^
Treatment
Ethanol 
20 % v/v
Ethanol 
10 % v/v 
+ sucrose
Sucrose
equicaloric
to
20 % ethanol
Control 
food & 
water 
ad libitum
No. % No. % No. % No. %
1 2nd PB 55 56 48 42 49 37 51 46
2 2-cell ggns [ns] 71 79* [ns] 69 8 8 " 66 88 80
3 3- to 4-ceU 64 66 80 70 89 66 83 75
4 5- to 16-cell 56 58 73 64 76 57 74 67
5 Blastocyst 19 24 20 18 25 19 22 20
Total number of 
embryos
97 114 134 110
2 Fragment-
mg°
6 6 2 2 5 4 7 5
3 17 18 11 10 13 10 14 10
4 38 39 22 19 32 24 34 25
5 68 70 85 75 78 58 65 49
results are pooled from four experiments; the number of embryos and the 
percentage of the total are shown at each stage of development; 
developmental stage scored as shown in fig. 3.2; firagmenting embiyos 
occurred as cells broke up in dead or dying embryos; PB, polar body; irÿ  
significantly different, p  > 0.05; , significantly different, p  < 0.05; ,
significantly different, p  < 0.01 from untreated control; not significantly 
different from sucrose control, p  > 0.05
Fertilization rate (measured by the proportion of 2-cell embryos on 
day two; table 3.12, line 2) was significantly reduced in cultures from sperm 
treated with 174 mM or 870 mM ethanol (p < 0.01) but unaffected (p > 0.05) 
in cultures from sperm treated with 435 mM ethanol. There was no further 
treatment-related effect on either the subsequent development of the pre­
implantation embryos (table 3.12, lines 3, 4 & 5) or the fragmentation rate 
(table 3.12, lines 7, 8, 9 & 10).
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Table 3,12 The effect of ethanol treatment of mouse sperm in vitro on in vitro fertilization
rate and pre-implantation embryo development
Day
of
cul­
ture
Stage of 
develop­
ment^
Treatment
Ethanol 
870 mM
Ethanol 
435 mM
Ethanol 
174 mM
Control 
0 mM
No. % No. % No. % No. %
1 2nd PB 13 27 27 56 17 39 91 64
2 2 -cell 36"" 75 4 4 ns 92 3 3 " 75 132 92
3 3- to 4-cell 9 19 33 69 18® 55 61*^ 60
4 5- to 16-cell 18 38 35 73 24 55 96 67
5 Blastocyst 0 0 3 6 4® 36 20^ 18
Total number of 
embryos
48 48 44 143
2 Fragment­
ing^
0 0 1 2 1 2 4 3
3 6 13 2 4 5® 15 8^ 8
4 18 38 8 17 14 32 31 22
5 40 83 45 94 7® 64 95^ 83
results are pooled from seven experiments; the number of embiyos and the 
percentage of the total are shown at each stage of development; 
developmental stage scored as shown in fig. 3.2; fragmenting embiyos 
occurred as cells broke up in dead or dying embryos; n = 33; n = 101*^ ®, 
n = 11; ^ n = 114; PB, polar body; not significantly different, p > 0.05; ,
significantly different, p  < 0.01, from control
3.4 DISCUSSION
The e ffects  o f eth an o l on  
in vitro fertiliza tion
The initial results presented in this chapter validated the in vitro 
fertilization and pre-implantation embryo culture system. The criterion that 
80 to 100 % of control embryos had reached the 2-cell stage on day 2 of 
culture was usually met and few experiments were eliminated from the
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analyses on these grounds. Once the appropriate time had been established 
for the timing of superovulation, a large number of ova could be routinely 
obtained from each female. Hyaluronidase treatment (used to disperse 
cumulus cells) was not found to adversely affect fertilization or development 
of the cultured embryos and was therefore routinely used in order to 
distribute ova from different females amongst the treatment groups. Sperm 
concentration was found to influence fertilization rate and was therefore 
kept constant between different treatment groups.
The experimental results, in which some of the reproductive effects 
of ethanol were investigated, showed that treatment with ethanol in vivo or 
in vitro did not adversely affect in vitro fertilization rate in mice in a 
consistent manner at the doses given and thus contradict the findings of 
Anderson et al (1980a, 1982, 1983). Treatment of mice with ethanol was 
found to inhibit growth, as indicated by a lower bodyweight after 12 weeks 
of treatment (experiment 1), and for this reason, pair-fed controls were used 
subsequently (experiment 2). The treatment regimens (10 to 20 % ethanol 
for 6, 12 or 16 weeks) were not found to consistently affect in vitro 
fertilization rate or pre-implantation embryo development in vitro.
Ethanol has been shown to penetrate the seminiferous tubules of the 
rat within a few minutes of IP dosing (Salonen & Eriksson, 1989). Both the 
dose and the duration of ethanol treatment have been found to affect testis 
pathology (Willis et al, 1983). In their initial experiments, Anderson et al 
(1980b) found in vitro fertilization rate in mice to be unaffected by chronic 
ethanol treatment of males (5 %, 5 weeks), although the morphology of the 
testis was affected. Subsequently (1982, 1983), they found a dramatic 
decrease in in vitro fertilization rate using either a longer treatment (5 %, 
20 weeks) or a higher dose of ethanol (6 %, 6 weeks), although there was 
still no effect with 5 % ethanol at 10 weeks.
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The discrepancy between the results presented in this chapter and 
those of Anderson et al (1982, 1983) could be due to the different strains of 
mice used, to differences in the treatment regimen (liquid diet vs. drinking 
water) or possible differences in the purity of the ethanol used {e.g. < 0.01 
% methanol in these studies; not specified by Anderson et al). Anderson et 
al (1982,1983) had a much lower control in vitro fertilization frequency than 
was obtained in the studies presented in this chapter. This could indicate 
that sperm function was already compromised in some way and therefore 
more sensitive to the antifertility effects of ethanol.
There is a ‘threshold effect’ for the number of sperm required to 
achieve fertilization in vivo (Moore, 1986), which relates to the concept of 
gamete redundancy (Cohen, 1975). It is therefore possible that the use of 
too high a sperm concentration in in vitro fertilization may mask the effect 
of a toxic chemical even though equal numbers are used in control and 
treated dishes. Sperm concentration may reach a saturation limit (all 
competent oocytes fertilized), beyond which an increase in sperm number 
would not further increase fertilization rate. If an ethanol-induced decrease 
in fertihzing ability occurred above this limit, this would not be detected by 
measuring the proportion of oocytes fertilized. Initial results presented in 
this chapter indicated that a decrease in sperm number decreased 
fertilization rate. The sensitivity of the system would be maximized by the 
choice of a sperm concentration at (or just below) the saturation limit.
Although it was not measured in the studies presented in this 
chapter, no effect on sperm motility was observed qualitatively under the 
microscope, a finding which agrees with that of Anderson et al (1983).
Treatment of sperm with ethanol in vitro (up to 870 mM) during the 
30 min dispersal phase of preparation for in vitro fertilization did not inhibit 
their fertilizing capacity in a consistent manner, although it was significantly 
decreased at two of the three conentrations of ethanol. Again, this finding
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is in contrast to the results of Anderson et al (1982) since they observed a 
dose-related reduction in in vitro fertilization rate after a 60 min treatment 
at one tenth of the dose levels used. Cash & Rogers (1981) also found that 
in vitro treatment of human sperm with ethanol (87 mM) decreased 
fertilizing capacity as measured in the zona4xee golden hamster ova 
penetration test.
It is possible that any loss of fertilizing ability that had been induced 
in the sperm during the 30 min exposure in vitro to high levels of ethanol 
was restored during the following 90 min incubation prior to addition of the 
oocytes. Anderson et al (1982) found that a partial recovery from the effects 
of 60 min ethanol exposure was possible after a further 60 min incubation 
without ethanol. In vitro fertilizing ability was also inhibited after ethanol 
treatment of sperm during capacitation in vitro but not through its inclusion 
in other incubation media (Anderson et al, 1982). This effect was attributed 
to an inhibition of the capacitation process, since forward progression was 
not altered and the acrosome reaction was not inhibited.
P ossib le  m echanism s o f action  
o f an tifer tility  agen ts
Potential physiological targets for chemicals causing male infertility 
include the epididymal maturation process, capacitation, the acrosome 
reaction and spermatogenesis (Anderson et al, 1983). It is known that 
alterations in the chemical components of culture medium can affect both 
metabolism and fertility, and it is possible that other chemicals (e.g. 
antifertility agents) may act similarly (Fraser & Lane, 1987). Inhibition of 
ADH with pyrazole eliminated the effect of in vitro ethanol treatment 
(Anderson et al, 1982). However, acetaldehyde was without effect, indicating
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that another product of this oxidative metabolism mediated the effect 
(Anderson et al, 1982) (see section 1.2).
Since chemical treatment is known to produce abnormal sperm 
morphology (Wyrobek & Bruce, 1975) this could provide a mechanism for 
the reduction in fertilizing ability. Such a reduction, in response to ethanol 
treatment, was indeed attributed to an increase in the proportion of 
morphologically abnormal sperm (Anderson et al, 1983). Any resulting 
impairment of forward progression may render such sperm incapable of 
penetrating the egg vestments, in particular the cumulus cells, which 
provide a barrier to penetration (Krzanowska & Lorenc, 1983) (see section 
6.3). Morphologically abnormal mouse sperm were found to bind less 
frequently, and in an abnormal manner, to the zona pellucida in vitro than 
morphologically normal sperm (Kot & Handel, 1987). It is unlikely that such 
sperm would get the opportunity to bind in vivo since they would be unable 
to travel through the female reproductive tract (Krzanowska, 1974).
Treatment with 1,3-dinitrobenzene resulted in detachment of germ 
cells (see chapter 5) at specific stages of spermatogenesis resulting in 
decreased fertility in vivo due to decreased sperm numbers at the 
corresponding times (Holloway et al, 1990b). When this effect of sperm 
concentration was removed by using an in vitro fertilization procedure, 
fertility was still found to be reduced and was thought to be due to a direct 
effect on germ cells that were not shed from the Sertoli cells at the time of 
treatment (Holloway et al, 1990b).
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T h e  p o t e n t i a l  f o r  t h e  u s e  o f  in vitro f e r t i l i z a t i o n
a n d  p r e - im p la n t a t io n  e m b r y o  c u l t u r e  i n  t h e
in v e s t i g a t io n  o f  a n t i f e r t i l i t y  a g e n t s
Technical complexity
The process of fertilization has many stages, any of which may be 
disrupted by chemical insult. The use of in vitro fertilization techniques 
gives the opportunity for precise pinpointing of the function which has been 
damaged through close monitoring of events (Moore, 1986). As far back as 
1978, Brackett concluded that in vitro fertilization had a value in screening 
chemicals for their antifertility effect. It could be taken as an indication of 
the technical complexity of the procedure that few studies have actually 
utilized this technique.
Holloway et al (1990a) chose to develop the rat in vitro fertilization 
system as a toxicity screen, on the grounds that this species is more 
commonly used in conventional reproductive toxicology tests. However, the 
mouse is also a commonly used laboratory animal and the in vitro 
fertilization system in this species is technically less demanding, and has 
been established longer, than the rat in vitro fertilization system (Moore,
1986). This means that the former requires a lower investment of resources 
to set up as a screening system, hence its use in the studies presented in 
this chapter.
Despite this relative simplicity, conditions for successful in vitro 
fertilization using mouse gametes remain technically demanding. The 
measurement of sperm parameters other than fertilizing ability {e.g. sperm 
velocity, sperm morphology), whilst not having the advantage of identifying 
the precise disrupted function, are easier to carry out (Moore, 1986). Some 
human sperm parameters are found to correlate reasonably well with 
fertility, and the correlation may not be improved by the use of more
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elaborate procedures including the zona-îxee golden hamster oocyte 
penetration test (Wang et al, 1988; Mao & Grimes, 1988). A correlation 
between motility parameters and in vitro fertilizing ability has been 
observed in human sperm (Bongso et al, 1989). These examples are from 
studies of patients with unexplained infertility but, as in human infertihty 
diagnosis, the correlation of sperm parameters with fertilizing ability in 
experimental animals would justify their use in investigating chemical 
toxicity.
Holloway et al (1990a,b) effectively doubled the number of replicate 
measurements of fertilizing ability made by taking the epididymides of each 
male separately. Again, this increased the technical complexity of the 
method since specific surgical skills are required.
Embryo development
In addition to the measurement of effects of male treatment on fertil­
izing ability, assessment of effects on pre-implantation embryo development 
was also an objective of these studies. This enabled comparison with the 
experiment presented in chapter 4 in which males were treated with CP and 
their fertility and development of their offspring was assessed in vivo. It 
was also possible to compare with the in vitro culture of post-implantation 
embryos as presented in chapter 2. (See chapters 1 and 6.)
As in the case of post-implantation embryos (see chapter 2), 
development of pre-implantation embryos progressed more slowly in vitro 
than in vivo, an observation that Carney & Foote (1990) found to be 
dependent on precise culture conditions. A similar result was observed in 
a comparison of dry mass in mouse pre-implantation embryos (Turner et al, 
1990).
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Comparison with in vivo studies
A further advantage of the in vitro system is the reduction in the 
number of animals required in an experiment in order to account for inter­
animal variability (Moore, 1986; Holloway et al, 1990a).
Holloway et al (1990a) concluded that in vitro fertilization in the rat 
provided a sensitive assay compared with a conventional in vivo reproductive 
toxicity assay for ethylene glycol monomethyl ether-induced infertihty and 
were able to rule out the decrease in sperm concentration as the cause of 
the infertihty. Tsunoda & Chang (1976) found a good correlation between 
the a-chlorhydrin-induced reduction in fertilizing ability of rat sperm in vitro 
and in vivo, assessed as the proportion of penetrated ova. However, they 
concluded that the in vivo system provided a better measure of fertihty, 
since it was technically less demanding and more physiological. This was 
despite the fact that the antifertihty effects of a-chlorhydrin could 
presumably have been explained by the dose-related decrease in sperm 
motility which was observed in vitro (Tsunoda & Chang, 1976), and the fact 
that the recovery of oocytes or embryos from the uterus is reported to be a 
laborious and inefficient process in the rat (Moore, 1988).
One of the disadvantages of in vitro over in vivo measurement of 
sperm fertihzing capacity is the requirement for a very high sperm 
concentration at the oocyte, presumably indicating that the process is less 
efficient (Moore, 1986). As discussed above, this may compromise the 
sensitivity of the endpoint in vitro.
Cytogenetic analysis of the male and female pronuclei can be 
performed at the first cleavage division of embryos (Donahue, 1972; Fraser 
& Maudlin, 1979) or at later stages (Rohrborn & Easier, 1984) after parental 
treatment and fertihzation in vivo. In vitro fertihzation provides an
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alternative means of cytogenetic investigation in the pre-implantation 
embryo after treatment of the male. Control can be exercised over the 
events of fertilization and embryo development (Matsuda et al, 1989b) and 
improved synchronization of division provides metaphases of a higher quality 
than in vivo fertilization (Fraser & Maudlin, 1979). One-cell mouse embryos 
were able to repair X-ray- or mitomycin C-induced damage to sperm DNA 
which would otherwise result in chromosome breaks at the first cleavage 
division (Matsuda et al, 1989b).
The culture of mouse pre-implantation embryos in the serum from 
treated animals, or from human males or females who are infertile, provides 
a method for assessing toxicity at this stage through the measurement of 
survival or SCE frequency (Porter & Singh, 1988; Porter et al, 1988). Again, 
a similar approach can be used in vivo after treatment of females early in 
pregnancy and measurement of SCEs or chromosome aberrations at a later 
stage (Vogel & Spielmann, 1989).
C onclusions and  future p ossib ilities
One of the major uses to which in vitro fertilization and pre­
implantation embryo culture can be put is in the field of human infertility 
diagnosis and treatment. The techniques of amniotic fluid or chorionic villus 
sampling are widely used for the prenatal diagnosis of many inherited 
disorders (e.g. Lehmann aZ, 1985). Recent advances in human m uiZm 
fertilization and pre-implantation embryo culture have led to new 
approaches to this type of analysis which obviate the need for therapeutic 
abortion (reviewed by Adinolfi & Polani, 1989). Successful diagnosis of B- 
thalassaemia has been made using 4- to 8-cell mouse embryos and applying 
the polymerase chain reaction technique (Holding & Monk, 1989). Biopsy
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for this purpose was not shown to compromise embryo development in vitro 
or in vivo after embryo transfer (Wilton & Trounson, 1989).
There are many parallels that can be drawn between the use of in 
vitro fertilization systems in the diagnosis of human infertility and in 
toxicity testing. In order for in vitro systems to predict in vivo fertility 
accurately, it will be necessary to use a battery of tests to evaluate a range 
of sperm function criteria (Yanagimachi, 1984). The application of more 
sophisticated techniques in in vivo fertilization or a combination of in vivo 
and in vitro methods (Moore, 1986) may ultimately provide a better system 
for routine toxicity screening.
In vitro treatment of sperm makes the best use of the in vitro 
fertilization technique for toxicity testing purposes in the light of the 
advantages outlined in above. As discussed in chapter 1, metabolism must 
be taken into account in such studies and, since ethanol is known to be 
metabolized to acetaldehyde in vivo, it would be of interest to assess the 
direct effects of this metabolite on sperm in vitro. The investigations into 
the protective effects of L-ascorbic acid and DL-a-tocopherol carried out in 
cultured post-implantation embryos (chapter 2) and cultured Sertoli cells 
(chapter 5) could be pursued in sperm in vitro or in cultured pre­
implantation embryos.
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CHAPTER 4
THE INCIDENCE OF TUMOURS AND 
MALFORMATIONS IN THE ADULT 
OFFSPRING OF MALE RATS TREATED 
WITH CYCLOPHOSPHAMIDE
i.]L
Although the potential reproductive hazards resulting from female ex­
posure to chemicals are widely recognized, the risk posed by exposure of the 
male often is not. This chapter deals with the possibility of inducing genetic 
effects in adult offspring, mediated via male germ cells, by investigating the 
effects of cyclophosphamide (CP) in rats.
E vidence for paternally-m ediated  
effects on offspring in  hum ans
Most human studies on the effects on offspring of paternal exposure 
to chemical toxins have been carried out by ascertaining the probable 
exposure of fathers (usually occupational) at around the time of conception 
of children with a particular abnormality. There are many problems 
associated with the design of such studies (Joffe, 1979).
The reviews by Brown (1985), Cohen (1986) and Joffe (1979) all con­
cluded that there may be an important paternal contribution to congenital 
abnormality and genetic disorder. Conversely, in reply to a letter to the 
Journal of the American Medical Association, Frederiksen (1988) advised the 
general practitioner of a man receiving medication that, since the risks of 
maternal exposure are so much higher, no cessation of drug treatment need 
be considered before conception.
Pubhc concern over the influence of paternal exposure to mutagenic 
agents on carcinogenic events in their children has been heightened recently 
through newspaper reports on fathers' occupation at nuclear power plants 
and childhood leukaemia (Gardner et al, 1990a,b).
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0/1 o^^ri/ig os c/ii/dre/i o/id odoZ s^
Some childhood cancer syndromes are known to be associated with 
chromosome deletions, for example Wilms’ tumour (Francke et al, 1979), 
retinoblastoma (Yunis & Ramsay, 1978) and Frader-WiUi syndrome (Cassidy 
eZ oZ, 1989).
A high proportion of the fathers of children with Prader-Willi syn­
drome (often characterised by a deletion of the q-arm of the paternal 
chromosome 15) have been found to have been occupationally exposed to 
hydrocarbons (Cassidy eZ al, 1989; Strakowski & Butler, 1987). The fathers 
of children with Wilms’ tumour tend to have been occupationally exposed to 
lead (Kantor et al, 1979) although this association was not confirmed by 
Wilkins & Sinks (1984). Two groups (Wilkins & Hundley, 1990; Johnson & 
Spitz, 1989) have found an apparent association between male occupational 
exposure to electromagnetic fields and the incidence of tumours of the ner­
vous system in the offspring. Olshan et al (1989) concluded that no partic­
ular risks of this type could be determined for the occupations of fathers of 
children with Down’s syndrome (trisomy 21). Seven papers concerned with 
the association of childhood cancer and paternal occupation were reviewed 
by Terracini et al in 1983. They were unable to draw any firm conclusions 
from these data but felt that, since some associations had been found in 
some studies, further investigations could be informative.
Intelligence quotient (IQ) test score obtained from 18-year old French 
army recruits indicated an inverted U-shaped curve with respect to fathers’ 
age (Auroux eZ uZ, 1989) with the decrease at greater age possibly being due 
to longer environmental exposure to a wide variety of mutagens.
FocZaZ a/zd j^ crZ/zaZaZ
Low birth weight was associated with, though not necessarily caused 
by, paternal ethanol consumption at around the time of conception (Little
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& Sing, 1987). Infant and foetal deaths from anencephaly were found to be 
associated with fathers who worked with paint, but not with those who 
worked with pesticides (Brender & Suarez, 1990). Children bom to firemen 
(who are potentially occupationally exposed to many toxic chemicals) could 
be at an increased risk of a congenital heart defect (Olshan et al, 1990). The 
nematocide dibromochloropropane is known to cause male infertility (Whor- 
ton et al, 1977) but it caused no birth defects after recovery of exposed 
males (Potashnik & Phillip, 1988).
Spontaneous abortion was examined in the partners of males known 
to have consumed ethanol (Halmesmaki et al, 1989). It was concluded that 
moderate drinking at around the time of conception did not have an effect. 
Again using women who had had a spontaneous abortion as the group under 
study, correlation was sought with 24 paternal occupational groups (McDon­
ald et al, 1989). Although an association with the occupations of mechanics 
and repairers was found, it was felt that this could have been due to chance 
and did not provide evidence of a causal relationship.
The exposure to herbicides which occurred in Vietnam has been as­
sociated with an increase in malformations in offspring (Can, 1984).
M easurem ent o f p aternally-m ediated  
e ffects  on offspring in  exp erim en tal an im als
There are several standard toxicology tests for measuring the induc-
tion of germ line mutations in experimental animals. These include tests 
for dominant lethal mutations, heritable translocations, dominant cataracts 
and specific locus mutations (Venitt & Pariy, 1984; UKEMS, 1990).
Other indicators of paternally-mediated effects have also been consid- 
ered in experiments using animals. Since, like mutagenesis, carcinogenesis 
can also involve alteration of the genetic material, it is logical to consider
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the possibility that a mutation in the male germ line might lead to tumours 
in the offspring. Many behavioural tests have been developed for experi­
mental animals and these have been found to provide sensitive endpoints for 
the detection of paternally-mediated effects on offspring (Adams et al, 1982). 
The greatest genetic burden that can be caused is one that can be passed on 
through subsequent generations (Lyon & Renshaw, 1988).
Some of the standard toxicology tests have been compared with other 
endpoints of interest. Knudsen et al (1977) has described a modification of 
the dominant lethal test in rats, in which foetal abnormalities can be 
detected in the same experiment. No difference was observed between the 
level of CP-induced dead implants measured either at mid-term or at term, 
and several malformations were detected in the day-20 embryos. A herit­
able translocation has been shown to be associated with a neurological mut­
ation (leading to behavioural anomalies) in the offspring of a male mouse 
exposed to ethylene oxide (Lewis et al, 1990). This was presumed to be due 
to the occurrence of one of the chromosome breakpoints in the region of the 
affected gene. The assessment of external and skeletal foetal malformations 
in mice has been shown to be as sensitive an endpoint for the analysis of 
germ cell damage as the specific locus test (Nagao & Fujikawa, 1990). Five 
mutagens known to be positive in the specific locus test were found to cause 
malformations in the offspring.
o/z o^%)rz/zg os ndzzZZs
Nomura (1982) reported that paternal treatment with either X-rays 
or urethane brought about a high frequency of lung tumours in the adult 
offspring. Tomatis eZ nZ (1981,1990) found an increase (though statistically 
non-significant) in the incidence of tumours of the nervous system in the F^  
progeny of male rats treated with ethylnitrosourea.
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Nomura (1983) demonstrated that paternal treatment with X-rays 
gave rise to heritable ‘tumour mutations’, which led to an increased number 
of both ‘spontaneous’ and urethane-induced lung tumours in the progeny. 
Inheritance of this effect followed a dominant pattern with 40 % penetrance 
for ‘spontaneous’ lung tumours and an increased penetrance produced by ur­
ethane. Lyon & Renshaw (1988) demonstrated that some of the normal 
male offspring (FJ of female mice exposed to X-rays before mating, them­
selves produced offspring (Fg) which carried congenital malformations. 
These were shown to be due to the inheritance of dominant mutations of 
low penetrance; i.e. the mutations were suppressed in the F, animals and ex­
pressed in the Fg. Auroux et al (1990) have made a similar observation for 
the CP induction of a heritable mutation causing behavioural changes.
Adams et al (1982) and Auroux & Dulioust (1985) noted modified 
learning behaviour in the offspring of male rats exposed to CP. Paternal 
ethanol consumption in mice and rats modified offspring behaviour mediated 
via changes in neurochemistry (Abel & Bilitzke, 1990). Joffe et al (1990) 
found similar changes in the offspring of methadone-treated rats, which 
were not accompanied by effects on foetal and perinatal viability and growth.
Foetal and perinatal effects
Trasler et al (1985) and Jenkinson et al (1990) observed a dominant 
lethal effect and an increased frequency of foetal malformations in the off- 
spring of male rats treated chronically with CP. Mankes eZ nZ (1982) demon­
strated a similar effect of ethanol, although Randall eZ uZ (1982) obtained an 
opposite result with mice. These studies also reported results on the gen­
eral reproductive performance of the treated males. For example, Jenkinson 
eZ aZ (1990) reported no effect on pregnancy rate, sperm abnormalities or 
sperm count but, in contrast, Mankes cZ uZ (1982) observed gross changes in 
testis histology in the studies discussed above.
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C yclophospham ide
CP is frequently used as a positive control in genotoxicity assays since 
it is known to be mutagenic, carcinogenic, clastogenic and teratogenic (see 
below).
Use and metabolism
CP is a toxic drug (Auroux et al, 1990) that is widely used in chemo­
therapy as an anticancer and immunosuppressive agent (Trasler et al, 1987). 
The initial step in its metabolism is a cytochrome P-450-mediated 
hydroxylation to 4-hydroxy-CP (Connors, 1978). Subsequent reactions may 
either detoxify this to 4-keto-CP or result in its breakdown to acrolein and 
phosphoramide mustard (Domeyer & Sladek, 1980) (see fig. 4.1). The latter 
is believed to provide both the anticancer and the cytotoxic activity (Struck 
et al, 1975) through its action as an alkylating agent at physiological pH 
(Domeyer & Sladek, 1980).
Toxicity and mutagenicity
CP is mutagenic in bacterial assays (Hales, 1982) and carcinogenic in 
animals (Schmal & Habs, 1979). Sister chromatid exchanges (SCEs) have 
been reported to be induced by CP in human lymphocytes m uiuo (Mc- 
Dairmid et al, 1990) and in vitro (Deknudt, 1986), and micronuclei in mouse 
bone marrow (Adler & Kliesch, 1990). Chromosome aberrations can be 
induced in human leukocytes and in the bone marrow of experimental 
animals (Mohn & Ellenberger, 1976).
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Fig. 4.1 Metabolic pathway of cyclophosphamide
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Treatment of rats during pregnancy induced a teratogenic response 
(Hales, 1981). An m study carried out by Mirkes aZ (1981) investig- 
ating the teratogenicity of the three stable metabolites of CP, concluded 
that phosphoramide mustard, and not acrolein or 4-keto-CP, caused the foe­
tal malformations seen in vivo. Vogel & Spielmann (1989) have suggested 
that chromosome aberrations and SCEs may not be induced by the same CP 
metabolites.
CP is known to cross the blood-testis barrier (Forrest eZ aZ, 1981). It 
caused oligozoospermia, azoospermia and increased follicle stimulating 
hormone in human subjects (Watson et al, 1985) and decreased testis weight 
and testicular DNA, RNA and protein synthesis (Lee & Dixon, 1972). Since 
it is administered to men of reproductive age (Trasler et al, 1987), and 
recovery of spermatogenesis is possible after cessation of treatment 
(Buchanan et al, 1975), there is a potential hazard to the progeny of such 
men, in that they may be at risk of congenital malformation (Trasler et al, 
1985).
There is, in fact, little evidence either for or against the induction of 
congenital malformations by paternal CP treatment in humans. The birth 
of one malformed child has been reported by Russell et al (1976) and other 
workers have reported the birth of seven normal children (Li & Jaffe, 1974; 
Etteldorf et al, 1976; Blake et al, 1976; Hinkes & Plotkin, 1973).
As described above, CP produces a wide range of effects on the 
offspring of treated male animals. In addition to the production of dominant 
lethal mutations and foetal abnormalities in rats, Jenkinson aZ (1990) 
demonstrated that structural and numerical chromosome aberrations were 
detected in the karyotypes of malformed foetuses.
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E xperim ental system
As can be seen from the flowchart in fig. 1.1, damage to either the 
male or female gametes may induce problems in the resulting embryos or 
offspring. The reason for the choice of males in experimental work is that 
direct effects (e.g. through maternal systemic effects) can be more easily 
ruled out (but see section 4.4).
Treatment regimen
Dominant lethal studies are normally carried out using an acute treat­
ment regimen (Anderson, 1984). This enables the specific stage(s) of sperm­
atogenesis affected to be pinpointed since the same males can be mated to 
successive sets of females at different times after treatment (Anderson, 
1984). However, it was concluded by Jenkinson et al (1987) that acute 
dosing with CP was not the most effective regimen by which to detect male- 
mediated foetal abnormalities. In the work of Trasler et al (1985, 1986,
1987), Adams et al (1981, 1982), Auroux & Dulioust (1985), Auroux et al 
(1990), Hales et al (1986), Hales & Robaire (1990) and Jenkinson et al (1990) 
a chronic dosing regimen has been used because this more closely mimics 
the human treatment situation.
In the study reported in this chapter, treatment was carried out at a 
lower level during the first four weeks in order to reduce the high level of 
dominant lethality expected to be induced at the post-meiotic stages 
examined by Jenkinson et al (1990). The selected dose (5.1 mg kg') was 
beheved to be equivalent to that used in human treatment (i.e. 1 - 2 mg kg ' 
day ') (Trasler et al, 1987). It was continued for 30 weeks so that all stages 
of the spermatogenic cycle (see section 1.1) were exposed to CP (10 weeks) 
and further, to mimic the usual exposure situation in humans. Thus, the 
treatment time was equivalent to a 'working life' exposure duration.
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Selection of endpoints
Although infertility and spontaneous abortion of malformed foetuses 
represent a serious concern in humans, children born with congenital ab­
normalities and genetic disorders, which may persist into adulthood, present 
a potential problem of much greater magnitude. The discovery of major 
karyotype abnormalities in the malformed foetuses of CP-treated male rats 
(Jenkinson et al, 1990) indicated that some, if not all, of the observed mal­
formations were genetic in origin.
In order to investigate the possible induction of ‘tumour mutations' 
(Nomura, 1983), a population of F, individuals from CP-treated males was 
observed over a two-year period. The random division of this population in­
to subgroups for post mortem examination (PM) at 3-monthly intervals 
during the second year of life was intended to detect any lowering of the age 
of onset of tumours (in the early groups) without missing the occurrence of 
unusual tumours which might have had a later onset (in the late groups).
The scope of the study allowed examination of adult animals for 
macroscopic, but not microscopic, lesions at PM. Histological classification 
of tumours was performed where possible. Karyotypes were prepared from 
bone marrow metaphases from both abnormal and macroscopically normal 
offspring since minor pathological abnormalities may have been overlooked.
Whilst it is not always possible to extrapolate directly from animal 
studies to the human situation (Joffe, 1979), this type of investigation pro- 
vides a means of researching the paternal effects of a chemical from the a 
priori point of view and without the introduction of a series of confounding 
factors.
Objectives
The aim of the work presented in this chapter was to investigate 
whether the paternally-mediated effects of CP were still present in offspring
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as adults. Two populations of rats, from fathers treated chronically with a 
low dose of CP and from control fathers, were examined for macroscopic 
abnormahties and karyotype anomalies between 12 and 24 months of age.
4.2 METHODS
M aterials
The materials used in the work presented in this chapter were as 
follows:-
Acetic acid, 
glacial, AnalaR
Centrifuge, 
model Centaur 2
Centrifuge tube, 
plastic, 1 1  ml
Colcemid,
Demecolcine (N-diacetyl-N-methyl colchicine) 
crystalline
Colchicine,
C2 2 IÎ 2 5 NO6 , crystalline
Cyclophosphamide,
Endoxana
Diet pellets,
rat & mouse no. 3 (modified)
DPX,
mountant
Eosin,
water soluble, yellow shade
Formalin,
10 % buffered, made from 10 % KH2 PO4  (224 
mM; GPR), 10 % Na^HPO^ (353 mM; GPR), 
10 % formaldehyde solution (37 - 41 %; GPR)
Giemsa stain,
Q u i t ’s  improved R6 6
Gurr’s buEer, 
pH 6.8
FSA Laboratory Supplies, 
Loughborough, UK
MSE Scientific Instruments, 
Crawley, UK
Nunc, Gibco BRL Ltd., 
Paisley, Scotland, UK
Sigma Chemical Co. Ltd., 
Poole, UK
Sigma Chemical Co. Ltd.,
Poole, UK
Ward Blenkinsop Pharmaceuticals 
Ltd., Bracknell, UK
Special Diet Services,
Waltham, UK
BDH Chemicals Ltd.,
Poole, UK
BDH Chemicals Ltd.,
Poole, UK
Made in house using reagents
supplied by BDH Chemicals Ltd., 
Poole, UK
BDH Chemicals Ltd., 
Poole, UK
BDH Chemicals Ltd., 
Poole, UK
120
Haematoxylin,
Harris
Hank’s balanced salt solution,
without calcium and magnesium
Lithium heparin,
from porcine intestinal mucosa
Methanol,
AnalaR
Microscope, 
model Laborlux 12
Needle,
19 gauge, 2 inch 
Potassium chloride
Rat,
Sprague Dawley 
Sodium chloride
George T. Gurr,
London, UK
Gibco BRL Ltd.,
Uxbridge, UK
Sigma Chemical Co. Ltd.,
Poole, UK
FSA Laboratory Supplies, 
Loughborough, UK
Leitz,
Germany
Sabre International Products Ltd. 
Reading, UK
FSA Laboratory Supplies, 
Loughborough, UK
Harlan Olac Ltd.,
Bicester, UK
FSA Laboratory Supplies, 
Loughborough, UK
G eneral M ethods
For a diagrammatic representation of the method see fig. 4.2. 
Treatment and matings were carried out as described by Jenkinson et al 
(1990).
T reatm ent and study design
Animals
Male Sprague-Dawley rats at eight to ten weeks of age were randomly 
allocated to two treatment groups, one for cyclophosphamide treatment (n 
= 18) and one as control (n = 6). Two sexually mature virgin females of the 
same strain were randomly allocated to each male for mating at the end of 
the treatment period. Animals were kept as described in section 2.2.
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Fig. 4.2 Method for investigating the incidence of 
tumours and malformations in the offspring of male rats
rats treated
6  males 18 males
cydophoGphamWe
treatment for 33 weeks
control treatment 
for 33 weeks
rats mated
2  females per male 2  females per male
litters born
offspring counted
litters weighed
offspring assigned to 5 groups 
for post mortem examination
PM at
79 weeks
PM at
52 weeks
PM at
6 6  weeks
PM at
91 weeks
r PM at
104 weeks
19 CP
23 con
21 CP
28 con
16 CP
28 con
17 CP 
24 con
13 CP
13 con
PM, post mortem examination; CP, cyclophosphamide; con, control
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Treatment
Animals were dosed daily with either cyclophosphamide in 0.85 % 
saline or 0.85 % saline alone (10 ml kg"^ ) for 30 weeks according to the 
scheme illustrated in table 4.1.
Table 4.1 Dosing scheme for cvclophosphamide- 
and control-treatment of male rats
Treatment
group
n Treatment
week
Dosing level
CP mg kg'^ in 
0.85 % saline
Days per week
CP-treated 18 1 - 4 3.5 7
5 -  12 5.1 7
13 - 33 5.1 5
Control 6 1 - 4 0 7
5 - 12 0 7
13 - 33 0 5
CP, cyclophosphamide; n, number of males in group 
Mating
Thirty weeks after the beginning of treatment, each male was caged 
with two females for one week or until the females were sperm positive in 
a vaginal smear. Treatment was continued during the mating period. 
Offspring were counted and weighed as a litter at birth and again at 
weaning.
After weaning, offspring were caged chronologically in sets of ffve 
until they were twelve months old, when they were split into sets of two or 
three. Offspring were evenly assigned to five groups for PM examination, 
i.e. some offspring from each female were placed in each group and, where
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this was not possible due to a small litter size, it was ensured that some 
offspring from each male were placed in each group.
E xam ination  o f an im als
PMs were carried out at 54, 66, 79, 91 and 104 weeks of age (by Mrs. 
S.K Doubell). Animals that died during this time, or which were killed for 
humane reasons due to sickness, were also subject to a full PM. Animals 
were weighed and the following tissues were examined for macroscopic 
abnormalities:
adrenal, bladder, brain, caecum, colon, diaphragm, duodenum, 
epididymis, eye, Harderian, heart, ileum, kidney, liver, lung, 
lymph node, mammary, ovary, pancreas, pituitary, prostate, 
salivary, skin, spleen, stomach, testis, uterus, vagina
Most of the anomalies observed were those commonly seen in rats of
this age and strain and were therefore not included in subsequent data
analyses. Tissues exhibiting abnormahties which were considered to be
more unusual and tissues with tumours were recorded. A sample of such
tissue was fixed in 10 % buffered formalin where possible.
Tissue for histological examination was processed by standard 
methods, as described by Bancroft & Stevens (1977). Some of the fixed 
tissue samples were embedded in paraffin wax and cut into 5 Aim sections. 
These were mounted on shdes, stained with haematoxylin and eosin, and 
examined under a light microscope (by Dr. J. G. Evans). Tumours were 
classified according to the scheme of Turusov & Mohr (1990).
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Cytogenetic analysis
Metaphase preparation
Four hours before being killed for PM, animals were given 3 ml kg^ 
of 1 mg ml ' colchicine by intraperitoneal injection in order to arrest dividing 
cells in metaphase.
Metaphases were prepared from bone marrow by the method of 
Anderson & Richardson (1981), as follows. One femur was removed from 
each animal and the closed ends cut off. A 2 ml syringe fitted with a 19 
gauge, 2 inch needle, was filled with Hank’s balanced salt solution containing 
colchicine (100 pg ml ') and lithium heparin (100 /ig ml '). This was inserted 
into the end of the femur and the bone marrow aspirated from it into a 
plastic centrifuge tube. This operation was repeated several times; total 
volume 10 ml. After centrifuging at 170 g for 3 min, the supernatant was 
removed and the cells resuspended in 0.075 M KCl (hypotonic) containing 
colcemid (0.1 /ig ml ') and left for 15 min in order to swell the cells. After 
centrifuging as before, the cells were fixed in 3:1 methemol:acetic acid.
The fixed-cell suspension was dropped onto wet microscope slides and 
allowed to air dry. Slides were stained with 5 % Giemsa in Gurr’s buffer, 
pH 6.8, for 5 min. They were air dried and mounted in DPX for examin­
ation under the light microscope at a magnification of x 1000.
All slides were examined and chromosome counts were made in 
several metaphases on those which had spreads of sufficient quality. Each
karyotype was compared with the standard karyotype of the Norway rat 
(Committee for a Standardized Karyotype of Rattus norvégiens, 1973). The 
best quahty metaphase from some of the slides was photographed.
125
Statistical analysis
Pre-weaning data
A Fisher’s exact test (Siegel, 1956a) was used to compare pregnancy
rate.
The number of offspring per litter at birth, the mean pup weight at 
birth, the number of offspring per litter at weaning, the mean pup weight 
at weaning and animal weight at PM were tested for homogeneity of 
variance by Bartlett’s test (Snedecor & Cochran, 1968b). All four of these 
parameters were tested for normality using a Kolmogorov-Smirnov test 
(Siegel, 1956c).
For comparison of the mean pup weights and animal weights at PM, 
where Bartlett’s test was not significant, a two-sided pooled two-sample 
Student’s t-test (Snedecor & Cochran, 1968e) was carried out. For 
comparison of the number of offspring, a two-sided Mann-Whitney test 
(Siegel, 1956b) was carried out.
Pre-weaning mortality was compared using a Fisher’s exact test.
Two analyses were carried out on the incidence of gross abnormalities 
using the methods described by Peto nZ (1980). These methods compare 
the tumour incidence in two populations, taking into account both the 
frequency of occurrence of the particular tumour and the age of the animal 
in which it occurred. In the first, the lesions were classified as fatal and a 
*fatal analysis’ was performed; in the second, the lesions were classified as 
incidental and an 'incidental analysis’ was performed. The tumours were 
separated by site, but not by histological class, in both analyses.
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4.3 RESULTS 
Pre-w eaning data
Data on paternal treatment, mating and offspring at birth and 
weaning are shown in table 4.2.
Table 4.2 Pre-weaning data on offspring from 
cvclophosphamide-treated and control male rats
Parameter CP-treated
group
Control group
Number of males 15^ 6
Number of females 31^ 1 2
Number of htters 24*= 1 0
Pregnancy rate, % 90°^ 83
At birth Number of offspring 1 1 2 126
Number of offspring per litter, 4.7*** 1 2 . 6
X ± SD ± 2.32 ± 1.26
Weight of pup, g, 7.1** 6 . 2
X ± SD ± 0.75 ± 0.61
At weaning Number of offspring 8 6 116
Number of offspring per litter, 3.6*** 1 1 . 6
X ± SD ± 2.80 ± 0.97
Weight of pup, g. 72.7*** 57.9
X ± SD ± 6.90 ± 4.67
Pre-weaning mortality, % 23** 8
3 died during treatment 15/18 were mated; 1 male mated to 3 females 
instead of 2; in addition^ 4 females had litters which were^totally lost; 
not significant, > 0.05; , significantly different, p  < 0.01; , significantly
different, p  < 0 . 0 0 1
Three of the 18 males receiving CP died (or were killed for humane 
reasons) during the treatment period, one at week 18 and two at week 20 
(table 4.2, line 1). Fourteen of the remaining 15 were mated to two females
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each and one was mated to three females; the six control animals were each 
mated to two females (table 4.2, line 2).
Pregnancy rate was calculated as the percentage of females in each 
group delivering a litter. There was no significant difference (p > 0.05) in 
pregnancy rate between females mated to either the CP-treated or control 
males (table 4.2, line 4). The number of litters counted in the CP-group was 
smaller than would have been expected from the pregnancy rate since four 
htters were totally lost soon after birth (possibly due to cannibalism by their 
mothers); no litters were totally lost in the control group (table 4.2, line 3).
Data were collected from litters of pups at birth and at weaning and 
statistical tests were carried out as described in section 4.2. The number of 
offspring per litter counted at birth was significantly lower (p < 0.001) for 
litters from CP-treated males than for litters from controls (table 4.2, line 
5). The mean weight of the pups in these litters was significantly higher (p 
< 0.01) in the CP-offspring than in the controls (table 4.2, line 7). Some 
offspring were lost from both groups in the pre-weaning period but there 
still remained a significant difference (p < 0.001) in number of offspring per 
fitter and mean weight of offspring at weaning (table 4.2, fines 9 & 10 
respectively). Pre-weaning mortality was significantly higher (p < 0.01) in 
the offspring from the CP-treated males than in offspring from control 
males (table 4.2, fine 11).
Adult offspring
Data on the macroscopically normal and abnormal adult offspring, 
broken down by age at PM, are shown in tables 4.3 to 4.10 and statistical 
tests carried out as described in section 4.2.
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Animals were placed in three main categories: those in which no gross 
abnormality was seen at PM, those which had a tumour at one or more 
sites, and those which had hydronephrosis in one or both kidneys. Animals 
in the second category were further classified according to the site of the 
tumour. The figures in the tables represent the number of animals with a 
particular abnormality, so that an animal that exhibited two (or more) 
separate abnormahties has two (or more) entries in the table. Such animals 
have been marked with a superscript to indicate this fact and appear in the 
‘totals’ only once.
A karyotype was produced for as many of the offspring as possible (see 
below). Those from which metaphases of sufficient quality were obtained 
are indicated in the table in parentheses so that the origin of karyotypes 
from the CP-treated and control groups can be seen.
Female offspring
Table 4.3 describes the distribution of female offspring from the CP 
group between the three main categories at each of the five PM times; table 
4.5 shows the same information for female offspring from the control group.
In both groups of female offspring it can be seen that the frequency 
of animals with no macroscopic abnormality decreased during the 
observation period (tables 4.3 & 4.5, line 1). This was mainly due to a 
corresponding increase in the proportion of animals with tumours (tables 4.3 
& 4.5, line 2). The frequency of hydronephrosis did not vary much with age 
but was significantly higher (p < 0.01) in the female offspring of CP-treated 
males when compared with controls (tables 4.3 & 4.5, line 3).
Table 4.4 shows a breakdown by tumour site of those female offspring 
from the CP group that had one (or more) tumour(s) identified macroscopic­
ally; table 4.6 shows the same information for female offspring from the 
control group.
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Table 4.3 Fem ale offspring from cvclophosphamide-
trea ted  male rats: normal and macroscopically abnormal
Macro­
scopic
abnorm
ality
Age at post mortem examination (weeks) ALL
AGES
0 - 54 5 5 -6 6 6 7-79 80 - 91 92 -102
None 6(4) 6(4) 3(3) 2 (2 ) 1  (1 ) 18 (14)
Tumour 1  (1 ) 6^(4^) 5^(5^) 5(:(5 )^ 6^(54) 23^b,c,d
2^ Qa,b,c,d^
Hydro­
nephrosis
2  (1 ) 2 ^(2 )^ i ^ d h 3^ (3(=) 2^(24) 2 Qa,b,c,d^ga,b,c,d^
TOTAL 9 (6 ) 13 (9) 8 (8 ) 9(9) 8  (7) 47 (39)
Table 4.4 Fem ale offspring from cvclophospham ide- 
tre a te d  male rats: offspring with tumours
Tumour
site
Age at post mortem examination (weeks) ALL
AGES
0 - 54 5 5 -6 6 67 - 79 80 - 91 92 -102
Mam­
mary
1  (1 ) 5^(3) 5^(5^) 4C(4C) 4d(4d) 2gb,c,d,e (1 7 b,C,d)
Uterus 0 l^(l^) l ^ l h 1  (1 ) 1  (1 ) (4 a,b)
Pituitary 0 0 0 0 2 (^ (1 (^ ) 2 ^^ (1 *^)
Vagina 0 1 ^(0 ) 0 0 0 1 ®
Lymph
node
0 0 0 0 0 0
Liver 0 0 0 0 0 0
Lung 0 0 0 0 0 0
Ovary 0 0 0 0 0 0
TOTAL 1  (1 ) 6  ^ (4^) 5^ (5^) 5^ (5(=) 6 ^^ (5^) 2 ga,b,c,d(2oa,b,c,d)
figures indicate the number of animals in each age-group with each 
macroscopic abnormality or tumour; figures in parentheses indicate the 
number of animals in each group from which a karyotype was made; letters 
indicate animals in which more than one abnormality was found
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Table 4.5 Fem ale offspring from control male rats: normal and macroscopically abnormal
Macro­
scopic
abnorm­
ality
Age at post mortem examination (weeks) ALL
AGES
0 - 54 55 - 6 6 67 - 79 8 0 -91 92 -102
None 1 1  (5) 1 2  (1 2 ) 9 (7) 4(3) 2  (1 ) 38
Tumour 1  (1 ) 3(2) 8(5) 1 0 *(8 *) 5^(3) 27a,b
(19^)
Hydro­
nephrosis
1  (0 ) 0 1  (1 ) 1 *(1 *) 1 ^(0 ) 4 a,b
TOTAL 13 (6 ) 15 (14) 18 (13) 14 (11) 7 (4) 67 (48)
Table 4.6 Fem ale offspring from control male rats: offspring with tumours
Tumour
site
Age at post mortem examination (weeks) ALL
AGES
0 - 54 55 - 6 6 6 7 -7 9 80-91 92 -102
Mam­
mary
1  (1 ) 2  (2 ) 8'=(5'=) 8  (7) 4(3) 23^ (18^)
Uterus 0 0 0 0 0 0
Pit­
uitary
0 1  (0 ) 0 1 *(1 *) 1 ^(0 ) 3 a,b
Vagina 0 0 0 1  (0 ) 0 1  (0 )
Lymph
node
0 0 1 ^(1 ) 0 0 1  ^ (iC)
Liver 0 0 0 0 1 ^(0 ) 1 ^ (0 )
Lung 0 0 0 0 1 *)(0 ) 1 ^ (0 )
Ovary 0 0 0 0 i^Yo) 1 ^ (0 )
TOTAL 1  (1 ) 3 (2) 8(:(5 )^ 1 0 ^(8 )^ 5^ (3) 27R,b
(19^)
figures indicate the number of animals in each age-group with each 
macroscopic abnormality or tumour; figures in parentheses indicate the 
number of animals in each group from which a karyotype was made; letters 
indicate animals in which more than one abnormality was found
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In both groups of female offspring it can be seen that the mammary 
gland was the most frequent tumour site (tables 4.4 & 4.6, line 1). Four of 
the mammary tumours from animals in the CP group were examined 
histologically (one at 55 - 66 weeks; two at 67 - 79 weeks; one at 80 - 91 
weeks) and four from animals in the control group (one at 67 - 79 weeks; 
one at 80 - 91 weeks; two at 92 - 104 weeks) and all were adenofibromas.
Whereas no uterine tumours were seen in the control group, four 
were encountered in the CP group (tables 4.4 and 4.6, line 2) (p < 0.05). 
Two were examined histologically: one was an adenoma and one a sarcoma.
Pituitary tumours were present in both groups at low frequency 
(tables 4.4 & 4.6, line 3) and were all found to be adenomas. There was one 
vaginal tumour in each group (tables 4.4 & 4.6, line 4) and one lymph node 
tumour in the control group (table 4.6, line 5), all of which were 
fibrosarcomas.
One female offspring in the control group (identified by the 
superscript in tables 4.5 and 4.6) had several tumours. These were shown 
by histological examination to have arisen from a fibrosarcoma with multiple 
metastatic sites.
Bodyweights at PM were higher in the offspring of CP-treated males 
(522.2 ± 85.6 g) than in offspring from control males (494.1 ± 79.8 g) but 
this difference was not significant (p > 0.05).
MaZe
Table 4.7 shows the distribution of male offspring from the CP group 
between the three main categories at each of the five PM times; table 4.9 
shows the same information for male offspring from the control group.
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Table 4.7 Male offspring from cvclophospham ide-treated
male rats: normal and macroscopically abnormal
Macro­
scopic
abnorm­
ality
Age at post mortem examination (weeks) ALL
AGES
0 -5 4 55 -6 6 67 -7 9 80 - 91 92 -102
None 4(3) 6(5) 7 (4) 6(4) 3(3) 26 (19)
Tumour 1  (1 ) 1  (1 ) 1  (1 ) 1  (1 ) 2 (2 ) 6 (6 )
Hydro­
neph­
rosis
4(4"^) 0 0 1  (1 ) 2 (2 ) 7(7"^)
TOTAL 9 (S'^) 7 (6 ) 8(5) 8 (6 ) 7 (7) 39 (32^ )^
Table 4.8 M ale offspring from cvclophospham ide-treated  
male rats: offspring with tumours
Tumour
site
Age at post mortem examination (weeks) ALL
AGES
0 - 54 55 - 6 6 67 - 79 80 - 91 92 -102
Mam­
mary
0 1  (1 ) 0 0 1  (1 ) 2  (2 )
Pit­
uitary
0 0 0 1  (1 ) 1  (1 ) 2 (2 )
Lymph
node
1  (1 ) 0 1  (1 ) 0 0 2 (2 )
TOTAL 1  (1 ) 1  (1 ) 1  (1 ) 1  (1 ) 2 (2 ) 6 (6 )
figures indicate the number of animals in each age-group with each 
macroscopic abnormality or tumour; figures in parentheses indicate the 
number of animals in each group from which a karyotype was made; two 
of these karyotypes abnormal (see figs. 4.3 and 4.4)
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Table 4.9 Male offspring from control
male rats: normal and macroscopicallv abnormal
Macro­
scopic
abnorm­
ality
Age at post mortem examination (weeks) ALL
AGES
0 -5 4 5 5 -6 6 67 -7 9 80 91 92 - 1 0 2
None 13(9) 9(7) 10(9) 1 0 (6 ) 4(2) 46(33)
Tumour 0 0 0 0 1 *(0 ) 1 *(0 )
Hydro­
neph­
rosis
0 0 0 0 1 (0 ) 1 (0 )
TOTAL 14*(9) 9(7) 10(9) 1 0 (6 ) 6 (2 ) 49*(33)
Table 4.10 M ale offspring from control 
male rats: animals with tumours
Tumour
site
Age at post mortem examination (weeks) ALL
AGES
0 - 54 55 - 6 6 67 - 79 80 - 91 92 -102
Mam­
mary
0 0 0 0 1 *(0 ) 1 *(0 )
Pit-
uitary
0 0 0 0 1 *(0 ) 1 *(0 )
Lymph
node
0 0 0 0 0 0
TOTAL 0 0 0 0 1 (0 ) 1 (0 )
figures indicate the number of animals in each age-group with each 
macroscopic abnormality or tumour; figures in parentheses indicate was 
number of animals in each group from which a karyotype was made;  ^
indicates an animal in which more than one abnormality was found; one 
animal not examined
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The proportion of male offspring with a macroscopic abnormahty was 
lower than that found in female offspring from the same group. This was 
due to a much lower frequency, in both groups, of animals with tumours 
(tables 4.7 & 4.9, line 2), although there were more male offspring with a 
tumour from the CP-treated group than from the control group (p > 0.05). 
The frequency of hydronephrosis was significantly higher (p < 0.01) in the 
male offspring of CP-treated males (tables 4.7 & 4.9, line 3).
Table 4.8 shows a breakdown by tumour site of those male offspring 
from the CP group that had a tumour identified macroscopically; table 4.10 
shows the same information for male offspring from the control group.
The reason for the difference between male and female offspring in 
the number of animals with tumours can be seen to be due to the lack of 
mammary tumours in the males (tables 4.8 & 4.10, line 1). There were two 
mammary tumours in males from the CP group: the one found at 54 - 66 
weeks was a lipoma and that found at 92 - 104 weeks was a fibrosarcoma. 
One animal in the control group had a mammary tumour, which was not 
examined histologically, and a pituitary tumour, which was an adenoma 
(table 4.10, line 2). Two male offspring from the CP group had pituitary 
tumours, both of which were adenomas (table 4.8, line 2).
There were two tumours of the lymph node in males from the CP 
group: the one found at 0 - 54 weeks was a fibrosarcoma and the one found 
at 67 - 79 weeks was a lipoma (table 4.8, line 3). No tumours of the lymph 
node were found in males from the control group (table 4.10, line 3), 
indicating a significantly higher level (p < 0.01) in male offspring from the 
CP group, as measured by incidental analysis only.
Bodyweights at PM were higher in the offspring of CP-treated males 
(789.7 ± 128.2 g) than in offspring from control males (757.5 ± 84.1 g) but 
this difference was not significant (p > 0.05).
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K aryotypes
Table 4.11 shows the distribution of karyotype abnormalities amongst 
the offspring of CP-treated and control males.
Table 4.11 Distribution of karyotype abnormalities in the adult 
offspring of CP-treated and control male rats
Paternal treatment No. of adult offspring No. of karyotypes
Analysed Abnormal
Cyclophosphamide Normal 44 33 0
With macroscopic abnormality 42 38 2 (5  %)
TOTAL 8 6 71 2 (3  %)
Control Normal 84 61 0
With macroscopic abnormality 31 2 0 0
TOTAL 115 81 0
Karyotypes were examined from 71 out of 86 offspring from CP- 
treated males and from 81 out of 115 offspring from control males as 
indicated in tables 4.3 - 4.10. None of the karyotypes examined from female 
offspring from the control or CP-treated groups had abnormalities. Two of 
the karyotypes examined from the male offspring from the CP-treated 
group, but none from the control group, had abnormalities. Both of these 
animals exhibited hydronephrosis but they did not have a tumour. There 
was an additional minute chromosome (centric fragment) present in every 
metaphase of one of these males, making a chromosome count of 43 (fig. 
4.3). There was a centromeric fusion of chromosomes 5 and 6 present in 
every metaphase of the other male (fig. 4.4).
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Fig. 4.3 Karyotype for one male offspring from a CP-t.reated male
An additional minute chromosome (centric fragment) present in eyeiy metaphase
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Fig. 4.4 Karyotype for one male offspring from a CP-treated male
Centromeric fusion of chromosomes 5 and 6 present in every metaphase
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4.4 DISCUSSION
The effects o f  
cyclophospham ide on  offspring
The results presented in this chapter demonstrate that the paternal 
exposure of rats to CP has an effect on pregnancy outcome, but that few of 
the effects on offspring persist into adulthood.
Pre-weaning effects
Fertihty, as measured by pregnancy rate, was not affected by CP 
treatment, confirming the findings of Jenkinson et al (1990).
The number of offspring born to females mated with CP-treated 
males was greatly reduced in comparison with those born to females mated 
with control males. Perinatal death was common in pups of the CP-treated 
group but not in those of the control group, resulting in an even larger 
difference in litter size at weaning. It is probable that, at the first time of 
counting, some of the severely abnormal pups had already been cannibalized 
by their mothers. The discrepancy between the observed litter size of 4.7 
in this study and that of 5.5 found by Jenkinson et al (1990) after pups were 
obtained by caesarian section may thus be explained.
Pup birth weight was much higher in the CP-group than in the 
control group, a difference which was proportionally greater at weaning. 
This was presumably due to the fact that since there were significantly 
fewer pups in each litter in the CP-group, each pup had access to a greater 
share of the available nutrition both in utero and up to weaning.
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Examination of the offspring as adults aged between one and two
years yielded a set of results in which the majority of gross and pathological 
findings, including tumours, were not associated with treatment. No 
unusual abnormahties or tumours were observed and the age of onset of 
those that were found was not unusually early. Two abnormalities did, 
however, show significantly raised incidences in offspring from the CP- 
treated group, namely uterine tumours and hydronephrosis, but the 
biological importance of these results is difficult to assess.
In the case of uterine tumours, a low incidence would have been 
expected in control animals of this strain and age (Greaves, 1990), but in fact 
none was seen in the offspring of the control males in this study. The low 
incidence noted in the offspring of the CP-treated males was therefore 
significantly increased. If it were the Fq population that was being examined 
for tumours, the fact that the two uterine tumours which were examined 
histologically (of four found) were of different histological type would argue 
against there having been a treatment effect. However, since these tumours 
were found in the Fj population, there is no reason why they should be of 
the same histological type, as a mutation in the paternal germ cell is the 
presumed treatment effect. Nomura (1983) has pointed out that the type 
of germ cell mutation that would lead to an increased occurrence of tumours 
in the offspring (a so-called tumour mutation) is one that results in a genetic 
predisposition. It is, therefore, conceivable that tumours resulting from Fq 
tumour mutations could have arisen from a general predisposition of the F, 
animals to different tumour types rather than a specific predisposition to a 
particular tumour type. The distribution of tumour types in the offspring 
of X-ray-exposed male mice was the same as that in the offspring of control 
males, with all types increasing in the same ratio with treatment (Nomura, 
1982).
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In the case of hydronephrosis, again a finding that is not unusual in 
animals of this strain, the difference in incidence between offspring from the 
CP-treated and control groups was probably caused by the treatment, 
though not by a direct genetic mechanism. An increase in dietary intake 
and bodyweight is known to be associated with hydronephrosis (JG Evans, 
personal communication). The offspring from the CP-treated group weighed 
significantly more than those from the control group at birth, and, through 
faster growth, at weaning, although bodyweights at PM were not 
significantly different. This could have accounted for the observed 
difference in the frequency of hydronephrosis, which was thus an indirect 
effect of CP-treatment.
No abnormal karyotypes were observed in the offspring of control rats 
whereas two offspring from CP-treated males had minor karyotypic 
anomalies. In relation to the number of macroscopically abnormal offspring 
from which karyotypes could be made (38), this represented 5 % as 
compared to 31 % seen by Jenkinson et al (1990). This discrepancy can 
presumably be explained by the fact that the most severe structural and 
numerical chromosome aberrations would have caused death either in utero 
or immediately post partum. The offspring examined in this study would 
have been at a different point on the scale of genetic changes (Auroux & 
Dulioust, 1985) than those examined in the study of Jenkinson et al (1990).
The background incidence of this type of chromosome damage is 
extremely low: it is found only rarely in f/z z;zæ cytogenetic studies in rats 
(e. .^ Anderson & Richardson, 1981). Thus, an incidence of 5 % (2/38) of 
abnormal offspring (or 3 % (2/71) of all offspring) from CP-treated males is 
probably of biological importance since it represents genetic damage to germ 
cells that has persisted into adulthood.
Since both animals with karyotype abnormalities had hydronephrosis 
and did not bear a tumour, it is not possible to correlate this chromosome
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damage with a tumourigenic event. However, it is possible that such a 
correlation may have been missed in a study of this scope. Histological 
examination at PM of organs with no macroscopic lesion may have revealed 
neoplastic changes which had not yet developed into tumours and it is 
possible that other, more subtle, alterations in the offspring {e.g. 
biochemical, behavioural, skeletal) might have been present (Auroux & 
Dulioust, 1985). Only major structural and/or numerical chromosome 
alterations would have been detected by the methods used in this study. A 
strategy involving chromosome banding or molecular biology would have 
been required in order to detect more subtle chromosome or gene 
alterations. However, CQ banding of chromosomes from paternally exposed 
mice did not enable the detection of any additional chromosome aberrations 
(Nomura, 1987).
P ossib le m echanism s o f  
paternally-m ediated  effects
Spermatogenesis
Male germ cells can be affected at any stage of the spermatogenic 
cycle (see section 1.1) (Lyon, 1981). CP has been shown to cause pre­
implantation loss through treatment of spermatocytes or late spermatids, 
post-implantation loss through treatment of spermatids (and other stages 
to a lesser extent) and foetal malformations through treatment of 
spermatids and spermatogonia (Trasler et al, 1985). It has been shown that 
treatment during the time when spermatozoa are maturing in the 
epididymis can cause pre-implantation loss (Trasler aZ, 1987; Hales eZ uZ, 
1986).
Several behavioural studies have been performed on the offspring of 
CP-treated male rats. Using an acute dosing regimen, Adams eZ uZ (1982)
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showed that the post-meiotic stages of spermatogenesis were affected. 
However, Auroux & Dulioust (1985) were still able to detect behavioural 
anomalies 100 days after the cessation of treatment, indicating an effect on 
spermatogonia. Thus, it is possible that more than one germ cell stage is 
affected by CP. Alternatively, since these two studies differed in the aspects 
of behaviour measured and the age of the pups examined, there may be 
behaviour-specific differences in the germ cell stage affected.
Prevention of spermatogenesis by hormonal control prior to CP 
treatment was found to reduce the adverse effects on the progeny conceived 
after cessation of CP treatment (Dulioust et al, 1989). This indicates that 
proliferating cells are more susceptible to the effects of CP than resting 
cells, as would be anticipated in other biological systems.
Germ cell mutation
Mutations of male germ cells that are expressed immediately in the 
Fi generation are presumably dominant and it is their penetrance that 
determines the number of offspring affected (Lyon & Renshaw, 1988). They 
could result from large or small chromosome aberrations or single or 
multiple gene mutations (Lyon & Renshaw, 1988; Brown, 1985).
The presence of tumours in the offspring resulting from mutated 
germ cells would indicate that a mutation was present in all cells of that F, 
individual but that its expression was only manifested in some of those cells 
(Nomura, 1983). The expression of such mutations induced by X-rays in the 
Fg was increased by F^  treatment with urethane indicating that F^  
individuals existed which carried the mutation but did not express it 
(Nomura, 1983). In other words, the tumour mutation corresponds to the 
initiation stage of carcinogenesis, the affected cells of the progeny having 
been made sensitive to the action of promoters (Nomura, 1987).
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Many human genetic disorders have an unknown and comphcated 
inheritance pattern and the importance of late onset disorders, including 
cancer, has been recognized (Nomura, 1987). Nomura et al (1990) have 
pointed out that most congenital disorders found in humans are of a 
functional, rather than a morphological, nature. They have presented 
results indicating that paternal ethylnitrosourea treatment can bring about 
respiratory distress (and other disorders) in newborn mice.
Indirect routes
It has been shown by radioactive labelling that CP can be transferred 
from male to female during mating (Hales et al, 1986). This would provide 
an indirect route for the effect of paternal treatment on offspring, for 
example, by an effect on the uterus, the intrauterine environment or the 
process of implantation (Joffe, 1979). However, fertilization and 
development of the pre-implantation embryo have not been shown to be 
affected by treatment in a way which gives rise to foetal malformation 
(Brown, 1985) (but see section 3.1). Post-implantation embryos are much 
more sensitive to toxic insult but it is hard to conceive of a mechanism 
whereby a chemical could remain in the uterus long enough to have an 
effect on this stage (Brown, 1985).
In the case of male exposure to mutagenic agents in humans, a 
pathway to the offspring via the mother is even harder to exclude since 
environmental exposure of the female (through clothes, hving in the vicinity 
of the factory, eZc.) is often likely (Brender & Suarez, 1990). It is possible 
that whilst exposure of the male to an agent does not affect the offspring, 
a synergism with an effect via exposure of the female will be set up.
Abel (1989a) has proposed the hypothesis that rather than acting on 
the DNA of male germ cells, an agent might effectively eliminate a 
particular population of spermatozoa during maturation (by altering
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viability, motility, etc.) so that there is an increased likelihood of subsequent 
offspring having resulted from a gamete carrying the trait observed. In 
other words, the trait and the resistance of sperm to the agent are 
connected, but there is no experimental evidence in support of this proposal.
U se o f an im al m odels  
and im p lications for h iunans
Human epidemiological studies can be hypothesis-generating or 
hypothesis-testing, but many biases are inherent to each type (Terracini et 
al, 1983). In human studies, additional confounding factors to those given 
above include sibling order (which is itself confounded by maternal and 
paternal ages) and socio-professional status of parents (Auroux et al, 1989). 
A further problem in epidemiological studies is the accurate establishment 
of male exposure level (Cassidy et al, 1989). Animal studies provide a means 
of generating data with the inclusion of appropriate controls and the 
exclusion of confounding effects. However, species differences have been 
reported, for example, species and strain differences have been found for 
paternally-mediated behavioural effects of ethanol (Abel, 1989b).
The result of studies such as that presented in this chapter may only 
hint at a paternally-mediated effect on the incidence of malformations in 
adult offspring. Nevertheless, they should lead to the recognition of the 
possibihty that offspring can be affected via a paterneil route (Joffe, 1979). 
This, in turn should lead to the introduction of better safety precautions for 
men in the workplace (Scialli, 1989) and the recommendation that children 
should not be conceived during a time when, for example, cytotoxic drugs 
are being taken (Joffe, 1979) (see section 6.2).
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Conclusions and future possibilities
Both foetal malformations and tumours have been induced in 
offspring by paternal exposure to X-rays or urethane (Nomura, 1987). In the 
same experiments, dominant lethal mutations were induced by X-rays but 
not by urethane. The results of Jenkinson et al (1990) showing not only 
foetal malformations and dominant lethal mutations, but also chromosome 
aberrations in the offspring of male rats treated with CP, led to the proposal 
that tumour mutations might also occur. This possibility has been 
investigated in this study.
It is much more likely that paternal treatment will result in a mild 
functional disorder that slightly affects many offspring than a severe 
morphological disorder affecting only a few (Auroux & Dulioust, 1985). 
Indeed, in this study, the most striking effect of paternal treatment on the 
adult offspring was mediated by a non-genetic mechanism: the reduction in 
litter size brought about by the occurrence of dominant lethals in the litters 
of CP-treated males led to an increase in the size and growth of surviving 
Fi individuals which, in turn, led to hydronephrosis.
Only germ cells carrying genetic lesions of a minor enough nature to 
persist through meiosis would be viable (Auroux & Dulioust, 1985). This is 
in agreement with the results of this study in which the karyotype 
anomalies that existed in adult offspring involved minor deletions and 
duplications. Alternatively, damage to post-meiotic germ cells could occur 
but, again, only the most minor lesions would be expected to persist through 
embryogenesis. Again, this accords with the results of this study in that, 
whilst Jenkinson eZ uZ (1990) found 31 % of day-20 rat embryos from CP- 
treated males carried a gross chromosome aberration, only 5 % of the adult 
offspring investigated in this chapter did.
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Nomura (1982) found that although the incidence of lung tumours in 
the progeny of X-ray-exposed males and the incidence of translocations in 
this Fi population were both raised, there was no correlation between the 
occurrence of the two events in individual offspring. He suggested that 
small cytogenetic changes may have been present but undetected. 
Urethane, whilst giving rise to an increase in tumour incidence in the 
offspring of exposed males, did not lead to chromosome rearrangement 
(Nomura, 1987). In the study presented in this chapter, there was a 
statistically significant increase in the incidence of uterine tumours in the 
offspring of CP-treated males, but it was not possible to confidently ascribe 
this to the treatment, nor was it found to be associated with chromosome 
damage.
Due to the lethality of many anomalies immediately post partum, a 
higher frequency of anomalies was evident before rather than after birth 
following paternal X-ray or urethane treatment (Nomura, 1982). This 
corresponds well with the findings of this study in which few malformations 
were observed in adult animals compared with that of Jenkinson et al (1990) 
in which many malformations were found in foetuses.
Lyon & Renshaw (1988) concluded that there was a variety of genetic 
causes of parentally-induced malformations of different levels of penetrance 
(and also various non-genetic causes). Many mutations, especially those with 
high penetrance, would be eliminated in the first generation through the 
severity of the malformations in which they result. Lyon & Renshaw (1988) 
have used this argument to explain why there is a lower proportion of 
mutants in the Fg generation. A similar effect was observed in this study, 
in that a higher level of karyotype abnormahties and malformations were 
observed in the foetal F, animals found by Jenkinson eZ uZ (1990) (many of 
these would be eliminated before sexual maturity) in contrast to the level
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found in F, adults in this study (these reached sexual maturity and therefore 
had the potential to produce a subsequent generation).
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CHAPTERS
A COMPARISON OF SEVERAL IN VITRO 
MEASURES OF RAT SERTOLI CELL 
FUNCTION FOLLOWING THE ADDITION 
OF VARIOUS CHEMICAL AGENTS 
IN A DUAL COMPARTMENT SYSTEM
5.1 INTRODUCTION
There are many cell types within the testis, each performing a specific 
function that may potentially be a target for toxicity. The use of in vitro 
systems involving particular cell types enables the determination of specific 
toxic effects. This chapter deals with the use of Sertoh/germ cells in 
culture, incorporating a metabolizing system to enhance the characteristics 
of the model.
The S erto li cell
Structure and function
The testis is described in section 1.1 and fig. 1.2.
Sertoli cells are found on the inner surface of the seminiferous 
epithelium. They are epithelial somatic cells involved in the physical 
support of germ cells and the hormonal paracrine control of spermatogenesis 
(Dym & Fawcett, 1970). Substances may reach the germ cells but only after 
passing through the SertoH cell cytoplasm (Hadley et al, 1985; Ritzén et al, 
1989) and it is therefore assumed that toxic effects on spermatogenesis are 
mediated via the Sertoli cells (Amann, 1989).
Many secreted factors have an effect, either directly or indirectly, on 
Sertoh cells. The secretion of a peritubular factor modulating Sertoli cells 
(P-Mod-S) by the peritubular cells, in response to testosterone, causes an 
increase in the production of androgen-binding protein and transferrin by 
the Sertoh cells (Skinner & Fritz, 1985). Sertoli cells have receptors for the 
pituitary follicle stimulating hormone (FSH) and responses to this hormone 
(see below) are mediated via a cyclic adenosine monophosphate (cAMP) 
cascade (Tindall eZ uZ, 1985). Leydig cells respond to the other pituitary
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gonadotrophin leutinizing hormone (LH) by releasing testosterone (Tindall 
eZ (zZ, 1985).
Many proteins are secreted by the Sertoli cells (Ritzén et al, 1989), 
whose functions have not always been characterized (Tindall et al, 1985). 
Such secretion may take place either into the lumen of the seminiferous 
tubule or into the interstitial compartment of the testis (Amann, 1989). 
Some of these proteins are involved in local transport. Androgen-binding 
protein binds androgens, transferrin is an iron-transporting protein and plas­
minogen activator may be involved in the physical movement of germ cells 
within the seminiferous tubule (Ritzén et al, 1989). Other proteins are 
involved in longer distance communication. Inhibin and activin are secreted 
into the interstitial compartment in response to FSH (Bicsak et al, 1987) and 
form a feedback loop affecting the secretion of FSH and LH by the pituitary 
(Amann, 1989). Steroidogenesis in Leydig cells, resulting in the production 
of testosterone and oestradiol (Papadopoulos et al, 1987), is stimulated by 
protein factors released by Sertoli cells in response to FSH (Benhamed et al, 
1985).
Both peritubular cells and Sertoh cells contribute to the formation 
of extracellular matrix and the basal lamina: type IV collagen is secreted 
from both cell types, laminin from Sertoh cells and type I collagen and 
fibronectin from peritubular cells (Skinner et al, 1985).
Developing germ cells rely on the Sertoh cells for their energy supply 
since they are unable to utilize glucose (Jutte eZ uZ, 1981). Lactate and 
pyruvate are produced by Sertoh cells, in response to FSH, and are essential 
for the maintenance of protein synthesis in pachytene spermatocytes and 
round spermatids (Jutte et al, 1983).
An alteration in any of the cheiracteristics outlined above, or 
morphological disruption observed by histopathological or ultrastructural 
examination, may be used to evaluate Sertoh cell toxicity.
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In vitro models
Procedures for the isolation of Sertoli cells for culture were initially 
devised by physiologists in order to study their structure and function 
(Chapin & Phelps, 1990). In vitro systems incorporating Sertoli cells enable 
either the pinpointing of these cells as targets for the toxicity of some 
chemicals (Foster et al, 1987) or their exclusion for other agents known to 
be testicular toxins in vivo (Gray, 1986). In a system as structurally and 
functionally complex as the testis, separation of the different cell types is 
useful for the determination of specific susceptibilities (Gray, 1986). For 
example, Sertoli cell cultures can be ‘purified’, without long-lasting damage 
to the Sertoli cells themselves, by exploiting the differential osmolarity of 
the testicular compartments and removing germ cells using hypotonic 
treatment (Galdieri et al, 1981). However, such isolation could be 
misleading in an overall analysis of toxicity (Gray, 1986). For example, there 
is a feedback from germ cells to Sertoli cells, as indicated by their 
stimulatory effect on androgen-binding protein and transferrin secretion 
(Castellon et al, 1989a).
In order to determine the involvement of other cell types in the 
targeting of Sertoli cells by testicular toxins, the effects of conditioned 
medium from one testicular cell type on another can provide a means of 
incorporating cell-to-cell interactions into the culture system (Benhamed et 
al, 1985; Hutson et al, 1987) although this can only be a static, one-way 
interaction. The use of co-cultures of different testicular and other cell 
types extends the number of endpoints which can be examined i/z z/zZro and 
more closely models the z/z z/zz/o situation (Chapin & Phelps, 1990). The use 
of a dual environment assembly enables the co-culture of different testicular 
cell types (Hadley eZ uZ, 1987) and provides the potential for a dynamic, two- 
way interaction to be incorporated into the zzz z/zZro system (Byers eZ uZ, 
1986; Janecki & Steinberger, 1988) (see illustration in fig. 5.1).
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Since the effects of chemicals on the testis may be mediated via their 
metabolism (e.g. in the hver), the inclusion of a metabolizing system in the 
in vitro model may be important (Working, 1989). The commonly used 
metabolizing system for in vitro toxicity assays, the addition of 8-9, is not 
possible in Sertoli cell cultures due to its own toxicity to these cells (Foster, 
1987, cited in Chapin & Phelps, 1990). An alternative approach has been to 
add known metabolites directly to the culture medium as done by Foster et 
al (1987) with 1,3-dinitrobenzene (1,3-DNB) and Gray (1986) with di-(2- 
ethylhexyl) phthalate (DEHP). There is a report of a dual-compartment 
system incorporating both Leydig cells and Sertoli cells to evaluate the 
toxicity of tri-o-cresyl phosphate (Chapin & Phelps, 1989). A simpler use of 
the dual-compartment system is to incorporate hepatocytes, which are 
relatively easily isolated, in the outer compartment and Sertoli cells in the 
inner compartment, as described in this chapter.
A ction  o f Serto li ce ll tox in s
The flowchart in fig. 1.1 shows the inter-relationship between targets 
for reproductive toxicity. It can be seen that an effect on the testis can have 
a bearing upon all the later events in the reproductive process. The 
endpoints used for the detection of Sertoli cell toxicity in the work described 
in this chapter included germ cell detachment, lactate secretion, protein 
synthesis and cell morphology (see below).
P/zZ/zuZuZc csZers
Industrial uses for phthalate esters include the manufacture of 
plastics (Fukuoka cZ uZ, 1989), with DEHP and di-n-butyl phthalate in 
particular being widely used (Moss eZ aZ, 1988).
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Gray (1986) showed that DEHP and its metabolite mono-(2- 
ethylhexyl) phthalate (MEHP) can induce germ cell detachment in rats in 
vivo. MEHP was also found to induce germ cell detachment in vitro but 
DEHP and its other hydrolysis product 2-ethylhexanol did not (Gray, 1986). 
MEHP caused an increased lactate concentration in the culture medium of 
Sertoh/germ cells (Williams & Foster, 1988).
Di-n-butyl phthalate gave rise to germ cell detachment in the testes 
of rats (Fukuoka et al, 1989). Mono-zz-butyl phthalate, but not /z-butanol, 
displayed the same toxic effects in vivo as di-7z-butyl phthalate (Cater et al, 
1977). The branched isomer of this monoester was devoid of toxicity in vivo 
(Foster et al, 1980). The in vitro system of Gray & Beamand (1984), in 
which germ cell detachment was measured after treatment with a series of 
phthalate esters of differing in vivo toxicity, reflected this differing response 
to mono-TZ-butyl phthalate and mono-ZerZ-butyl phthalate (MTBP). Using a 
series of phthalate esters similar to that used by Gray & Beamand (1984), 
Moss et al (1988), reported an increase in the lactate/pyruvate ratio by those 
esters which exhibited testicular toxicity in vivo, and established a good 
correlation with the in vitro results for germ cell detachment reported by 
Gray & Beamand (1984).
In vivo studies by Creasy et al (1983) showed that vacuolation of 
Sertoli cells is the first visible testicular effect following administration of 
di-7i-pentyl phthalate to rats, and germ cell detachment of undamaged germ 
cells occurs subsequent to this. Morphological damage of an ultra- 
structurally comparable form was also caused by MEHP m uzZro and 
similarly occurred before germ cell detachment (Creasy eZ uZ, 1986).
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Dinitrobenzenes
Industrial uses for dinitrobenzene (DNB) include the manufacture of 
dyes, explosives and plastics (Blackburn et al, 1988). The mixture of DNB 
used commercially contains all three isomers, but mostly 1,3-DNB (Working, 
1989).
Although all three isomers cause toxicity, in the form of methaemo- 
globinaemia in rats in vivo, 1,3-DNB was found to be the most potent via 
the intraperitoneal route (Facchini & Griffiths, 1981) with both 1,3-DNB and 
1,4-dinitrobenzene (1,4-DNB) giving rise to equal toxicity after oral dosing 
(Blackburn et al, 1988). Only 1,3-DNB (given in the drinking water) caused 
testicular toxicity (Cody et al, 1981).
Morphological damage to Sertoli cells, in the form of vacuolation, was 
observed after oral dosing of rats with 1,3-DNB, whereas no such damage 
was observed with 1,4-DNB (Blackburn et al, 1988). Subsequent to this, 
morphological damage to germ cells and germ cell detachment was also seen. 
The secretion of lactate and pyruvate has been reported to be increased by 
1,3-DNB in vitro (Williams & Foster, 1988, 1989), as has germ cell 
detachment (Foster et al, 1987).
1,4-DNB was only found to be toxic in tubule fragment cultures, at 
much higher doses than 1,3-DNB (Working, 1989).
Hexanediones
The industrial solvents zz-hexane and methyl-zz-butyl ketone are 
metabolized to 2,5-hexanedione (2,5-HD) through which they exert their 
toxic effects on the nervous system and the testis (Krasavage eZ uZ, 1980).
Sertoli cell enzymes were modulated after dosing rats with 2,5-HD 
(Chapin eZ uZ, 1982). Doses of 2,5-HD which were too low to have neurotoxic 
effects could cause germ cell detachment after Sertoli cell vacuolation in rats 
(Boekelheide, 1988a).
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In vitro studies by Chapin et al (1986) revealed an increase in the 
secretion of lactate induced by 2,5-HD. Their in vivo studies (Chapin et al, 
1982) had previously shown changes in testicular morphology to be induced 
by this compound. Germ cell-effects of 2,5-HD were believed to have 
occurred subsequent to Sertoh cell damage (Chapin et al, 1982).
Studies in the BIBRA laboratories (JC Phillips et al, unpublished 
observations) have indicated that 2,4-hexanedione (2,4-HD) was non-toxic 
with respect to the testes at doses at which 2,5-HD induced marked 
testicular damage characterized by a 50 % reduction in testis weight.
Antifertility drugs
There has been extensive research into the possibility of developing 
a male contraceptive (Aitken & Paterson, 1988). Three of the potential 
agents for this purpose, gossypol, 1 -(p-chlorobenzyl)-1 H-indazole-3-carboxylic 
acid (AF1312/TS) and lonidamine, have been found to act on Sertoli cells.
Tanpaichitr et al (1984) have studied the effects of gossypol on a rat 
Sertoli cell tumour line and noted a decrease in protein synthesis. Reyes et 
al (1986), using a transformed mouse Sertoli cell line, noted an increase in 
lactate production.
De Martino et al (1975) showed that germ cell detachment occurred 
in vitro in response to treatment with AF1312/TS, a compound known to 
affect the Sertoli cell in a similar way zn z/zuo. This finding was confirmed 
by Gray (1986).
Lonidamine has been reported to affect rat Sertoli cell morphology z/z 
z/zZro and also the biochemical process of aromatization whereby testosterone 
is converted to oestradiol (Galdieri eZ uZ, 1984).
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Oxygen radicals
As discussed in section 1.2, many chemicals mediate their toxic effects 
via the production of active oxygen species. The xanthine (X)/xanthine 
oxidase (XO) radical generating system can be used to investigate the direct 
effects of such species, as in the cultured post-implantation rat embryos 
described in chapter 2. Antioxidants L-ascorbic acid and DL-a-tocopherol 
have been shown to protect against these radicals (chapter 2).
Glutathione may react with certain toxins and thus provide protection 
for the cell in which it is present (Grootegoed et al, 1989). The presence of 
both glutathione and glutathione-S-transferase in the testes suggests a 
protective role for this tripeptide in this tissue (Grootegoed et al, 1989). 
This in turn suggests that oxidative stress may be a problem.
A decrease in glutathione concentration in vitro caused an 
enhancement of the toxicity of 1,3-DNB (Cave & Foster, 1990). This is 
presumably because the intracellular glutathione present in Sertoli cells 
protects them from the action of reactive intermediates, such as those 
formed by the metabolism of 1,3-DNB (Cave & Foster, 1990). 1,3-DNB 
toxicity can be reduced by the addition of ascorbate to the culture medium, 
presumably through its action as a radical scavenger (Cave & Foster, 1990).
D ual-com partm ent cu lture system
An illustration of the dual-compartment culture system is shown in 
fig. 5.1.
CuZZzzre condzZzons
Requirements for the dual-compartment system include a high cell 
density and a permeable filter support coated with a substrate appropriate 
for the cells (Hadley eZ uZ, 1987). Various coatings have been utilized as the
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substrate for Sertoli cell cultures (e.g. seminiferous tubule biomatrix; Tung 
& Fritz, 1984) and the precise morphology, including polarity and structure, 
of the Sertoli cells is dependent on the nature of this substrate (Hadley et 
al, 1985; Tung & Fritz, 1984). However, the biochemical function of 
cultured Sertoli cells, as measured by androgen-binding protein and 
transferrin production, was not found to be affected by the use of 
extracellular matrix in vitro (Anthony & Skinner, 1989) even though their 
morphology was dramatically altered compared with cells cultured on a 
plastic substrate (Tung & Fritz, 1984).
Fig. 5.1 The dual-compartment culture system for 
Sertoli/germ cells and hepatocytes
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A, atmosphere of 5 % COg in air; CM, culture medium; F, fibronectin coating, 
simulating the extracellular matrix; GO, germ cells, forming a layer attached 
to the Sertoli cells; H, hepatocyte layer, acting as a metabolizing system; IC, 
inner compartment, simulating the lumen of the seminiferous tubule; L, lid; 
M, porous Millipore membrane, simulating the basal lamina of the 
seminiferous epithelium; 0 0 , outer compartment, simulating the interstitial 
compartment of the testis; SC, Sertoli cells, forming a layer as in the 
seminiferous epithelium; SF, supporting foot, allowing circulation of culture 
medium
Fibronectin is secreted by the peritubular cells as part of their 
contribution to the extracellular matrix of the seminiferous epithelium m
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vivo (Tung et al, 1984). Preliminary work in this laboratory showed 
fibronectin to provide a readily available and consistent substrate upon 
which the Sertoli cells had a columnar morphology similar to that found in 
vivo (PhiUips et al, 1989).
A cell density of 5 x 10® ml ' produced a layer of Sertoli cells which 
reached a minimum permeability to %-inulin after 5 days (JC Phillips et al, 
unpublished observations). The cells were plated very densely in order to 
encourage the formation of a monolayer of columnar Sertoli cells and it is 
probable that some of the Sertoli cells did not attach to the fibronectin- 
coated membrane itself but to other Sertoli cells (Hadley et al, 1987).
28-day old rats were used for the Sertoli/germ cell preparations since 
they have been shown to be more sensitive to the effects of DEHP in vivo 
and MEHP in vitro (Gray & Beamand, 1984).
Experimental design
Initially, cultures set up by the methods described in section 5.2 
yielded an uneven distribution of Sertoh cells both within and between 
Millicells®. In order to counteract this, considerable effort was made to 
ensure that cells were evenly aliquotted to, and distributed within, the 
Millicells® (thorough mixing of the cell suspension during pipetting and 
agitation of cultures immediately after plating) and Millicells® from early, 
middle and late platings were evenly distributed amongst the treatment 
groups. Germ cell detachment was rather sensitive to the physical action 
of pipetting culture media and great care was therefore taken when 
refeeding the cultures.
Incubation was carried out at the rat scrotal temperature of 32 °C, 
except when hepatocytes were present in the outer compartment, in which 
case incubation was carried out at 37 °C, since it was their metabohzing 
capacity that was of particular interest in these experiments. Positive and
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negative control cultures, as well as the experimental cultures, were 
incubated at 37 °C and results using the selected endpoints (see below) did 
not differ from those obtained at 32 “C.
Selection of endpoints
Since germ cells are known to require lactate produced by Sertoh cells 
(Jutte et al, 1981), perturbation of lactate production by Sertoli cells in vitro 
provides a relevant marker for toxicity even though the mechanism may not 
be understood (Williams & Foster, 1988). Exfoliation of germ cells is 
frequently observed in vivo (e.g. Creasy et al, 1983) in response to Sertoli 
cell toxins and this endpoint can also be observed in vitro using the 
Sertoh/germ cell co-culture system developed by Gray & Beamand (1984).
Both of these endpoints can be determined simultaneously in the 
culture medium and the remaining cell layer can either be used for the 
measurement of macromolecule synthesis, or stained for morphological 
examination. Since some of the main functions of Sertoli cells involve 
secretion of specific proteins (Ritzen et al, 1989) (totalling approximately 100 
different types; Allenby et al, 1990), alteration in the overall rate of protein 
synthesis may indicate a toxic reaction.
Objectives
The maintenance of at least some of the structural and/or functional 
features described above is a prerequisite of any m Sertoh ceh model 
(Gray, 1986). Alterations in these features (c. .^ morphology, secretion) may 
be used to give an indication of a toxic effect even if the mechanisms by 
which such alterations occur are not always clear (Chapin & Phelps, 1990). 
The purpose of the work described in this chapter was to enhance the 
characteristics of the m model developed by Gray & Beamand (1984) 
for investigating testicular toxicity. The use of the dual-compartment
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system, both with and without a metabolizing system, increased the efficacy 
and vahdity of the toxicological investigations.
5.2 METHODS
M aterials
The materials used in the work presented in this chapter were as 
follows:-
6 -well plates,
plastic, 35 mm diameter wells, sterile 
AF1312/T8,
l-(p-chlorobenzyl)-lH-indazole- 
3-carboxylic acid
L-ascorbic acid,
(vitamin C) free acid, 20 - 200 mesh 
Beta counter,
liquid scintillation analyser, 
model 2200CA Tri-carb
Bolting cloth,
1 0 0  fjm  pore size
Bolting cloth,
75 pm pore size
Bonin’s fixative,
75 ml picric acid, 25 ml 40 % formaldehyde, 5 
ml acetic acid glacial
Bovine serum albumin, 
fraction V, 96 - 99 %
Centrifuge,
model Superminor
Centrifuge tube,
plastic, 1 1  ml
Collagenase,
A, from Clostridium histolyticum, lyophilized, 
for hepatocyte preparation
Nunc,
Gibco BRL Ltd., Uxbridge, UK
Upjohn Co.,
KWamazoo, USA
Sigma Chemical Co. Ltd.,
Poole, UK
Packard,
Berkshire, UK
Lockertex,
Warrington, UK
Lockertex,
Warrington, UK
Made in house using reagents 
supplied by BDH Chemicals Ltd., 
BIBRA
Sigma Chemical Co. Ltd.,
Poole, UK
MSE Scientific Instruments, 
Crawley, UK
Nunc, Gibco BRL Ltd.,
Paisley, Scotland, UK
Boehringer Mannheim,
Lewes, UK
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Collagenase,
type I from Clostridium histolyticum 
[EC.3.4.24.3], 300 U mg'^, for Sertoli/germ cell 
preparation
Copper II sulphate,
cupric sulphate (CuSO^.SHgO)
Cotton wool, 
non-absorbent
Coulter counter,
model Dn with coincidence correction 
Di-(2-ethylhexyl) phthalate
Diet pellets,
rat & mouse no. 3 (modified)
Dimethylsulphoxide,
CH3 .SO.CH3
1.3-dinitrobenzene, 
m-dinitrobenzene, 97 %
1.4-dinitrobenzene,
98%
DNAase,
type I from bovine pancreas [EC.3.1.21.1]
DPX,
mountant
Eagle’s minimal essential medium, 
with Earle’s salts, without L-glutamine
Eosin,
water soluble, yellow shade 
Fibronectin,
from bovine plasma, sterile 
Foetal calf serum
Folin & Ciocalteau’s phenol reagent, 
contains 10 % v/v HCl (SG 1.16) and 5 
H3PO3
Gentamycin
L-glutamine,
200 mM (lOOx)
Glycine,
free base, approx. 99 %
Gossypol acetic acid,
(2 ,2 ’-binaphthalene)-8 ,8 ’-dicarbox-
aldehyde-l,l’,6,6’,7,7’-hexahydroxy-
5,5’-diisopropyl-3,3’dimethyl
v/v
Sigma Chemical Co. Ltd.,
Poole, UK
FSA Laboratory Supplies,
Loughborough, UK
FSA Laboratory Supplies, 
Loughborough, UK
Coulter Electronics Ltd.,
Luton, UK
BP Chemicals Ltd.,
Pengarth, South Glamorgan, UK
Special Diet Services,
Waltham, UK
FSA Laboratory Supplies,
Loughborough
Aldrich Chemical Co. Ltd., 
Dorset, UK
Aldrich Chemical Co. Ltd., 
Dorset, UK
Sigma Chemical Co. Ltd.,
Poole, UK
BDH Chemicals Ltd.,
Poole, UK
Gibco BRL Ltd.,
Uxbridge, UK
BDH Chemicals Ltd.,
Poole, UK
Sigma Chemical Co. Ltd.,
Poole, Uk
Seralab Ltd.,
Crawley, UK
FSA Laboratory Supplies, 
Loughborough, UK
Gibco BRL Ltd.,
Uxbridge, UK
Gibco BRL Ltd.,
Uxbridge, UK
Sigma Chemical Co. Ltd.,
Poole, UK
Sigma Chemical Co. Ltd.,
Poole, UK
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Gurr’s buffer, 
pH 6.8
Haemacytometer,
counting chamber, improved Neubauer
Haematoxylin,
Harris
Hank’s balanced salt solution, 
without calcium and magnesium
2,4-hexanedione
2,5-hexanedione, 
acetonylacetone, 97 %
Hydrochloric acid,
AnalaR, sp. gr. 1.18
Hydrocortisone-21-succinate, 
(llB,17a,21-trihydroxy-4-pregnene-3,20-dione 
21 -hemisuccinate) sodium salt
Hydrazine,
dihydrochloride, crystalline 
Incubator,
37 °C, for culture of hepatocytes 
Incubator,
LEEC model, 32 °C, for Sertoli/germ cell 
culture
Industrial methylated spirits
Insulin,
from bovine pancreas 
Isoton,
n, balanced electrolyte solution, azide free
Lactic dehydrogenase,
type II, from rabbit muscle, crystalline,
suspension in 3.2 M (NH^lgSO^ solution, pH 6
L-leucine,
L- [4,5-^H] -leucine, 65 Ci mmol'^
L-leucine,
isoleucine and methionine free 
Lonidamine,
l-(2,4-dichlorobenzyl)-indazole-3-carboxylic 
acid (AF1890)
Methionine
Microscope, 
model Laborlux 12
BDH Chemicals Ltd.,
Poole, UK
Weber Scientific International Ltd., 
Lancing, UK
George T. Gurr,
London, UK
Gibco BRL Ltd.,
Uxbridge, UK
Aldrich Chemical Co. Ltd.,
Dorset, UK
Aldrich Chemical Co. Ltd.,
Dorset, UK
BDH Chemicals Ltd.,
Poole, UK
Sigma Chemical Co. Ltd.,
Poole, UK
Sigma Chemical Co. Ltd.,
Poole, UK
ICN Flow,
High Wycombe, UK
Genetic Research Instrumentation, 
Essex, UK
Infrakem Ltd.,
Wigan, UK
Sigma Chemical Co. Ltd.,
Poole, UK
Coulter Electronics Ltd,
Luton, UK
Sigma Chemical Co. Ltd.,
Poole, UK
Amersham International pic, 
Amersham, UK
Sigma Chemical Co. Ltd., 
Poole, UK
Upjohn Co.,
Kalamazoo, USA
Sigma Chemical Co. Ltd., 
Poole, UK
Leitz,
Germany
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Millicell,
30 mm diameter, culture plate insert, 
0.4 /im pore size, sterile
Mono-n-butyl phthalate
Mono-tert-butyl phthalate
Mono-(2-ethylhexyl) phthalate.
B-Nicotinamide adenine dinucleotide 
grade VII: from yeast, sodium salt, approx. 
90%
Non-essential amino acids,
MEM (xlOO)
Optiphase safe,
multi-purpose liquid scintillation cocktail
Pasteur pipette,
glass, short-form, 145 mm
Penicillin and streptomycin, 
solution, 10 000 lU ml penicillin,
1 0  0 0 0  fjg ml"^ streptomycin
Perchloric acid,
60 %,SLR
Petri dish,
plastic, 1 0 0  mm diameter, sterile 
Rat,
Sprague Dawley 
RPMI 1640
Scintillation vial, 
plastic, 2 0  ml
Sodium carbonate, 
anhydrous
Sodium chloride
Sodium hydroxide
Sodium tartrate, 
[CH(0H).C00Na]2.2H20
Sonicator,
model Soniprep 150
Millipore UK Ltd.,
Hertfordshire, UK
Made in house by the method of 
Albro et al (1973),
BIBRA
Made in house by the method of 
Albro et al (1973),
BIBRA
Made in house by the method of 
Albro et al (1973),
BIBRA
Sigma Chemical Co. Ltd.,
Poole, UK
Gibco BRL Ltd.,
Uxbridge, UK
LKB Scintillation Products,
FSA Laboratory Supplies, 
Lougborough, UK
John Poulten Ltd.,
Barking, UK
Gibco BRL Ltd,
Uxbridge, UK
FSA Laboratory Supplies, 
Loughborough, UK
Sterilin Ltd.,
Hounslow, Middlesex, UK
Harlan Olac Ltd.,
Bicester, UK
Gibco BRL Ltd.,
Uxbridge, UK
Packard,
Berkshire, UK
FSA Laboratory Supplies, 
Loughborough, UK
FSA Laboratory Supplies, 
Loughborough, UK
FSA Laboratory Supplies, 
Loughborough, UK
FSA Laboratory Supplies, 
Loughborough, UK
MSE Scientific Instruments, 
Crawley, UK
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Spectrophotometer, Cecil,
model MPS 2000 Cambridge, UK
Test tube, Sterilip Ltd.,
plastic, 16 mm diameter Hounslow, UK
Trichloracetic acid. FSA Laboratory Supplies,
(CClg.COOH) AnalaR Loughborough, UK
Trypan blue. BDH Chemicals Ltd.,
technical Poole, UK
Trypsin, Gibco BRL Ltd.,
solution, 2.5 % (1:250) prepared in normal Uxbridge, UK
saline
Wash bottle. Jencons Scientific Ltd.,
plastic, 250 ml Leighton Buzzard, UK
Water bath. Grant Instruments,
Grant model JB 2 Cambridge, UK
Xanthine, Sigma Chemical Co. Ltd.,
(2,6-dihydroxypurine) grade V, Poole, UK
99 - 100 %, crystalline
Xanthine oxidase. Sigma Chemical Co. Ltd.,
grade III from buttermilk Poole, UK
G eneral M ethods
For a diagrammatic representation of the method see fig. 5.2.
o/'Se/ŸoZZ/^erm ceZZs 
Four 28-day old (85 -105 g) rats were used for each Sertoli/germ cell 
preparation. Animals were maintained as described in chapter 2 but were 
used within two days of arrival. They were killed by cervical dislocation and 
the testes dissected out and weighed in a small beaker containing Hank's 
balanced salt solution. Subsequent procedures were carried out under 
aseptic conditions.
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Fig. 5.2 Method for investigating the effects of chemicals on 
rat Sertoli-germ cell co-cultures
8  testes
\ /
15 min
3 min 30 s
^trypsin digestio^
collagenase digestion
fibronectin- culture culture culture culture
coated 1 2 3 4
48 h
treatment 
B
treatment 
A
treatment 
C
reatment
D
reatment 
E
28 day old rats
Sertoli-germ
celleo-culture
Tubules sqmated, 
chopped & dissociated
CeDs released 
fiom dissociated 
tubules
Sertoli & germ 
cells seeded at 
5 X 10^ ml"^
Culture 
for 5 days
treatment
culture Seitoli
medium cell
monolayer
Culture
Endpoints
^  germ cell \  
W etachm enW
r  lactate 
V secretion
protein ^  
synthesis j
^  SerWli cell
^  morphology
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The testes were washed again with Hank’s balanced salt solution and 
transferred to a 100 mm plastic petri dish. The tunica albugenia was cut, 
without cutting the tubules, and removed with the blood vessel. The 
tubules of the decapsulated testes were teased apart and sliced into 
approximately twelve evenly sized pieces using a scalpel blade. The Hank’s 
balanced salt solution was removed and the pieces transferred to a 100 ml 
conical flask containing approximately 10 gg DNAase in 27 ml 0.25 % trypsin 
in Hank’s balanced salt solution.
The conical flask was plugged with non-absorbent cotton wool, capped 
with foil and placed in a water bath at 37 °C. The flask was shaken every 
3 min in order to assist the dissociation of the tubules. After exactly 15 min 
incubation the dissociated tubules were poured onto a wetted 100 gm 
bolting cloth filter and washed with a jet of Hank’s balanced salt solution 
from a plastic wash bottle. The tubules were scraped into a second 100 ml 
conical flask containing 27 ml collagenase in Hank’s balanced salt solution 
(1 mg ml'O-
The conical flask was plugged with non-absorbent cotton wool, capped 
with foil and placed in the water bath. The flask was shaken every 1 min 
in order to assist the digestion of the tubules. Incubation was continued 
until the tubule fragments were less than 2 mm in length and a finer cell 
suspension was evident (approximately 3 min 30 s). The cell aggregates 
and small tubule fragments were poured onto a wetted 75 gm bolting cloth 
filter, cleared of undigested material using a pasteur pipette and washed 
with Hank’s beilanced salt solution.
The bolting cloth was inverted over a 250 ml beaker and backwashed 
with Eagle’s minimal essential medium containing 4mM L-glutamine, 100 
lU ml^ penicillin, 100 /ig ml^ streptomycin, 0.1 mM non-essential amino 
acids and 15 % foetal calf serum. Larger tubules and aggregates were 
broken up using a 10 ml pipette and bulb. An estimate of the cell
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concentration was made using a haemacytometer and the cell suspension 
was adjusted to 5 x 10® mH by adding the appropriate volume of Eagle’s 
minimal essential medium containing serum and other additives, as above.
Dual-compartment system
For each Sertoli/germ cell preparation, twenty or twenty four 
fibronectin-coated, 30 mm diameter Millicells® were used. These tissue 
culture inserts had a porous filter base, plastic sides and small supporting 
feet.
Fibronectin was dissolved in deionised and filtered water at 1 mg ml^ 
and diluted with Eagle’s minimal essential medium without serum to 0.1 mg 
ml \  Each Millicell® was placed in a 35 mm diameter well of a 6-well plate 
and two 0.6 ml coats of fibronectin were applied. At least 7 h were allowed 
for each coat to dry, and the residue of culture medium was washed off with 
Hank’s balanced salt solution before use.
A 1.5 ml volume of Sertoli/germ cell suspension was added to each 
Millicell® and a volume of 1.75 ml Eagle’s minimal essential medium with 
serum in the outer compartment gave the same height of culture medium.
o/" ceZZs
Sertoli/germ cell cultures were maintained for 5 days before 
treatment. Twenty four hours after plating out, and at one other time 
before treatment, the culture medium was changed for Eagle’s minimal 
essential medium without serum (1.5 ml in the inner compartment, 1.75 ml 
in the outer compartment). Cultures were incubated at 32 in an 
atmosphere of 5 % COg in air.
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Hepatocytes
In experiments requiring metabolism of the test chemical, hepatocytes 
were grown in the outer compartment of the dual-compartment system, 
with Sertoli/germ cells in the inner compartment.
Hepatocytes were prepared from male Sprague-Dawley rats by the 
method of Paine et al (1979) using a collagenase perfusion technique 
(supplied by Ms JA Beamand). Cells were washed and suspended in RPMI 
1640® culture mediume containing 5 % foetal calf serum, 50 pg ml^ 
gentamycin, 10  ^M insulin, 10  ^M hydrocortisone-21-sodium succinate and 
5 X 10  ^M methionine. An estimate of the concentration of viable cells was 
made using a haemacytometer to count a sample of cells which had been 
exposed to 0.04 % trypan blue (viable cells excluded this dye).
The hepatocyte suspension was adjusted to 10® ml^ by adding the 
appropriate volume of complete RPMI (as above). A 1.75 ml volume was 
added to each 35 mm well of a 6-well plate and the cells incubated at 37 °C, 
5 % COg in air, for 2 - 3 h. After this time the hepatocytes had attached and 
the medium was substituted with Eagle’s minimal essential medium without 
serum prior to adding the Millicells® containing 5-day old Sertoli/germ cell 
cultures. Subsequent incubation was at 37 °C, 5 % COg in air.
T reatm ent
Cells were treated after 5 days in culture. Millicells® from each 6-well 
plate were evenly distributed amongst the treatment groups, each 
containing up to four rephcates.
u/iZZi Zz/mu/Ai SerZoZi ccZZ
Seven chemicals known to be toxic to Sertoli cells in rats Zn uZuo (see 
section 5.1) were used: MEHP, AF1312/TS, gossypol, lonidamine, 1,3-DNB,
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2,5-HD and mono-zi-butyl phthalate. Where possible, structurally related 
non-toxins were also used: DEHP (but see below), 1,4-DNB, 2,4-HD and 
mono-ZerZ-butyl phthalate.
Chemicals were dissolved in dimethylsulphoxide (DM80) and added 
to Eagle’s minimal essential medium without serum at 4 pi ml^ for 
treatment. An aliquot (1.5 ml) of treatment medium was placed in the inner 
compartment and/or 1.75 ml in the outer compartment. After evaluation 
of the chosen endpoint (see below) at 24 h, fresh Eagle’s minimal essential 
medium without serum was replaced in the inner and/or outer 
compartment for the remaining 24 h, with or without treatment as in the 
first 24 h.
Controls received vehicle only i.e. 4 pi mP DMSO. A positive control 
(400 pM AF1312/TS or 400 pM MEHP) was included in each experiment.
Metabolism
Six chemicals were investigated with respect to the modification of 
their toxic or non-toxic action by metabolism: MEHP, DEHP, 1,3-DNB, 1,4- 
DNB, 2,4-HD and 2,5-HD. In these experiments, hepatocytes were grown 
in the outer compartment (see above) and the chemicals were dissolved in 
DMSO, added to Eagle’s minimal essential medium without serum and 
placed in the outer compartment only. After measurement of the chosen 
endpoint (see below) in the medium in the inner compartment at 24 h, the 
treatment medium in the outer compartment was not changed since it 
contained the metabolites.
rucZZcuZs a/zZZo%Z(Za/^ Zs
The effect of oxygen radicals on the Sertoli/germ cell cultures was 
investigated by the addition of X/XO to the culture medium in the inner 
compartment. Treatment was carried out for 2 h after which time the
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treatment medium was replaced with fresh Eagle’s minimal essential 
medium without serum.
XO was thoroughly re-mixed and the appropriate volume for a given 
concentration was added. This varied according to the activity of the 
particular batch. X was prepared in 0.5 % sodium carbonate (1 mg ml 0 and 
the appropriate volume for a given concentration was added.
The effect of antioxidants on X/XO-induced damage was investigated 
by the addition of L-ascorbic acid or DL-a-tocopherol to the culture medium. 
L-ascorbic acid was prepared in Eagle’s minimal essential medium without 
serum (20 mM) and diluted further with medium to give the desired 
concentration. The pH was adjusted to 7.4 where necessary with sterile 
4 M NaOH. DL-a-tocopherol was suspended in Eagle’s minimal essential 
medium without serum (0.95 mg ml^) by sonication for 5 min in 5 s bursts 
at amplitude 3 with medium power, and diluted further with medium to 
give the required concentration (used within 2 h). For some experiments 
cultures were pretreated with DL-a-tocopherol for 24 h before the 2 h 
treatment.
Endpoints
Germ ceZZ cZeZ<%cZi7?%e7iZ
Germ cells detached during the treatment period were collected by 
removing the culture medium from the inner compartment after 1, 2, 24 or 
48 h. The cultures were washed with 1 ml of Eagle’s minimal essential 
medium without serum and the washings collected. The germ cell 
suspensions were diluted 1:8 with Isoton® and counted on a Coulter counter.
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JLocZaZe secreZZon
Lactate secreted during the treatment period was collected by 
removing the culture medium from the inner compartment after 24 h. The 
medium was either processed immediately or frozen at -20 °C until the assay 
was carried out (assays carried out by Ms S. Tasker).
Each sample (0.05 ml) was mixed with 1 M perchloric acid (0.2 ml) 
and reacted with nicotinamide adenine dinucleotide (22 mg ml 0 in 0.5 M 
glycine/0.4 M hydrazine/2 M HCl, pH 9.0 (2.7 ml). Background absorbence 
was measured at 340 nm in a spectrophotometer before the reaction with 
lactic dehydrogenase (0.01 ml) 90 min and measurement of absorbence at 
340 nm. The amount of lactate (gmol per ml of sample) was calculated as 
(((A, - Ago) - blank) x 2.96) /  (6.22 x 0.2)
Protein synthesis
In order to measure the rate of protein synthesis after 48 h 
treatment, cells were washed twice with 1 ml Eagle’s minimal essential 
medium without serum, and 1.5 ml L-[4,5-%]-leucine (2 ^Ci m l\ 65 Ci 
mmol'O was added for 1 h. Cells were washed with 1.5 ml ice cold L-leucine 
(1.75 mM) in 0.9 % NaCl and scraped into 0.75 ml of this solution using a 5 
ml plastic pipette.
The cell suspension was transferred to a plastic centrifuge tube and 
an equal volume of cold 10 % trichloracetic acid added. The tubes were left 
at 4 °C for at least 1 h in order for the protein to precipitate, and centrifuged 
at 400 g for 5 min. The supernatant was removed and the cells resuspended 
in 3 ml 5 % trichloracetic acid. This wash was repeated four further times 
and, to ensure that all non-precipitated radioactive material (Z.e. non­
incorporated ^H-leucine) had been removed, a 250 gl sample of the final 
wash was taken for scintillation counting (see below).
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The cell pellet was dissolved in 1 ml 0.5 M NaOH, and 0.5 ml of this 
solution taken for scintillation counting. The protein solution was 
neutralized with 62.5 gl 4 M HCl, and 10 ml Optiphase-Safe® was added. 
Scintillation counting was carried out using disposable plastic scintillation 
vials on a B-counter. The scintillation counter automatically calculated 
disintegrations per minute from counts per minute (mean during a 5 min 
count) having been calibrated for %  counting efficiency. A background 
count was automatically subtracted from each experimental count.
An estimate of the cell density was made by measuring protein 
content in the remaining 0.5 ml protein solution (see below) and the results 
were calculated as %-leucine incorporation per mg protein.
Protein content
Trichloracetic acid-precipitable material from each culture was 
solubilized in 1 ml 0.5 M NaOH (see above) and diluted 1:5 with 0.5 M 
NaOH. The protein concentration was measured by the method of Lowry 
et al (1951).
Briefly, a 0.5 ml aliquot was placed in a plastic test tube and 5 ml of 
100:1:1 2 % disodium carbonate: 1 % CuSO :^ 1 % sodium tartrate was added. 
1:1 Folin & Ciocalteu’s phenol reagent: deionized and filtered water (0.5 ml) 
was added to each tube and the reaction mixture left for 1 h. The samples, 
and a set of bovine serum albumin (BSA) standards (0 to 60 mg ml^) 
prepared in the same way as the samples, were read on a spectrophotometer 
at 720 nm. The protein content of the samples was calculated by 
comparison of their absorbence with that measured in the protein standards.
cosZ/z sZuZ/zZ/zg
Mihicells® containing treated cells to be stained were washed twice 
with 1 ml phosphate buffered saline and fixed in Bouin’s fixative for at least
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20 min. They were stained in haematoxylin for 15 min and eosin for 15 s 
before dehydrating and mounting using DPX.
S ta tistica l analysis
Data from individual experiments were tested for difference from the 
vehicle control by the least significant difference test (Snedecor & Cochran, 
1968d) having first ensured that they fitted a normal distribution 
(Kolmogorov-Smirnov test; Siegel, 1956c) and that Bartlett’s test for 
homogeneity of variance was non-significant (Snedecor & Cochran, 1968b). 
In all experiments the positive control showed a significant difference from 
the vehicle control for either germ cell detachment or lactate secretion 
(Student’s t-test; Snedecor & Cochran, 1968e).
Repeated experiments were pooled, and the residual mean square 
value from a 2-way analysis of variance (ANOVA) (Snedecor & Cochran, 
1968c) used to test mean values from each group of cultures in a least 
significant difference test.
5.3 RESULTS
A ssessm en t o f Sertoli ce ll tox ic ity
For each treatm ent within an experiment there were up to four rep- 
hcate cultures. A negative control (vehicle only) and a positive control (400 
/iM AF1312/TS or 400 gM MEHP) were included in each experiment. Re­
sults were included in the analysis only when there was a significant differ­
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ence between the positive and negative control for germ cell detachment or 
lactate secretion.
Germ cell detachment was measured after the first 24 h treatment 
and again after the second 24 h. The results presented are means of the 
sums of these totals. Lactate secretion was measured after 24 h treatment 
and protein synthesis after 48 h.
P h th alate  esters
Direct effects
The results are shown in tables 5.1.A and 5.1.B.
A dose-related increase in germ cell detachment was observed after 
treatment with MEHP over the range 100 - 400 pM (table 5.1.A, column 1, 
lines 1 - 4), and 400 - 800 pM (table 5.1.A, column 1, lines 5 - 7). All 
differences were significantly different from control (p < 0.01). Lactate 
secretion was also significantly increased (p < 0.001) after MEHP treatment 
in the range 100 - 400 /xM (table 5.1.A, column 2, lines 1 - 4), but a 
relationship with dose was not apparent.
Protein synthesis was not significantly altered by MEHP treatment 
over the range 100 - 400 pM or 400 - 800 pM (table 5.1.A, column 3, lines 1 - 
4 & 5 - 7 respectively) except for a significant decrease (p < 0.01) at 100 pM 
which did not fit the overall pattern of effect.
DEHP did not cause a significant increase in germ cell detachment at 
100 or 200 pM (table 5.1.A, column 1, lines 8 -10). However, 400 pM DEHP 
did cause a small but significant (p < 0.01) increase in germ cell detachment 
(table 5.1.A, column 1, line 11), an effect which was not confirmed in a later 
series of experiments (see table 5.2, column 1, line 5). Lactate secretion was 
not significantly affected by DEHP treatment at 100 - 400 /xM (table 5.1.A, 
column 2, lines 8 - 11).
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Table 5.1.A Effects of phthalate esters on germ cell detachment, lactate secretion and
protein synthesis in Sertoli/germ cell cultures
Phthalate
ester
Concen­
tration
Germ cell 
detachment (48 h)
Lactate 
secretion 
(24 h)
Protein 
synthesis 
(48 h)
^M X 1 0 ^ ml’^ piaol ml'^ incorp­
oration mg"^
mean 
± SD
n mean 
± SD
n mean 
± SD
n
MEHP 0 27.2^ 1 0 1.26
(± 0.09)
5 56.2^ 1 0
1 0 0 39.8*''* 8 3.09*** 
(± 0.13)
5 43.6** 8
2 0 0 42.7*** 1 0 2 .6 8 *** 
(± 0.18)
5 52.5^^ 1 0
400 50.2*** 9 3.33*** 
(± 0.18)
5 55.9^^ 9
0 7.9
(± 1 .0 )
3 - - 57.1 
(± 5.5)
4
400 25.5**
(± 2 .1 )
3 - - 56.7^^ 
(± 9.1)
3
800 37.9***
(± 3.5)
4 - - 70.1^^ 
(± 11.9)
4
DEHP 0 23.3 
(± 3.0)
4 1 . 1 0  
(± 0 .1 2 )
4 - -
1 0 0 25.9^^ 
(± 1 .6 )
4 1 .1 0 ^  ^
(± 0 .1 2 )
4 - -
2 0 0 25.0°^ 
(± 2 .0 )
4 1.26^^ 
(± 0.05)
4 - »
400 32.5** 
(± 1.4)
4 1 .0 0 ^  ^
(± 0 .2 0 )
4 - -
5-day old cultures treated for 48 h; MEHP, mono-(2-ethylhexyl) phthalate; 
DEHP, di-(2-ethylhexyl)phthalate; n, number of cultures; SD, standard 
deviation; MS, mean square; imt significantly different, p > 0.05; , sig­
nificantly different, p  < 0 .0 1 ; , significantly different, p  < 0 .0 0 1 ; ^  2
experiments pooled, residual MS = 41.20; 2  experiments pooled, residual
MS = 99.18; -, not determined
There was a significant increase (p < 0.01) in germ cell detachment 
with mono-/^-butyl phthalate treatment over the range 5 - 2 0  mM (table 
5.1.B, column 1, lines 1 - 4), although there was no relationship between
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dose and effect. Lactate secretion was significantly increased (p < 0.001) by 
mono-n-butyl phthalate treatment at 5 mM (table 5.1.B, column 2, lines 1 
& 2). Mono-71-butyl phthalate treatment caused a dose-related increase in 
protein synthesis (table 5.1.B, column 3, lines 1 - 4 )  which was non­
significant at 5 mM and significant at 10 mM ip < 0.05) and 20 mM ip < 
0.001).
Table 5.1.B Effects of phthalate esters on germ cell detachment lactate secretion and 
protein synthesis in Sertoli/germ cell cultures (cont’d)
Phthalate
ester
Concen­
tration
Germ cell 
detachment (48 h)
Lactate
secretion (24 h)
Protein
synthesis (48 h)
mM X 10^ ml"^ pmol  ml*^ incorp­
oration mg'^
mean n mean n mean n
MNBP 0 15.9^ 8 0.97^ 9 62.2" 6
5 28.5*** 9 1.38*** 1 0 68.9"® 7
1 0 27.1*** 9 - - 70.2* 8
2 0 24.2** 5 - - 8 8 .6 *** 4
MTBP 0 18.8^ 8 1.41" 19 48.9^ 6
5 2 0 .0 *^^ 9 1.25* 2 0 48.3"® 7
1 0
17 ?ns 9 - - 47.4"® 8
2 0 17.8"® 5 - - 42.2* 4
5-day old cultures treated for 48 h; MNBP, mono-n-butylphthalate; MTBP, 
mono-fert-butylphthalate; n, number of cultures; MS, mean square; not 
significantly different, p >  (105; , significantly different, p  < 0.05; **, sig­
nificantly different, p  < 0.01; ***, significantly different, p  < 0.001; 2 experi­
ments pooled, residual MS = 24.58; 2 experiments pooled, residual MS =
0.04; 2  experiments pooled, residual MS = 58.89; 2  experiments pooled,
residual MS = 11.69; 4 experiments pooled, residual MS = 0.04; 2  experi-
ments pooled, residual MS = 29.86; -, not determined
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Similar doses of mono-^er^-butyl phthalate, however, did not cause a 
significant alteration in germ cell detachment (table 5. I B, column 1, lines 
1-4) .  A significant decrease (p < 0.05) was observed in lactate secretion 
after treatment with 5 mM mono-^e/t-butyl phthalate (table 5.1.B, column 
2, lines 5 & 6). A small but significant decrease (p < 0.05) in protein 
synthesis was observed after mono-^er^-butyl phthalate treatment at 20 mM 
but not at lower concentrations (table 5.1.B, column 3, lines 5 - 8).
Metabolism by hepatocytes
The results are shown in table 5.2.
The culture of hepatocytes in the outer compartment did not cause 
a significant increase in germ cell detachment in control cultures (table 5.2, 
column 1, lines 1 & 2). The positive control, MEHP at 400 pM, caused a 
significant increase ip < 0.001) in germ cell detachment compared with the 
corresponding control with or without hepatocytes (table 5.2, column 1, lines 
3 & 4). DEHP without hepatocytes did not significantly alter germ cell 
detachment but there was a significant increase ip < 0.001) caused by DEHP 
with hepatocytes (table 5.2, column 1, lines 5 & 6).
In contrast, the culture of hepatocytes in the outer compartment did 
cause a significant increase (p < 0.001) in lactate secretion in control cultures 
(table 5.2, column 2, lines 1 & 2). MEHP caused a significant increase ip < 
0.001) in lactate secretion compared with the corresponding control with or 
without hepatocytes (table 5.2, column 2, lines 3 & 4). DEHP significantly 
increased (p < 0.001) lactate secretion in the presence of hepatocytes but not 
in their absence (table 5.2, column 2, lines 5 & 6).
177
Table 5.2 Effects of metabolism of phthalate esters bv hepatocytes on
germ cell detachment and lactate secretion in Sertoli/germ cell cultures
p
h
t
h
a
1
a
t
€
Con H
e
P
Germ cell detachment 
(48 h)
Lactate secretion 
(24 h)
pM X 10'^  ml - 1 LSD test 
vs. control
pmol ml'^ LSD test vs. 
control
mean n
hep
+
hep
mean n
hep
+
hep
none 0 - 92.8" 8 - - 2.01^ 8 - -
+ 97.4 8 ns - 4.61 7 -
MEHP 400 - 155.3 8 *** - 3.60 8 *** -
+ 152.4 6 - *** 6.44 7 - ***
DEHP 400 - 84.2 8 ns - 2.49 8 ns -
138.7 8 - HtHcifc 6.19 8 - ***
5-day old cultures treated for 48 h; MEHP, mono-(2-ethylhexyl) phthalate; 
DEHP, di-(2-ethylhexyl) phthalate; n, number of cultures; con, concentration; 
hep, hepatocytes; LSD test, least significant difference test; MS, mean square; 
ns, not significantly different, p  > 0.05; **, significantly different, p  < 0.01; 
***, simificantly different, p  < 0.001; ", 2 experiments pooled, residual MS = 
490.3; , 2 experiments pooled, residual MS = 0.49; -, not determined
D in itrobenzenes
Direct
The results are shown in table 5.3.
A dose-related increase in germ cell detachment was caused by 1,3- 
DNB treatment over the range 125 - 500 pM (table 5.3, column 1, lines 1 - 
4). The difference was non significant at 125 pM but significant at 250 pM 
(p < 0.05) and 500 pM (p < 0.001). Lactate secretion was significantly 
increased (p < 0.001) at 500 pM (table 5.3, column 2, lines 1 & 4). There
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was a concentration-related increase in protein synthesis over the range 125 
- 500 /iM (table 5.3, column 3, lines 1 - 4). All differences were significantly 
different from control (p < 0.01).
Table 5.3 Effects of dinitrobenzenes on germ cell detachment lactate secretion and 
protein synthesis in Sertoli/germ cell cultures
Dinitro­
benzene
Concen­
tration
Germ cell 
detachment (48 h)
Lactate 
secretion 
(24 h)
Protein 
synthesis 
(48 h)
pm. X 1 0 “^ ml'^ pmol mT^ incorporation
mg'^
mean n mean 
± SD
n mean 
± SD
n
1,3-DNB 0 29.2^ 6 1.80^ 1 0 67.1 
(± 2 .2 )
2
125 34.0^^ 8 - - 90.4** 
(± 5.7)
3
250 38.7 '^ 9 - - 85.1** 
(± 2 .1 )
4
500 1 0 3.98*** 1 0 1 0 0 .1 *** 
(± 1.7)
4
1,4-DNB 0 21.9^ 8 1 . 1 1
(± 0.05)
5 150.1 
(± 24.6)
2
1 0 24.0""^ 7 - - 156.57^ 
(± 31.4)
3
50 2 ^gns 5 - - 171.69^^ 
(± 9.9)
4
1 0 0 62.9*** 1 0 1.98** 
(± 0.19)
5 170.4^^ 
(± 14.1)
4
5-day old cultures treated for 48 h; 1,3-DNB, 1,3-dinitrobenzene; 1,4-DNB,
1,4-dinitrobenzene; n, number of cultures; SD, standard deviation; MS, mean 
square^ not significantly different, p  ^JO.05; , significantly different, p  < 
0.05; * , significantly different, p  < 0.01; ***, significantly different,p  < 0.001;
2 experiments pooled, residual MS = 83.07; 2 experiments pooled,
residual MS = 0.17; 2  experiments pooled, residual MS = 47.69; -, not
determined
A concentration of 100 1,4-DNB caused a significant increase in
germ cell detachment (p < 0.001) but concentrations of 10 or 50 pM did not 
(table 5.3, column 1, lines 5 - 8). 1,4-DNB also caused a significant increase
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(p < 0.01) in lactate secretion (table 5.3, column 2, lines 5 & 8) but protein 
synthesis was not significantly increased at any of the three concentrations 
used (table 5.3, column 3, lines 5 - 8).
Metabolism by hepatocytes
The results are shown in table 5.4.
The positive control cultures of MEHP without hepatocytes and 
DEHP with hepatocytes both caused a significant increase in germ cell 
detachment (p < 0.01; p < 0.05) compared with control cultures without 
hepatocytes (table 5.4, column 1, lines 1, 5 & 7). 1,3-DNB without
hepatocytes caused a significant increase (p < 0.01) in germ cell detachment 
which was abolished by the addition of hepatocytes in the outer 
compartment (table 5.4, column 1, lines 3 & 4).
Lactate secretion was significantly increased ip < 0.001) by the 
presence of hepatocytes in control cultures (table 5.4, column 2, lines 1 & 2 
and lines 8 & 9). DEHP without hepatocytes did not increase lactate 
secretion but there was an increase with hepatocytes which was significant 
ip < 0.01) in the first experiment (table 5.4, column 2, lines 6 & 7) but not 
in the second (table 5.4, column 2, lines 12 & 13). Again, the significant 
increase ip < 0.01) in lactate secretion caused by 1,3-DNB without 
hepatocytes was abolished by their addition (table 5.4, column 2, lines 3 & 
4). There was only a slight increase in lactate secretion induced by 1,4-DNB 
in the outer compartment and the presence of hepatocytes did not enhance 
or diminish this level of secretion (table 5.4, column, lines 10 & 11).
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Table 5.4 Effects of metabolism of dinitrobenzenes bv hepatocytes on germ cell detachment
and lactate secretion in Sertoli/germ cell cultures
Treat­
ment
Con H
e
P
Germ cell detachment 
(48 h)
Lactate secretion 
(24 h)
pM X 1 0 ^ mT^ Scheffe’s 
test vs. 
control
pmol ml'^ Scheffe’s 
test vs. 
control
mean 
± SD
n
hep
mean 
± SD
n
hep
+
hep
none 0 - 76.8 
(± 3.4)
4 - 1.76 
(± 0 .1 )
4 - -
+ - - - 4.32
(± 0 .1 )
4 *** -
1,3-
DNB
500 - 107.6 
(± 6 .2 )
4 ** 3.58 
(± 0 .1 )
4 ** -
+ 80.9 
(± 2.3)
4 ns 5.13
(± 0 .1 )
4 - ns
MEHP 400 - 108.0 
(± 4.1)
4 ** - - - -
DEHP 400 - - - 1.95 
(± 0 .1 )
4 ns -
+ 1 0 2 . 6  
(± 3.8)
4 * 5.94 
(± 0.5)
4 - **
none 0 - - - - 1.17 
(± 0 .1 )
2 - -
+ - - - 4.10 
(± 0 .1 )
3 *** -
1,4-
DNB
100 - - - - 1.56 
(± 0 .1 )
2 ns -
+ - - - 3.54 
(± 0.0)
3 - ns
DEHP 400 - - - - 1 . 2 0  
(± 0.0)
3 ns -
+ - - - 5.30 
(± 0.5)
3 - ns
5-day old cultures treated for 48 h; 1 ,3 -DNB, 1,3-dinitrobenzene; 1,4-DNB,
1,4-dinitrobenzene; MEHP, mono-(2 -ethylhexyl) phthalate; DEHP, di-(2 -ethyl- 
he^ Q^ l) phthalate; n,number of cultures; con, concentration; hep, hepatocytes; 
SD, standard deviation; con, concentration; hep, hepatocytes; ns, not sig­
nificantly different, p  > 0.05; **, significantly different, < 0.01; ***, sig­
nificantly different, p  < 0 .0 0 1 ; -, not determined
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H exanediones
Direct effects
The results are shown in table 5.6.
Low concentrations of 2,4-HD (0.05, 0.1 and 0.5 mM) did not 
significantly increase germ cell detachment (table 5.5, column 1, lines 1 - 3 
and 4 - 5 ) .  Higher concentrations (1 and 5 mM) did cause a significant 
increase (p < 0.05). There was a concentration-related increase in germ cell 
detachment after treatment with 2,4-HD at 5, 10 and 20 mM (table 5.5, 
column 1, lines 6-10)  with the top two concentrations being highly signifi­
cant (p < 0.001).
Lactate secretion was determined only at one treatment level of 2,4- 
HD (10 mM) at which there was a highly significant increase (p < 0.001; 
table 5.5, column 2, lines 7 & 9).
Doses of 2,4-HD that significantly affected germ cell detachment also 
significantly affected protein synthesis. Concentrations of 0.05, 0.1 and 0.5 
mM caused non significant decreases in protein synthesis (table 5.5, column 
3, lines 1 - 3 )  and 1 mM caused a significant decrease (p < 0.01; table 5.5, 
column 3, lines 4 & 5). There was a concentration-related decrease in 
protein synthesis with 2,4-HD treatment at 5, 10 and 20 mM (table 5.5, 
column 3, lines 7-10)  with each treatment giving a significant decrease (p 
< 0.001).
None of the treatment concentrations of 2,5-HD (0.5 to 20 mM) had 
a significant effect on germ ceh detachment (table 5.5, column 1, fines 11 - 
17), although lactate secretion was significantly increased (p < 0.001) by a 
10 mM concentration (table 5.5, column 1, lines 14 & 16).
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Table 5.5 Effects of hexanediones on germ cell detachment lactate secretion and
protein synthesis in Sertoli/germ cell cultures
Hexane-
dione
Concen­
tration
Germ cell 
detachment (48 h)
Lactate 
secretion 
(24 h)
Protein 
synthesis 
(48 h)
mM X 1 0 ^ ml"^ pmol ml'^ ^H incorporation 
mg'^
mean 
± SD
n mean n mean 
± SD
n
2,4-HD 0 12.9 
(± 1 .1 )
5 - - 58.0 
(± 3.0)
4
0.05 13.8^^ 
(± 0.9)
5 - - 51.2*3 
(± 3.0)
4
0 . 1 14.7^^ 
(± 1.7)
5 - - 51.1*3 
(± 3.5)
4
0 12.5 
(± 1 .0 )
5 - - 67.5 
(± 2 .8 )
4
0.5 14.5^^ 
(± 1 .2 )
5 - - 62.8*3 
(± 1 .8 )
4
1 16.0* 
(± 0.5)
5 - - 54.6** 
(± 2 .6 )
4
0 16j:7* 8 1.47^ 8 65.1^ 4
5 22.9* 9 - - 53.5*** 7
1 0 38.2*** 9 3.25*** 9 28.7*** 8
2 0 86.3*** 5 - - 19.1*** 4
2,5-HD 0 28.5 
(± 1 .8 )
5 - - 101.9 
(± 5.7)
4
0.5 28.5*3 
(± L2 )
5 - - 76.7** 
(± 1.9)
4
1 27.2*3 
(± 2 .2 )
5 - - 81.6**
(± 4.1)
4
0 2&5d 8 L5ie 8 57.1^ 4
5 21.1*3 9 - - 53.4*3 7
1 0 21.8*3 1 0 2.51*** 8 46.3* 8
2 0 21.3*3 5 - - 53.3*3 4
5-day old cultures treated for 48 h; 2,4-HD, 2,4-hexanedione; 2,5-HD, 2,5- 
hexanedione; n, number of cultures; SD, standard deviation; MS, mean 
square^ not significantly different, p  > J^0.05; , significantly different, p  < 
0.05; * , significantly different, p  < 0.01; ***, significantly different, p  < 0.001;
2  experiments pooled, residual MS = 30.22; 2  experiments pooled,
residual MS = 0.05; 2  experiments pooled, residual MS = 9.48; 2
experiments pooled, residual MS = 18.95; ^,2 experiments pooled, residual MS 
= 0.05; 2 experiments pooled, residual MS = 118.9; -, not determined
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The effects of 2,5-HD on protein synthesis did not follow any pattern. 
There were significant ip < 0.01), but not concentration-related, decreases 
after 0.5 or 1 mM treatment, a significant decrease (p < 0.05) after 10 mM 
treatment but no significant change after 5 or 20 mM treatment (table 5.5, 
column 3, lines 11 - 17).
Metaholism by hepatocytes
The results are shown in table 5.6.
2,4-HD was assessed for its effects on germ cell detachment in the 
presence and absence of hepatocytes. The positive control, MEHP, produced 
a significant increase (p < 0.001) in germ cell detachment but the positive 
control with hepatocytes, DEHP, only produced a non-significant increase 
(table 5.6, lines 4 & 5). In contrast to the results presented above, 2,4-HD 
produced a non-significant decrease in germ cell detachment which was not 
influenced by the presence of hepatocytes.
The two experiments for the assessment of 2,5-HD revealed a 
significant increase in germ cell detachment (p < 0.001) for both the positive 
controls with and without hepatocytes (table 5.6, lines 9 & 10). Results with
2,5-HD were consistent with those presented above in that there was no 
significant effect on germ cell detachment (table 5.6, line 7). Hepatocytes 
had no effect (table 5.6, line 8).
A n tifertility  drugs
Direct
The results are shown in table 5.7.
Over the range 100 - 400 pM, AF1312/TS resulted in a concentration- 
related increase in germ cell detachment (table 5.7, column 1, lines 1 - 4), 
this being non-significant at 100 pM and significant (p < 0.001) at 200 and
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400 fiM. In a separate experiment 400 and 800 fxM AF1312/TS produced a 
highly significant increase (p < 0.001) in germ cell detachment (table 5.7, 
column 1, lines 5-7) .
Table 5.6 Effects of metabolism of hexanediones bv hepatocytes on 
germ cell detachment in Sertoli/germ cell cultures
Treat­
ment
Concentration Hepatocytes Germ cell detachment 
(48 h)
X 1 0 "^ ml'^ Scheffe’s test vs. 
control
mean 
± SD
n - hepatocytes
none 0 - 92.5 
(± 3.0)
4 -
2,4-HD 1 0  mM - 83.7 
(± 6 .0 )
4 ns
+ 81.4 
(± 3.5)
4 ns
MEHP 400 - 133.0
(± 1 .8 )
4 * * *
DEHP 400 ^M 4- 106.8 
(± 2.5)
4 ns
none 0 - 103.7^ 8 -
2,5-HD 10 mM - 106.1 8 ns
+ 108.0 8 ns
MEHP 400 pM - 144.2 7 * * *
DEHP 400 pU + 132.6 8 ***
5-day old cultures treated for 48 h; 2,4-HD, 2,4-hexanedione; 2,5-HD, 2,5- 
hexanedione; MEHP, mono-(2-ethylhexyl) phthalate; DEHP, di-(2-ethylhexyl)- 
phthalate; n, number of cultures; SD, standard deviation; ns, not significantly 
different, p > 0.05; ***, significantly different, p < 0.001; 2 experiments
pooled, residual mean square = 106.1; -, not determined
Lactate secretion was measured after treatment with 400 /iM 
AF1312/TS and was found to be significantly increased (p < 0.001; table 5.7, 
column 2, lines 1 & 4).
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Table 5.7 Effects of antifertility drugs on germ cell detachment lactate secretion and
protein synthesis in Sertoli/germ cell cultures
Anti-
fertility
drug
Concen­
tration
Germ cell 
detachment 
<48 h)
Lactate 
secretion 
<24 h)
Protein 
^nthesis 
<48 h)
pM X 10'  ^ml’^ pmol ml'^ incorporation
mg‘^
mean 
± SD
n mean 
± SD
n mean 
± SD
n
AF1312/TS 0 35.0^ 9 1.38^ 15 61.1^ 15
100 41.5"^ 9 - - 53.2* 13
200 51.2*** 9 - - 44.4*** 15
400 69.4*** 10 3.31*** 14 46.5*** 15
0 7.9
(± LO)
3 - - 57.1 
<± 5.5)
4
400 30.8*** 
(± 1.2)
4 - - 48.9^^ 
<± 3.9)
4
800 31.6*** 
(± 3.7)
4 - - 4 1 .4 :^ ^
<± 9.3)
3
Gossypol 0 15.2*^ 10 1.38^ 15 66.6^ 8
5 29.6*** 1 0 - - 65.7^ 8
1 0 68.7*** 10 - - 44.0*** 8
2 0 85.0*** 1 0 3.03*** 15 1.8*** 7
Lonidamine 0 35.4^ 8 1.34^ 8 - -
1 0 0 98.7*** 7 3.06*** 8 - -
2 0 0 134.3*** 8 3.80*** 8 - -
400 146.5*** 8 3.69*** 8 - -
5-day old cultures treated for 48 h; AF1312/TS, l-(p-chlorobenzyl)-lH- 
indazole-3-carboxylic acid; lonidamine, l-(2,4-dichlorobenzyl)-lH-indazole-3- 
carboxylic acid; n, number of cultures; SD, standard deviation; MS, mean 
square^ not significantly different, p > 0.05; , significantly different, p  < 
0.05; * , significantly different, p  < 0 .0 0 1 ; 2  experiments pooled, residual
MS = 52.73; 3 experiments pooled, residual MS = 0.13; 3 experiments
pooled, residual MS = 76.93; 2  experiments pooled, residual MS = 49.96;
% 3 experiments pooled, residual MS = 0.08; 2 experiments pooled, residual
MS = 47.84; 2  experiments pooled, residual MS = 591.3; 2  experiments
pooled, residual MS = 0 .2 2 ; -, not determined
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There was a concentration-related decrease in protein synthesis over 
the range 100 - 400 /iM AF1312/T8 when results for three experiments
were combined (table 5.7, column 3, lines 1 - 4). Individual decreases were 
all significant ip < 0.05). However, although this effect was still apparent 
in a further single experiment using concentration levels of 400 and 800 pM, 
the results were not significant (table 5.7, column 3, lines 5 - 7).
Gossypol at doses of 5 to 20 pM caused a concentration-related 
increase in germ cell detachment with each level individually causing a 
statistically significant increase (p < 0.001; table 5.7, column 1, lines 8 - 11). 
Lactate secretion was also significantly increased (p < 0.001) by 20 pM 
gossypol (table 5.7, column 2, lines 8 & 11).
At concentration levels of 5 to 20 pM gossypol induced a concentra­
tion-related decrease in protein synthesis (table 5.7, column 3, lines 8-11). 
The decrease was not significant at 5 pM but was large and highly 
significant (p < 0.001) at the higher concentrations.
Like AF1312/TS, lonidamine produced a concentration-related 
increase in germ cell detachment over a dose of 100 - 400 pM (table 5.7, 
column 1, lines 12 -15). Each concentration (100, 200 and 400 pM) produced 
a significant increase (p < 0.001).
A significant increase (p < 0.001) in lactate secretion was also found 
for dose levels of lonidamine of 100 to 400 pM, although there was no clear 
concentration-dependent response (table 5.7, column 2, lines 12 - 15).
Oxygen rad icals and an tiox id an ts  
oxidase
Germ cell detachment was the only endpoint measured in this series 
of experiments. The results are shown in table 5.8.
187
Table 5.8 Effects of xanthine/xanthine oxidase on germ cell detachment in
Sertoli/germ cell cultures
Treatment n Germ cell 
detachment (48 h)
Damage to 
Sertoli cells
X lO'^  ml'^
X XO Treat­
ment
time
mean ± SD
pU mU ml"^ h
0 0 0 3 114.2 (± 23.5) none
129 0.25 48 4 116.6^^ (± 13.6) none
129 2.5 48 4 119.9^^ (± 1 0 .6 ) none
129 25 48 4 208.3**'' (± 6.9) severe
0 0 0 4 149.5 (± 34.4) none
129 5 48 4 124.3^^ (± 25.9) none
129 1 0 48 4 190.6^ (± 25.1) severe
129 15 48 4 204.8* (± 21.7) severe
0 0 0 4 162.4 (± 27.9) none
0 25 48 4 434.7*** (± 69.1) severe
64 25 48 4 331.1*** (± 63.1) severe
129 25 48 4 321.3** (± 35.0) severe
0 0 1 4 140.1 (± 12.0) none
0 0 2 4 132.7^^ (± 19.7) none
129 25 1 4 179.3* (± 24.0) none
129 25 2 4 199.4** (± 22.0) slight
5-day old cultures treated; X, xanthine; XO, xanthine oxidase; n, number of 
cultures; SD, standard deviation^ not significantly different, p  > 0^5; , 
significantly different, p < 0.05; , significantly different, p  < 0.01; , sig­
nificantly different, p < 0 . 0 0 1
Initially, treatment with X/XO was carried out in the same way as for 
the testicular toxins, i.e. X/XO remained in the culture medium for 48 h, 
and germ cells were counted at 24 and 48 h, with the treatment medium 
being renewed after 24 h.
188
There was a significant increase (p < 0.01) in germ cell detachment 
compared to controls when the highest level of XO (25 mU ml^) was used 
with 129 pM X (table 5.8, lines 1 & 4 and lines 9 & 12). Using the same 
concentration of X, at intermediate levels of XO there was a small increase 
in germ cell detachment which was significant (p < 0.05) at 15 mU mU and 
non-significant at 10 mU mU (table 5.8, lines 5, 8 & 7). At the lowest levels 
of XO (5, 2.5 or 0.25 mU ml^) there was no increase in germ cell detachment 
(table 5.8, lines 5 & 6 and 1, 3 & 2). Reducing the level of X (to 64 or 0 pM) 
with XO at 25 mU ml ' did not affect the rate of germ cell detachment, 
which remained significantly higher (p < 0.001) than controls (table 5.8, lines 
9, 11 & 10).
However, in contrast to the picture obtained with the testicular toxins 
presented above, the increase in germ cell detachment observed with X/XO 
treatment was accompanied by a severe toxic effect on the Sertoli cells. In 
order to obtain an increase in germ cell detachment without this toxicity, 
the time of treatment was reduced although the total germ cell detachment 
over 48 h was still used as the endpoint. There was a statistically significant 
increase (p < 0.01) in germ cell detachment in cultures treated with X (129 
pM) and XO (25 mU ml ') for 2 h (table 5.8, lines 14 & 16) and in cultures 
treated similarly for 1 h (p < 0.05) (table 5.8, lines 13 & 15). The 2 h 
treatment had only a slightly damaging effect on the Sertoli cells whilst the 
1 h treatment had no toxic effect.
acid
The results are shown in table 5.9.
L-ascorbic acid alone at 1 or 2 mM did not cause a significant increase 
in germ cell detachment (table 5.9, lines 2 & 6). The significant increase in 
germ cell detachment caused by 2 h treatment with X/XO was maintained 
in these sets of experiments (table 5.9, line 3,p < 0.05; line 7, p < 0.001).
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Table 5.9 Effects of L-ascorbic acid on germ cell detachment in
Sertoli/germ cell cultures
Treatment n Germ cell 
detachment (48 h)
X 1 0 “^ ml’^ LSD test
X XO AA mean vs. X vs. X/XO
/iM mU ml'^ mM
± SD
0 0 0 4 96.0 
(± 30.6)
- -
9 0 1 4 1 0 1 . 8  
(± 8.4)
ns -
129 25 0 4 152.3 
(± 20.9)
** -
129 25 1 4 153.1 
(± 29.2)
** ns
0 0 0 8 86.3^ - -
0 0 2 8 77.8 ns -
129 25 0 8 125.1 *** -
129 25 2 8 104.9 **
5-day old cultures treated for 2 h; X, xanthine; XO, xanthine oxidase; AA, L- 
ascorbic acid; n, number of cultures; LSD test, least significant difference test; 
SD, standard deviation; ns, not significantly different,p > 0.05; *, significantly 
different, p  < 0.05; **, significantly different, p  < 0.01; ***, significantly diff­
erent,/? < 0.001; 2 experiments pooled, residual mean square = 102.3; -, not
determined
The addition of L-ascorbic acid at 1 mM to cultures containing X/XO 
did not reduce germ cell detachment from the level seen in X/XO treated 
cultures (table 5.9, line 4). Cultures treated with X/XO and 1 mM L- 
ascorbic acid had a level of germ cell detachment which was still 
significantly different from control cultures (p < 0.01). At 2 mM, L-ascorbic 
acid significantly reduced germ cell detachment from the level seen in X/XO 
treated cultures (p < 0.001; table 5.9, line 8) although cultures treated with 
X/XO and 2 mM L-ascorbic acid had a level of germ cell detachment which 
was still significantly different from control cultures (p < 0.01).
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DL- a-tocopherol
The results are shown in table 5.10.
Table 5.10 Effects of DL-g-tocopherol on germ cell detachment 
in Sertoli/germ cell cultures
Treatment n Germ cell 
detachment (48 h)
X 10"^  ml’^ LSD test
X XO AT mean vs. X vs. X/XO
/(M mU ml"^ Pre­
treatment, h
pg ml'^
0 0 0 0 8 185.9^ - -
0 0 0 380 8 191.8 ns -
129 25 0 0 8 219.5 -
129 25 0 380 8 248.4 *** *
0 0 0 0 8 73.2^ - -
0 0 24 380 8 74.4 ns -
129 25 0 0 8 127.5 *** -
129 25 24 380 8 1 2 0 . 8 ns
5-day old cultures treated for 2 h; X, xanthine; XO, xanthine oxidase; AT, DL- 
a-tocopherol; n, number of cultures; LSD test, least significant difference test; 
MS, mean square; ns, not significantly different, p  > 0.05; *, significantly diff­
erent, p  < 0.05; significantly different,p  < 0.01; ***, significantly different, 
p  < 0.001; ^  2 experiments pooled, MS = 490.2; 2  experiments pooled, MS
= 324.4; -, not determined
DL-a-tocopherol alone at 380 pg ml ' did not cause an increase in germ 
cell detachment (table 5.10, line 2) even when cultures were pretreated with 
DL-a-tocopherol at this concentration for 24 h (table 5.10, line 6). The 
significant increase in germ cell detachment caused by 2 h treatment with 
X/XO was maintained in these sets of experiments (table 5.10, line 3, p < 
0.01; line 7,jo < 0.001).
The addition of DL-a-tocopherol at 380 gg ml ' to cultures containing 
X/XO did not reduce germ cell detachment from the level seen in X/XO
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treated cultures (table 5.10, line 4), but in fact, produced a further increase 
(p < 0.05). Pretreatment of cultures with DL-a-tocopherol for 24 h did not 
reduce germ cell detachment (table 5.10, line 8). Cultures treated with 
X/XO and 380 pg ml ' DL-a-tocopherol, with or without 24 h pretreatment 
with DL-a-tocopherol, had a level of germ cell detachment which was still 
significantly different from control cultures (p < 0.001; table 5.10, lines 4 & 
8).
5.4 DISCUSSION
E ffects o f Serto li ce ll tox in s
Phthalate esters
The results presented show that germ cell detachment and lactate 
secretion were increased by the presence of MEHP or mono-/z-butyl 
phthalate in the inner compartment medium of Sertoli/germ cell cultures 
grown in a dual-compartment system. The effect on germ cell detachment 
was related to concentration for MEHP but presumably a threshold had 
been reached for lactate secretion with MEHP and for germ cell detachment 
with mono-72-butyl phthalate. DEHP or mono-^er^-butyl phthalate did not 
have these effects except for a small increase in germ cell detachment with 
DEHP in one experiment only and an effect on lactate secretion with mono- 
^e/Y-butyl phthalate that was not seen with any other toxin, namely a 
decrease. The results, using dish cultures, of Gray & Beamand (1984) and 
Moss ef uZ (1988) are thus, for the most part, confirmed. Protein synthesis 
was not consistently affected by MEHP, although mono-/i-butyl phthalate 
produced a concentration-related increase. Mono-^er(-butyl phthalate had 
no consistent effect on protein synthesis.
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The use of hepatocytes in the outer compartment allowed DEHP (in 
the outer compartment medium) to cause an increase in germ cell 
detachment and lactate secretion. This presumably indicated that DEHP 
had been metabolized to MEHP by the hepatocytes, as has been shown to 
occur by Lake et al (1976). Also, the addition of MEHP to the outer 
compartment containing hepatocytes did not affect the increase in germ cell 
detachment and lactate secretion seen without hepatocytes. This 
presumably indicates that MEHP had not been fully metabolized to its non­
toxic metabolites (Gray, 1986) by the hepatocytes.
These results would tend to confirm the view that the partial 
hydrolysis of dialkyl phthalates (including DEHP and di-n-butyl phthalate) 
to monoalkyl phthalates (including MEHP and mono-n-butyl phthalate) in 
the gastro-intestinal tract is required in order for their toxic action to be 
exerted (Lake et al, 1977). The first two hydrolysis products of DEHP in 
rats are MEHP and 2-ethylhexanol (which is not a testicular toxin) and both 
of these are further metabolized oxidatively (Kluwe, 1982) (see fig. 5.3).
Williams & Foster (1988) reported that increased lactate secretion 
occurred at concentrations of MEHP well below those required to produce 
alterations in morphology in vitro or testicular toxicity in vivo. Indeed, they 
found that concentrations above 100 /LtM affected cell viability in as 
indicated by trypan blue exclusion (Williams & Foster, 1989). However, 
using the dual-compartment system, it was evident that higher 
concentrations of MEHP were required to give a comparable effect to that 
found in the dish cultures used by Gray & Beamand (1984), and 
morphological effects on Sertoli cells were not observed until a concentration 
of 800 pM was reached.
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Fig. 5.3 Metabolic pathway for phthalate esters
O CHg-CH^
C-O -CH g-CH -CH g-CH g-CH g-CH g
C-O -CH g-CH -CH g-CH g-CH g-CH g 
O CH2 -C H 3
di-(2-ethylhexyl) phthalate
ÇH2-CH3
+ H0-CH2-CH-CH2-CH2-CH2-CH3
2-ethylhexanol
C-O -C H 2-Ç H -C H 2-C H 2-C H 2-C H 3
O
mono-(2-ethylhexyl) phthalate 
1
CH2-CHj
C-OH
phthalic acid
+ H0-CH2-CH-CH2"CH2"^2^(^ 3
CH2-CH3
2-ethylhexanol
from Kluwe, 1982
Possible explanations for this difference are that the treatment 
medium placed in the inner or outer compartment was diluted by the 
medium without chemical placed in the other compartment, that the 
improved morphology of the Sertoh cells grown on the fibronectin-coated
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membrane rendered them more resistant to toxic insult or that light 
microscopic observation was not sufficient to conclude that cell morphology 
and viability were not impaired. Indeed, preliminary work in which the 
effects of MEHP on Sertoli cells grown in dishes and fibronectin-coated 
Millicells® were compared, indicated that the latter were more resistant to 
this toxin’s germ cell detachment-inducing effects (JC Phillips et al, 
unpublished observations).
Dinitrohenzenes
Both 1,3-DNB and 1,4-DNB caused an increase in germ cell 
detachment and lactate secretion when present in the inner compartment 
culture medium of the Sertoli/germ cells in the dual-compartment system 
used in these studies. This is not in full agreement with the results of 
Williams & Foster (1988) since, although they found 1,3-DNB to be as 
effective as MEHP in inducing these two reactions, 1,4-DNB was found to 
be ineffective. Protein synthesis was significantly increased by 1,3-DNB, but 
not in a concentration-related manner, and was not found to be consistently 
affected by 1,4-DNB.
In addition to its effect on germ cell detachment and lactate secretion, 
1,4-DNB was found to cause cytotoxicity of the Sertoli cells at concentrations 
at which 1,3-DNB did not. This is surprising, since 1,4-DNB has not been 
found to be a testicular toxin in vivo (Blackburn et al, 1988), but the 
discrepancy is similar to the in vitro findings of Gray & Beamand (1984) 
with mono-n-octyl phthalate, which is also non-toxic in vivo. This compound 
also caused germ cell detachment and it caused disruption of the Sertoli cell 
monolayer, an effect which was not seen with other phthalate monoesters, 
even those which caused germ cell detachment in vivo and in vitro (Gray & 
Beamand, 1984).
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In an attempt to resolve the disparity of these findings, both isomers 
of DNB were subjected to the metabolizing system of hepatocytes in the 
outer compartment. The increase in germ cell detachment and lactate 
secretion was eliminated by hepatocytes for 1,3-DNB. Metabolism of 1,3- 
DNB does take place in the Sertoli cells, as has been shown by the 
identification of metabolites in the medium of Sertoh/germ cell co-cultures 
(Foster et al, 1987). It is possible that the additional metabolic capacity 
provided by the hepatocytes allowed detoxication to take place.
However, 1,4-DNB in the outer compartment without hepatocytes 
produced a surprising result in that no increase in lactate secretion was 
observed. The presence of hepatocytes did not affect this result. It could 
be concluded that the observed Sertoli cell toxicity in response to 1,4-DNB 
was compartment-specific and that only treatment in the inner 
compartment gave rise to the effect. This may demonstrate the 
effectiveness of the blood-testis barrier, as modelled by the dual­
compartment system, since treatment in the outer compartment (equivalent 
to the interstitial compartment of the testis) did not give rise to toxicity. It 
has been suggested that extragonadal metabolism of 1,4-DNB may explain 
its lack of testicular toxicity in vivo; its metabolism is known to be different 
from that of 1,3-DNB (Working, 1989).
DNB is metabolized by conjugation with glutathione and also by 
nitroreduction, the balance between the two routes differing for the 
different isomers (Working, 1989; Nystrom & Rickert, 1987). The ultimate 
metabolites from the nitroreduction pathway (3-nitroaniline and 1,3- 
nitroacetanilide) were not themselves toxic and it was suggested that 
intermediates in the metabolic pathway actually led to the testicular toxicity 
observed (Foster et al, 1987).
As was the case with MEHP (see above), comparing these results with 
those of other workers using dish cultures (Williams & Foster, 1988, 1989;
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Gray & Beamand, 1984), it was found that higher concentrations of 1,3-DNB 
were required before toxicity was observed.
Hexanediones
The endpoints employed after treatment of Sertoli/germ cell cultures 
in the inner compartment gave different results for the toxicity of the two 
isomers of HD. 2,5-HD, which has been shown to be toxic in vivo 
(Boekelheide, 1988a,b), had no effect on germ cell detachment, but increased 
lactate secretion and slightly decreased the rate of protein synthesis. 
However, 2,4-HD, which exhibited no testicular toxicity in vivo (JC Phillips 
et al, unpublished observations), caused an increase in both germ cell 
detachment and lactate secretion and a decrease in protein synthesis. It is 
possible that the direct exposure of Sertoli cells to 2,4-HD in vitro caused 
cytotoxicity which resulted in these effects (2,4-HD was highly toxic in vivo; 
JC Phillips, unpublished observations).
Despite the fact that 2,5-HD is a neurotoxicological agent, its effect 
on the testis is not mediated via disruption of central nervous system- 
centred control systems (Chapin et al, 1982). Boekelheide (1988a) has 
proposed that 2,5-HD acts by disrupting the micro tubules of the Sertoli cells, 
since such damage has been observed to result in germ cell detachment 
(Russell et al, 1981). Isolated testis tubulin shows abnormal kinetics of 
assembly when exposed to 2,5-HD and, as the function of the microtubular 
cytoskeleton of the Sertoli cells in relation to germ cells may be one of 
support, this effect may be expected to lead to germ cell detachment 
(Boekelheide, 1988b). However, a time delay of several weeks was observed 
in vivo for the testicular toxicity of 2,5-HD (Boekelheide, 1988a) and it is 
possible that this prevented the observation of any effect m i/ifro over a 48 
h period.
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Two of the endpoints were re-evaluated with the HD isomers placed 
in the outer compartment with hepatocytes. No changes were observed in 
the effects on germ cell detachment by the addition of hepatocytes, 
presumably indicating either that no further metabolism had taken place 
(possible due to a slow rate of metabolism) or that the metabolites produced 
had equal toxicity to the parent compound.
Antifertility drugs
All three antifertility drugs assessed in the dual-compartment system 
resulted in an increase in germ cell detachment and lactate secretion. Both 
AF1312/TS and gossypol gave rise to a decrease in protein synthesis, an 
effect which was extremely marked with the latter compound.
The results with AF1312/TS are in agreement with those of De 
Martino et al (1975) and Gray (1986) who observed an increase in germ cell 
detachment in dish cultures. The process of testosterone conversion to 
oestradiol has been found to be affected by lonidamine in vitro (Galdieri et 
oZ, 1984).
The effects of gossypol reported confirm the findings of Tanpaichitr 
et al (1984) in the reduction in protein synthesis and the findings of Reyes 
et al (1986) in the increase in lactate production, which may occur through 
the uncoupling of oxidative phosphorylation in mitochondria.
Oxygen radicals
Treatment via the inner compartment culture medium with the 
oxygen radical generating system of 129 /iM X plus 25 mU ml^ XO (as used 
for cultured post-implantation embryos - see chapter 2) for 48 h (as used for 
the testicular toxins - see above) was found to have a severe morphological 
effect on the Sertoli cells. Reduction in the concentration of either the 
enzyme or the substrate reduced both the germ cell detachment effect and
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the morphological damage equally and both endpoints were simultaneously 
perturbed. A reduction in the time of treatment to 2 h, whilst still retaining 
the measurement of germ cell detachment at 48 h as the ultimate endpoint, 
provided a means of measuring the toxicity of oxygen radicals without the 
accompanying Sertoli cell cytotoxicity.
The addition of L-ascorbic acid to the system reduced the germ cell 
detachment induced by X/XO but did not restore it to the control level. L- 
ascorbic acid alone did not induce germ cell detachment indicating that it 
acted as an antioxidant, rather than as a pro-oxidant, in this system (see 
discussion in chapter 2). The addition of DL-a-tocopherol to the system did 
not reduce germ cell detachment; in fact germ cell detachment was actually 
increased in one series of experiments. Pre-treatment of the Sertoli cell 
cultures with DL-a-tocopherol for 24 h (as discussed in chapter 2) did not 
enhance its protective effect.
The results indicating the protective effect of L-ascorbic acid are in 
partial agreement with those of Cave & Foster (1990) who found a 
protective role for this radical scavenger against the reactive intermediates 
of 1,3-DNB metabolism. However, whilst they found a concentration of 2 
mM L-ascorbic acid to induce germ cell detachment in Sertoli/germ cell 
cultures in dishes, this level had no effect on such cultures in the dual­
compartment system described in this chapter. This is perhaps not surpris­
ing in the light of the results presented above for the effects of known 
Sertoli cell toxins in this system.
A cytochrome P-450 reductase, whilst not occurring in the 
seminiferous tubules, is found in the Leydig cells, thereby giving the latter 
the capacity to generate superoxide anion radicals in the interstitial 
compartment (Georgellis eZ aZ, 1988). However, testicular cytochrome P-450 
is primarily involved in testosterone biosynthesis and would not, therefore, 
be expected to have as extensive a role in the metabolism of toxins as the
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hepatic cytochrome P-450 (Chapin & Phelps, 1990). Since it acts in situ the 
its effect would be far more damaging (Working, 1989).
Sertoli cells have a role in glutathione synthesis in the germ cells, as 
shown by in vitro studies in hamsters (Grootegoed et al, 1989; den Boer et 
al, 1989). This may imply that there is a need for protection against oxygen 
radicals, indeed, peroxides generated in the seminiferous tubule may be 
inactivated in the Sertoli cells via the pentose phosphate pathway 
(Grootegoed eZ aZ, 1989).
The p o ten tia l for th e  u se o f S erto li/germ  ce ll  
co-cultures in  a dual-com partm ent system  in  
th e in vestiga tion  o f testicu lar  toxins
Sertoli/germ cell cultures
There are many advantages of using an in vitro system (see section
6.1) for the screening of potential testicular toxins, including rapidity and 
the scope for investigating mechanisms of action (Gray, 1986). The 
correlation of in vitro effects with in vivo responses is essential in the 
evaluation of a testicular toxicity screen, particularly since the ability of 
specific chemicals to cross the blood-testis barrier may not be known (Gray 
& Beamand, 1984).
The fact that various compounds have been found to cause 
qualitatively similar effects on Sertoli cells in vitro and in vivo supports the 
usefulness of such in systems in investigations of toxicity (Gray & 
Beamand, 1984; Foster aZ, 1987; Lloyd & Foster, 1988; Moss nZ, 1988; 
Williams & Foster, 1988; 1989). t/ZZro responses to a toxin may be 
observed at a concentration below that found in the testis after Z/i z/Zm 
treatment (Foster eZ aZ, 1987; Gray & Beamand, 1984). These quantitative
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differences may be explained by the effects of distribution of the compound 
within the testis in vivo, or by the cells having a greater resistance in vivo.
Endpoints
The use of a battery of endpoints measured in chemically-treated 
Sertoli cell cultures will increase the efficiency and sensitivity of the in vitro 
system (Working, 1989; Gray & Beamand, 1984). The system described in 
this chapter permits examination of multiple endpoints in the same cultures.
The increase in lactate production induced by MEHP in vitro is not 
in itself a toxic effect since germ cell detachment is not caused by an excess 
of lactate (Moss et al, 1988); indeed the opposite might be expected (Chapin 
& Phelps, 1990). However, the fact that various Sertoli cell toxins gave rise 
to an increase in lactate secretion, often in line with an increase in germ cell 
detachment and a correlation with in vivo toxicity, makes it a useful marker 
nevertheless (Chapin & Phelps, 1990). The sensitivity of lactate secretion 
as an in vitro endpoint of toxicity has been described by Williams & Foster
(1988): changes were reported at a lower level of toxin (1,3-DNB or MEHP) 
and after a shorter time than was required to affect morphology. In the 
absence of a biochemical explanation for this response, increased lactate 
secretion cannot be taken in isolation to indicate a toxic effect.
Germ cell detachment has been recommended as an endpoint for the 
screening of testicular toxins in vitro (Chapin & Phelps, 1990) since it as 
both simple to measure and relevant to the in vivo situation. Gray & 
Beamand (1984) reported that germ cell detachment occurred in vivo and 
Z/z uZZro after treatment with phthalate esters. A supplementary addition to 
the technique would be to investigate the viability of the germ cells which 
have been detached, since this may further differentiate between potential 
testicular toxins.
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Overall protein synthesis has not been widely used as an endpoint for 
Sertoli cell toxicity. From the results presented in this chapter it is 
concluded that this endpoint is not sensitive in identifying such toxins, 
producing a fairly small effect with a relatively large variability between 
cultures, gossypol being the obvious exception. However, given a sufficient 
number of replicates, most of the toxins analysed in this study were found 
to affect overall protein synthesis significantly. The system used in the 
studies presented in this chapter did not suffer from the drawback of filter- 
binding of secreted proteins that were being measured in the culture 
medium (Janecki & Steinberber, 1988) since culture medium contained 
foetal calf serum for the first 24 h and this would have saturated the 
protein-binding sites of the culture support (Janecki & Steinberger, 1988). 
A further improvement of the endpoint of protein synthesis, measured as 
uptake of radiolabelled amino acids, has been used by Anthony & Skinner
(1989) and involves analysis by SDS gel electrophoresis combined with 
fluorography, enabling the identification of proteins of particular molecular 
weights.
If morphology were to be a criterion for the assessment of toxicity, 
the use of a substrate, such as extracellular matrix or seminiferous tubule 
biomatrix, upon which Sertoli cells assume a morphology that more closely 
resembles that found in vivo is desirable (Anthony & Skinner, 1989; Tung 
& Fritz, 1984). Fibronectin used to coat the filter supports used in these 
studies was believed to provide such a substrate (see section 5.1).
The culture of Sertoli cells in plastic dishes provides a simple 
environment which falls short of modelling the complex in vivo conditions 
in the testis (Janecki eZ uZ, 1987). Since the features of Sertoli cells are 
dependent upon their culture conditions (AilenbergeZ nZ, 1990) extrapolation
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from the in vitro case is more realistic in a system, such as the dual­
compartment assembly described in this chapter, which more closely mimics 
the in vivo situation.
Most of the studies in which comparisons have been made between 
Sertoli cell function in dual- and single-compartment assemblies have been 
for physiological purposes, such as investigations of hormonal control 
(Ailenberg et al, 1990) or of the importance of cell contacts in Sertoli/germ 
cell interactions (Castellon et al, 1989b). Chapin & Phelps (1990) concluded 
that the additional expense (both technically and financially) incurred 
through the use of dual-compartment assemblies for toxicological 
investigations could not be justified for the measurement of many endpoints 
since results were similar to those from single-compartment systems. They 
have, however, used such a system in a toxicological evaluation of tri-o-cresyl 
phosphate, which had a toxic effect on Sertoli cells in the inner 
compartment only after metabolism by Leydig cells in the outer 
compartment (Chapin & Phelps, 1989).
Those chemicals that exert a toxic action on Sertoli cells may do so 
either directly or after metabolism, which may occur within the Sertoli cell 
(Foster et al, 1987), in the Leydig cells of the interstitial compartment of the 
testis (Chapin & Phelps, 1990) or elsewhere in the body (Working, 1989). 
Since the liver is a major site for the metabolism of exogenous chemicals in 
vivo, hepatocyte cultures have been used in the dual-compartment assembly 
described in this chapter to provide a model for this action in vitro.
The culture of Sertoli cells in a dual-compartment system permits a 
bipolar approach to treatment and measurement in the inner and outer 
compartments (Hadley eZ nZ, 1987; Janecki eZ nZ, 1987). More subtle 
endpoints that could be measured include the detection of polarized 
androgen-binding protein and transferrin secretion (Hadley eZ uZ, 1987). 
Although this would allow investigation of the control of such secretions it
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means that endpoints measured in dual-compartment systems may be quite 
different in magnitude from those measured in dishes (Hadley et al, 1987). 
For example, Ailenberg et al (1990) found that testosterone induced a 
decrease in the secretion of plasminogen activator in a dual-compartment 
system, but that in a single-compartment system the decrease was 
undetectable, a difference that was not apparent for transferrin secretion.
C onclusions and future p ossib ilities
The development of culture techniques for various testicular cell types 
means that there are possibilities for co-cultures to be set up in which to 
assess potential toxins (Gray, 1986). Using the dual-compartment system 
described in this chapter, it is possible to compare the effects of testicular 
toxins, with or without metabolism by hepatocytes in the outer 
compartment, on Sertoli/germ cell cultures in the inner compartment. 
Possibly the ultimate in vitro model would comprise Sertoli/germ cell co­
cultures on the inner surface of the membrane and peritubular cells on its 
outer surface with Leydig cells in the outer compartment. Since 
extragonadal metabolism has been proposed to explain why 1,4-DNB causes 
methaemoglobinaemia in the same way as 1,3-DNB but not the testicular 
toxicity observed with the latter compound (Working, 1989), this type of in 
vitro investigation could help to elucidate such a mechanism.
The ultimate goal of any screening system is to provide an assessment 
of toxic potential to humans. Methods for the culture of Sertoli cells can be 
modified for the preparation of human testicular material, thus providing a 
potential screening system in which extrapolation to the human uZuo 
situation is possibly more appropriate. The development of a testicular 
toxicity screen also provides a ^ stem  for the testing of drugs designed as 
male contraceptives, in that a knowledge of the specific functions that are
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disrupted is essential in such design (Reyes et al, 1986). Since male 
reproductive function in humans is less efficient (with respect to sperm 
production and reserves) than that of experimental animals, the risk from 
exposure to a particular chemical may be greater (Amann, 1989).
Not only metabolism, but also transport and distribution (including 
flow dynamics and pressure differences (Hadley et al, 1987) are missing from 
an in vitro system, and may affect the results obtained with chemicals (Gray 
& Beamand, 1984). An elaborate modification of the dual-compartment 
system, which also incorporates the continuous flow of fluid experienced by 
testicular cells in vivo has been described by Janecki et al (1987). This could 
be adapted for use in toxicological investigations.
The combination of treatment with antifertility agents and 
observation of or treatment with antioxidants could lead to an elucidation 
of the involvement of oxygen radicals in their toxicity. This approach has 
been used by Bender et al (1988) with gossypol in vivo and by Cave and 
Foster (1990) with 1,3-DNB in vitro, and it would be of interest to pursue 
the studies of the antifertility agents and antioxidant vitamins used in the 
studies described in this chapter.
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CHAPTER 6
FINAL DISCUSSION
Three in vitro approaches to reproductive toxicology have been 
investigated. Post-implantation rat embryos were found to be useful in the 
study of the protective effects of antioxidant vitamins, since their use 
enabled the identification of direct rather than maternally-mediated effects. 
The technically-demanding in vitro fertilization system was implemented 
and ethanol was used as a model compound in order to evaluate the method 
for toxicological purposes. Cultured Sertoli/germ cells were grown in the 
inner compartment of a dual-compartment system and treated with known 
and suspected testicular toxins in the outer compartment, with or without 
hepatocytes for metabolic activation.
Three aspects of male reproductive toxicity were considered. An in 
vitro fertilization system was used to study the effects of ethanol on male 
fertility, with treatment either in vivo or in vitro. The induction of 
heritable defects was examined in the offspring of male rats treated with 
cyclophosphamide (CP). Various measures of testicular damage specific to 
Sertoli cells were made through the use of an in vitro system.
Enzymically-generated oxygen radicals and two antioxidant vitamins 
were used to assess the potential impact of such species on reproductive 
systems. Both cultured post-implantation embryos and cultured Sertoli/ 
germ cells were investigated.
6.1 2N WTRO APPROACHES 
TO REPRODUCTIVE TOXICOLOGY
7/1 uZZno techniques that have been developed for studying the 
structure, function or physiology of reproductive systems may be adapted for 
use in toxicological investigations. Post-implantation rat embryo culture, 
mouse Zn uZZro fertilization and pre-implantation embryo culture, and cul­
tured rat Sertoli/germ cells have been used in the studies presented in this
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thesis. Parameters known to respond in vivo to certain reproductive toxins 
may be measured in such models. These parameters include morphology, 
growth and macromolecule synthesis, as well as functions specific to the 
particular cell/tissue type. Hence, neural suture abnormalities, fertilization 
rate, embryonic development, germ cell detachment, lactate secretion and 
protein synthesis have been measured in the systems detailed above.
The in vestiga tion  o f m echanism s
Whole animal systems are extremely complex and, whilst their use 
enables all the interactions to be taken into account, observation of isolated 
tissues/cells can give an insight into some of the detailed mechanisms in­
volved. Separation of particular tissue types and examination of their 
function in vitro permits the precise identification of target sites, metabolic 
capability and chemical vulnerability. Accessibility of the target to the 
chemical must be considered when in vitro systems are used in toxicological 
investigations (Russell & Steinberger, 1989).
Removal of embryos from their in vivo environment eliminates the 
confounding effect of maternal action (Brown et al, 1979). Cultured pre­
implantation embryos have been used to elucidate the embryonic 
contribution to the xenobiotic metabolism of benzo[a]pyrene (Filler & Lew, 
1981). The direct effect of oxygen radicals on cultured post-implantation 
embiyos has been detected as an increase in severity of neural suture 
abnormalities (chapter 2). Thus, if oxygen radicals are generated during the 
embryonic metabolism of a xenobiotic, this would provide a mechanism 
through which a damaging effect could be exerted.
The in fertilization system proved to have a greater sensitivity 
than in uiuo mating procedures for the detection of ethylene glycol 
monomethyl ether-induced disruption of fertilizing ability (Holloway uZ,
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1990a). In the case of fertility, behavioural effects can be removed by the 
use of an in vitro system (Anderson et al, 1983). The use of in vitro 
fertilization procedures permitted the precise pinpointing of the affected 
function in infertility (Holloway et al, 1990a,b). Holland & Orgebin-Crist 
(1988) used in vitro fertilization to show that some mutations known to af­
fect fertility in the mouse acted through decreased sperm-zona binding. 
Although various strategies were evaluated in the studies presented in 
chapter 3, it was not possible to demonstrate an inhibitory effect of ethanol 
on male fertilizing ability or on pre-implantation development in mice. The 
opportunity exists for distinguishing the different steps in fertilization and 
it is feasible that aspects of the process that remain to be investigated {e.g. 
treatment during the later stages of capacitation; metabolic activation) may 
be the crucial phases.
The treatment of cultured Sertoli cells with known metabolites has 
proved to be a useful approach to the evaluation of testicular toxins (mono 
(2-ethylhexyl) phthalate (MEHP), Gray, 1986; 1,3-dinitrobenzene (1,3-DNB), 
Foster et al, 1987). The incorporation of hepatocytes in the dual­
compartment system permits the metabolism of chemicals whose 
metabolites are unknown. The studies presented in chapter 5 have shown 
that the metabolites of di-(2-ethylhexyl) phthalate are toxic whereas the 
parent compound is not and thus provide an opportunity for examining 
other potential toxins.
C ontrol w ith in  th e  in vitro m ilieu
Observation of reproductive tissues in vitro, after chemical treatment 
in uiuo or in uiZro, permits close control over the environment (Moore, 1986) 
and precise timing of treatments and measurements (Matsuda ui, 1985).
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Matsuda & Tobari (1989) manipulated the environment of 1-cell 
embryos produced by in vitro fertilization such that their repair capacity 
could be elucidated. Fraser (1987) reported that manipulation of extra­
cellular calcium in in vitro fertilization could be used to recognize the 
specific sperm functions involved. In vitro fertilization allowed in vitro 
treatment of sperm, confined to a particular phase of fertilization and 
observation of the resulting embryos at any stage up to implantation.
The in vitro environment has an effect on Sertoli cell function, as 
shown by Ailenberg et al (1990) in the differential follicle stimulating 
hormone (FSH) response in dish cultures compared with the dual­
compartment system, and by Anthony & Skinner (1989) in Sertoli cell 
morphology. The culture system used in the studies presented in chapter 
5 provided inner and outer compartments in which treatments could be 
given and measurements made.
E ffic ien cy  o f in vitro system s
Generally, in vitro assays are rapid, simple and cheap, although the 
complex organs and processes involved in reproduction mean that complex 
in vitro procedures are required. There are limitations inherent to the use 
of in vitro models of processes as complicated as reproduction, namely the 
inability of conditions to support embryo implantation or spermatogenesis. 
Whilst such limitations are readily identified, overcoming them is a much 
more difficult process.
The detection of teratogenicity m uiuo requires the use of many 
laboratory animals and, since humans may potentially be exposed to a wide 
variety of chemical agents, increased use of the less costly in systems 
would seem justified for such investigations (New, 1978). Reduction in the 
number of animals used in toxicological investigation may result from the
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use of in vitro methods, through decreased statistical variability between 
animals (Moore, 1986). All the in vitro studies presented in this thesis 
involved the pooling of cells/embiyos from several animals and their even 
distribution among treatment groups. In addition, it was not necessary to 
treat the animals: the distress caused to those animals that were used was 
reduced since treatment could take place in the tissue cultures. Indeed, this 
approach was adopted in all the in vitro studies.
Efficiency may be further enhanced by assessing more than one 
endpoint in tissues from treated animals (Holloway et al, 1990a). In each in 
vitro procedure in these studies, a variety of endpoints was measured. This 
not only made the best use of the animals but also maximized the likelihood 
of observing a toxic effect. It is important that more than one parameter is 
measured since different toxic agents may affect different morphological 
aspects. For example, in post-implantation embryo culture, the number of 
somites may be unaffected (indicating a normal rate of development) but 
another parameter {e.g. appearance of the neural suture) may be disrupted 
indicating a toxic effect (Brown & Fabro, 1981).
6.2 CONSEQUENCES OF 
REPRODUCTIVE TOXICITY
The potential consequences of the action of toxic chemicals on 
reproductive processes range from direct damage to the reproductive organs 
themselves, through infertility, embryolethality and foetal malformation to 
heritable defects expressed in offspring. The impact of such events in the 
human population ranges from disorders in individuals, through infertility 
and repeated spontaneous abortion to the birth of individuals with 
congenital malformations. Minor effects on a large population are less likely
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to be detected, but should possibly be of greater concern to society, than 
dramatic effects on a few individuals.
The main target for reproductive toxicity in the male is the testis, 
resulting in either impairment of function leading to reduced fertility, or 
genetic damage to germ cells leading to effects on offspring. In the female 
the main target is the embryo in utero, resulting in malformations. The 
female germ cells are also targets for toxicity and may also lead to 
malformation if damaged; in humans the opportunity for such exposure to 
xenobiotics spans many years.
M ale-m ediated effects
Male-mediated effects may be manifested through disruption of 
different functions, varying in their impact on both the affected subjects and 
future generations. Testicular damage may affect not only sperm-producing 
capacity but also the endocrine functions of the testis. If the germ cells are 
affected they may still be capable of fertilization and thus pose a risk to 
offspring. Alternatively, such damage may render the male infertile.
Inherited defects
It is to be expected that a range of severity of disorders will be 
encountered in the offspring of treated males (Auroux & Dulioust, 1985): the 
more severe the disorder, the earlier in life it will be lethal, hence only the 
mildest will be seen in adult offspring and subtle experimental approaches 
may be required in order to detect them. A treatment that kills germ cells 
will cause infertility, whereas a less toxic treatment, which damages germ 
cells but allows them to remain viable, may cause embryolethality or 
malformations of the offspring. Potential effects of chemicals on offspring
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may be mediated directly or indirectly by mutations in male germ cells (Abel 
& Bilitzke, 1990).
The type of study carried out in chapter 4 provides an underestimate 
of the frequency of mutations since those that prevent meiosis, produce 
competitively weak sperm or result in non-viable embryos will not be anal­
ysed (Holden, 1982). However, those which are detected are of great 
significance. It has been shown that the perinatal effects of methadone 
(none) after paternal treatment in rats, do not predict the effects on adult 
offspring (on growth and behaviour) (Joffe et al, 1990). The results 
presented in chapter 4 showed that there was an increased incidence of 
uterine tumours in offspring from CP-treated males which could potentially 
be the result of induced tumour mutations, which may be heritable. There 
was also an increased incidence of hydronephrosis, which was believed to be 
caused by an indirect effect of reduced litter size. The finding of two 
offspring with karyotype abnormalities (3 %) would seem to indicate that 
genetic damage induced in the male germ cells of the rat by CP can be 
inherited by the offspring and persist into adulthood.
Lyon & Renshaw (1988) concluded that the genetic basis for 
malformations in the offspring of X-irradiated mice was heterogeneous and 
included chromosomal and gene mutations of high and low penetrance.
Measurement of infertility by the birth of live offspring provides 
perhaps the most relevant but the least informative result. Male ‘infertility’ 
may arise through the production of non-viable, severely malformed 
(chromosomally abnormal) embryos, which are spontaneously aborted early 
in pregnancy, rather than through the failure of fertilization itself. As 
shown in chapter 4, CP causes a reduction in litter size in rats without a
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reduction in pregnancy rate. Testicular heating in rats has been found to 
cause an effect at both stages (Setchell et al, 1988).
‘True’ effects on male fertility occur through the inhibition of 
spermatogenesis, mating ability, ejaculation, sperm motility or fertilizing 
capacity (Tsunoda & Chang, 1976). Discrimination of these functions, by the 
use of in vitro systems where possible, is necessary in order for the 
particular effects of a chemical to be determined.
Infertility may be caused by the action of chemicals on male germ 
cells, or through the disruption of reproductive hormones, spermatogenesis 
or epididymal maturation (Drife, 1987). In the case of DBCP, it has been 
shown that hormonal changes result in Sertoli cell damage, leading to a 
reduction in the number of sperm, causing infertility in rats; sperm 
abnormalities were not induced (Sod-Moriah et al, 1988). Ethanol did not 
influence the in vitro fertilizing ability of mouse sperm when animals were 
treated chronically in vivo or when sperm were treated at the beginning of 
capacitation in vitro (chapter 3). This indicated that ethanol-induced infert­
ility was either not apparent in this strain, that it was mediated via a 
function that was bypassed in this system {e.g. behaviour, mating, cumulus 
penetration) or that treatment was not carried out at a level or at a time 
when an effect could be induced.
Whilst infertility is a function that can be observed to be impaired by 
certain chemicals, its causes may be diverse, and measurement of alternative 
endpoints becomes necessary in order to elucidate the mechanisms of such 
toxic action (Winder, 1989). An agent that modifies sperm motility may 
affect fertilizing ability (Bongso et al, 1989) without posing a risk to 
offspring. Gossypol, for example, is thought to mediate its antifertility ac- 
tion through the inhibition of sperm motility (Breibart et al, 1989; Porat,
1990). Gossypol, lonidamine and l-(p-chlorobenzyl)-lH-indazole-3-carboxylic 
acid (AE1312/TS) were found to be toxic to Sertoli cells (chapter 5), and
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could result in infertility through disruption of their dual functions of 
maintaining the blood-testis barrier and physically supporting germ cells 
undergoing spermatogenesis (Holloway et al, 1990b).
Recovery from chemically-induced infertility gives rise to concern over 
possible inherited defects in the offspring (Trasler et al, 1985). An epidem­
iological study of the offspring of men who had been exposed to DBCP failed 
to detect any such defects (Potashnik & Phillip, 1988). As in the 
development of the female contraceptive pill, it is important in the 
development of a male contraceptive that the consequences of the chemical, 
either directly or indirectly through low sperm number, to any resulting 
offspring be established (Robaire et al, 1984).
E m bryotoxicity
Embryos may be targets for toxicity through a mutation in the germ 
cells. Alternatively, they may be damaged directly in utero during the pre- 
or post-implantation stages, with differing sensitivity at each stage.
Genetic
In humans, there are more embryos carrying a chromosomal 
abnormality at the pre-implantation stage than at the post-implantation 
stage (Houghton & Tomkins, 1982). Approximately half the embryos 
conceived, and one third of those spontaneously aborted, but only 1:200 live 
births carry a chromosome anomaly (Holden, 1982). The association of some 
of these chromosome aberration syndromes with maternal age suggests that 
environmental exposure to chemicals might be the cause, and this in turn 
suggests that males could also contribute to such syndromes.
Mutations with high penetrance will tend to cause embryotoxicity and 
thus will not be transmitted to subsequent generations (Lyon & Renshaw,
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1988) whilst those of low penetrance may still be present in an embryo but 
an effect will not be manifested. Litter size was reduced by two thirds by 
CP-treatment of male rats (chapter 4) and many of the embryos were 
malformed and carried gross chromosome anomalies (Jenkinson et al, 1990).
Reproductive
Xenobiotics may act to kill, severely malform, retard growth and 
development or induce minor abnormalities in embryos (Giavini, 1988). 
Chemicals do reach the pre-implantation embryo (Fabro, 1973) and persist 
here longer than in maternal tissues (Lutwak-Mann, 1973). Organogenesis 
is the most sensitive period of development with respect to teratogenesis, 
since earlier exposure usually results in embryolethality and later exposure 
may only affect a relatively small part of the embryo (New, 1978).
Although some agents exert effects on embryos that are so severe as 
to be immediately apparent {e.g. oxygen radicals; chapter 2), others may 
exert more subtle effects, for which detailed measurement and examination 
are required for their detection (Brown & Fabro, 1981).
R isk to  hum ans
The main purpose of toxicological investigation is to estimate the risk 
to humans. This may be approached through studies on experimental 
animals or on exposed human populations.
/rom anZmuZs
There are known to be strain and species differences in the responses
of rats and mice to paternally-administered ethanol (Abel & Bilitzke, 1990), 
CP (Anderson et al, 1987), X-rays and urethane (Nomura, 1982). This em- 
phasizes the difficulty in extrapolating from animal studies to the human
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situation. It is possible that humans may be more sensitive to such expos­
ure, for example humans are much more sensitive than rats (by a factor of 
twenty) to the antifertility effects of gossypol (Bernstein, 1984).
In humans, sperm are produced at a much slower rate than in 
experimental animals, resulting in an underestimation of human risk 
regarding the adverse effects of chemicals on male fertility (Amann, 1989). 
The level of embryonic cytochrome P-450 is higher in humans than rodents 
(Shanks et al, 1989) suggesting that they might have a greater capacity for 
xenobiotic metabolism.
Embryonic development in experimental animals takes a matter of 
days, rather than weeks or months as in humans (New, 1978), thus 
providing a good system for the investigation of possible deleterious effects.
Experimental animals have a higher metabolic rate than humans and 
potential reproductive toxins are usually administered at much higher doses 
than the anticipated level of human exposure (Webster, 1988). Such differ­
ences make extrapolation to the human situation difficult and tend to result 
in over cautious recommendations. It is important to consider exposure 
level when estimating human risk, particularly with regard to teratogens, 
since these are expected to have a threshold for toxic action (Brent & 
Beckman, 1990).
Workplace safety
Exposure to reproductive toxins can be occupational, environmental, 
medical or social. Chemicals that give rise to acute toxicity offer, perhaps, 
the least cause for concern since adequate safety precautions will probably 
already be in operation and exposure is, therefore, unlikely (Bernstein,
1984). Those chemicals for which exposure is at a chronic low level probably 
pose the greatest threat to reproductive targets. Hence, the treatment 
regimens used in the in uZuo studies presented in this thesis were chronic.
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Mice were exposed to ethanol through the drinking water for at least the 
length of time taken to complete one cycle of spermatogenesis (chapter 3). 
Rats were treated daily with CP at a low dose for a length of time estimated 
to be equivalent in length to the working-life exposure in humans (chapter 
4).
It is now widely recognized that the developing embryo is at risk from 
exposure to chemicals (e.g. oxygen radicals, chapter 2) and it is currently 
common for protective practices to be introduced in the workplace for 
pregnant women. Since reproductive outcome may be seriously affected by 
events in either the male or the female occurring long before pregnancy 
(Scialli, 1989), it would be prudent to consider extending such protection to 
all women of reproductive age. Control over the exposure of men to 
chemicals during reproductive years should be considered in the light of the 
many studies that have shown an adverse effect on pregnancy outcome in 
experimental animals (e.g. CP in rats, chapter 4). Since spermatogenesis 
takes a defined and relatively short time, protection of the male gametes 
could be effected without complete and continuous removal from the source 
of exposure.
Transmission o f defects
It could be considered that mutations resulting in embryolethality do 
not pose a risk to human populations since they will not persist into the 
next generation (Badr & Badr, 1975). Those which cause abnormalities 
which may not be manifested until adulthood are of greater concern (Auroux 
eZ aZ, 1990). In this case, the less damaging mutations carry a greater risk 
since offspring may be produced and the mutation inherited by subsequent 
generations (chapter 4).
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Human studies
Epidemiological studies in humans suffer from the drawback of 
confounding factors, since subjects who are matched for a particular variable 
may be diverse for any or all other variables (Wilkins & Sinks, 1984). A fur­
ther limitation of the human epidemiologic studies that have been carried 
out on male-mediated carcinogenesis is that they have tended to focus on 
childhood cancers, and effects on adult offspring have not been investigated 
(Tomatis et al, 1990).
The use of human clinical trials in the assessment of the beneficial 
effects of, for example, vitamins in pregnancy, may become unethical once 
a favourable outcome has emerged, thus leaving animal experimentation as 
a better option (Miller et al, 1989; MRC Vitamin Study Research Group,
1991).
Many in vitro methods offer the opportunity of using human tissue, 
thus making extrapolation to human risk assessment more accurate (Moore, 
1986). Human sperm can be assessed in vitro with either human zonae pel- 
lucidae (Liu et al, 1988; Tesafik, 1989) or zona-free golden hamster oocytes 
(Yanagimachi, 1984; Yanagimachi et al, 1976). Theoretically, human 
testicular cells can be grown in culture and used to evaluate toxicity.
6.3 PROTECTIVE MECHANISMS 
IN REPRODUCTIVE TOXICOLOGY
The complex physiology of the reproductive processes means that
many mechanisms exist for their protection from toxins. These include 
specialist physical barriers and the biochemical defence systems which are 
present in many cell types. There is also some capacity for repair if damage 
does occur.
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B arriers to  th e  
effects  o f tox ic ity
Internalization of reproductive processes, as seen in mammals,
reduces but does not eliminate, the level of direct exposure to exogenous 
chemicals (Brackett, 1978). Since disruption of such processes is extremely 
damaging, various barriers to the effects of xenobiotics exist.
Blood-testis barrier
The blood-testis barrier prevents the direct action of chemicals on 
developing germ cells; chemicals can only act directly on the supporting 
Sertoli cells or the spermatogonial stem cells (Amann, 1989). There are two 
features of the blood-testis barrier which prevent the passage of exogenous 
chemicals into the seminiferous tubule: firstly morphological (tight junctions 
between Sertoli cells) and secondly functional (polarized secretion) (Janecki 
e( uZ, 1987).
Testicular catheterization has been used to sample fluid from the 
seminiferous tubules of various animals and ethanol has been shown to cross 
the blood-testis barrier in the rat (in Mann & Lutwak-Mann, 1983). 
Conversely, Salonen & Eriksson (1989) have found the blood-testis barrier 
to be effective against ethanol penetration in the rat. Protection of germ 
cells by the blood-testis barrier can be bypassed if chemicals can reach the 
semen via the secretions of other reproductive organs (such as the epid- 
idymis) or result from the metabolic action of the testis itself (see section
1.2) (Mann & Lutwak-Mann, 1983).
The Z/i uZZro system used to study Sertoli cell toxicity (chapter 5) 
incorporated a feature which modelled the presence of the blood-testis 
barrier, namely the culture of Sertoli cells in the inner compartment of a 
dual-compartment system. CP given chronically to rats (chapter 4) evidently
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crossed the blood-testis barrier (or its metabolites did) in such a way as to 
result in mutations in sperm which were passed on to the offspring.
Female reproductive tract and egg vestments
The cervix, uterotubal junction, zona pellucida and cumulus cells 
provide barriers to oocyte penetration by sperm. In addition to providing an 
environment in which sperm can become capacitated (Chang, 1951), the 
female reproductive tract also acts as a filter to damaged sperm in that some 
of those with a morphological abnormality are unable to reach the oviduct, 
and are therefore prevented from fertilizing (Krzanowska, 1974). Moreover, 
the egg vestments (particularly the cumulus cells) provide a barrier to 
penetration (Krzanowska & Lorenc, 1983). The initial stage of fertilization 
itself, sperm-zonu binding, is where control is exerted over the species of 
sperm which fertilizes the oocyte (Dietl & Rauth, 1989). It is a further 
benefit conferred by sperm-zonu recognition, that morphologically abnormal 
sperm, made so by chemical treatment (Wyrobek & Bruce, 1975), will also 
be rejected.
In vitro, where passage through the female reproductive tract is 
bypassed, morphologically abnormal mouse sperm that bound to the zona 
pellucida were not usually capable of penetrating the oocyte (Kot & Handel, 
1987; Krzanowska & Lorenc, 1983). The in uZZro fertilization system used 
to investigate the antifertility effect of ethanol in mice (chapter 3), did not 
show a decrease in the ability of sperm to capacitate or to bind and 
penetrate the oocyte. Thus, it could be concluded that the infertility 
induced by ethanol may be mediated via the inability of sperm to penetrate 
the female reproductive tract or the cumulus cells, although Anderson uZ 
(1982, 1983) did find an effect uZZro.
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Placenta and yolk-sac
Whilst the female germ cells are not protected from toxic insult in the 
same way as the male germ cells, the embryo may gain a degree of 
protection from the placenta and the yolk-sac. The placenta does not 
provide a general barrier to chemicals in the maternal bloodstream 
(Harbison, 1978), since its role is to provide an interface between the 
maternal and embryonic blood supplies (Brent & Beckman, 1990). However, 
it may protect the post-implantation embryo from the action of a few chem­
icals, depending upon their ability to cross membranes, their size and their 
protein binding capability (Brent & Beckman, 1990).
Hence, ethanol rapidly reaches the embryo in utero after maternal 
ingestion (Brent & Beckman, 1990). The placenta was not found to provide 
a barrier to dibromochloropropane in rats, with the result that male 
offspring exposed in utero had compromised testicular function (Warren et 
aZ, 1988).
Mirkes et al (1981) have suggested that in rodents the yolk-sac 
provided a barrier, through macromolecule binding, to acrolein (a metabolite 
of CP) which was thus unable to exert its cytotoxicity on the embryo, 
although damage to the yolk-sac itself could result in teratogenicity. The 
yolk-sac has also been suggested to protect against the teratogenicity of 
trypan blue (reviewed by New, 1978).
Post-implantation embryos are normally explanted with the placenta, 
although placental function cannot be expected to be the same as it is in 
uZuo (New, 1978). The work presented in chapter 2 demonstrated that any 
chemicals that are subject to embryonic metabolism generating oxygen 
radicals would be potentially damaging.
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B ioch em ical p rotection
Antioxidant and radical scavenging mechanisms are found in different 
structures throughout the cell. Antioxidants may be consumed as part of 
the diet or synthesized.
Dietary antioxidants
The role of vitamin E in human reproductive success has long been 
known (reviewed by Cottrell, 1984). DL-a-tocopherol is the most effective 
form of this vitamin and is the most important lipid soluble, chain-breaking 
antioxidant present in mammalian cells (Burton & Traber, 1990). DL-a- 
tocopherol is a radical scavenger found within membranes (HaUiwell, 1984). 
It interacts with lipid peroxide radicals in such a way as to inhibit the 
propagation of lipid peroxidation, but it cannot prevent the initiation of lipid 
peroxidation (Halliwell, 1984; Frei et al, 1989).
DL-a-tocopherol is present in the testis (with vitamin A) (Kornbrust 
& Mavis, 1980) and can protect against oxygen radical-mediated damage to 
human sperm (Aitken & Clarkson, 1988). However, it was not possible to 
reduce the xanthine (X)/xanthine oxidase (XO)-induced increase in germ cell 
detachment by adding DL-a-tocopherol to the Sertoli cell culture medium 
(chapter 5).
DL-a-tocopherol could not be very readily transferred from maternal 
to embryonic blood in rats, but could be increased by administering large 
amounts in the diet of pregnant females (Iwasa et al, 1990). The addition 
of DL-a-tocopherol to the culture medium of post-implantation rat embryos 
reduced the neural suture abnormality-inducing effect of X/XO (chapter 2).
Given time to associate with membranes, DL-a-tocopherol protected 
against the sister chromatid exchange (SCE)-inducing effects of 
hypoxanthine/XO in Chinese hamster ovary (CHO) cells (Weitberg aZ,
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1985) and could protect against the chromosome-breaking action of 7,12- 
dimethylbenz(a)anthracene (DMBA) (Shamberger et al, 1973).
The possible prophylactic effects of vitamin C have been widely 
discussed in the literature and it has been suggested that L-ascorbic acid has 
a key role in protection against carcinogenesis (Cameron et al, 1979). 
Reduced L-ascorbic acid acts as a radical scavenger (Weitberg, 1987; 
Weitberg & Weitzman, 1985) and is a very effective in antioxidant protection 
by preventing the initiation of lipid peroxidation (Frei et al, 1989).
L-ascorbic acid can also act as a reducing agent, donating hydrogen 
ions, and can therefore convert 0% to hydrogen peroxide (HgOg) in a process 
of autoxidation (Halliwell & Gutteridge, 1984b; Shamberger, 1984). It can 
also reduce metal ions and the interaction of these two products would lead 
to the production of hydroxyl radicals (OH*), i.e. L-ascorbic acid can act as 
a pro-oxidant (Shamberger, 1984; Norkus et al, 1983).
L-ascorbic acid at high concentrations potentiated the SCE-inducing 
effect of hypoxanthine/XO in CHO cells, whereas at low concentrations it 
was protective (Weitberg, 1987; Weitberg & Weitzman, 1985). The 
mutagenic effect of L-ascorbic acid in CHO cells was mediated via the pro­
duction of HgOg (Rosin et al, 1980; Shamberger, 1984), and OH" may cause 
the SCEs observed (Weitberg, 1987). L-ascorbic acid did not increase the 
severity of neural suture abnormalities in cultured post-implantation rat 
embryos (chapter 2) or germ cell detachment in cultured rat Sertoli cells 
(chapter 5) and could not potentiate the damaging effects of X/XO.
It is questionable whether the in vitro finding that L-ascorbic acid 
acts as a pro-oxidant is applicable to the in vivo situation (Frei et al, 1989). 
In human blood plasma, levels of L-ascorbic acid up to 5 mM remained anti- 
rather than pro-oxidant due to the unavailability of metal ions (Frei et al,
1989). L-ascorbic acid was not cytotoxic or mutagenic in guinea pigs in uZuo 
(Norkus eZ uZ, 1983).
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L-ascorbic acid administered to CP-treated pregnant mice, protected 
against the induction of chromosome aberrations (but not SCEs) in pre­
implantation embryos (Vogel & Spielmann, 1989). Post-implantation rat 
embryos were protected by L-ascorbic acid from the induction of neural 
suture abnormalities by X/XO (chapter 2). It is also believed to contribute 
to the antioxidant defence of rat lenses, possibly through a reaction with 
HgOg (Varma et al, 1986) and to protect against the chromosome-breaking 
action of DMBA (Shamberger et al, 1973). Sertoli cells were protected by L- 
ascorbic acid from the germ cell detachment-inducing action of X/XO 
(chapter 5). Ethanol has been found to alter antioxidant metabolism, 
specifically that of L-ascorbic acid (giving rise to increased synthesis), in 
chronically dosed rats (Mochizuki & Yoshida, 1989).
Although not antioxidants themselves, folate and selenium are 
essential in the diet. A deficiency of folate has been shown to cause mal­
formations and growth inhibition in cultured rat embryos (Miller et al,
1989). Selenium is essential in the human diet since it is a constituent of 
glutathione peroxidase (Halliwell, 1984).
Intrinsic antioxidants
Intrinsic defences against the damaging effects of oxygen radicals 
include catalase, superoxide dismutase (SOD) and glutathione peroxidase 
(which act to prevent the formation of OH') and glutathione (Halliwell & 
Gutteridge, 1988; Burton & Traber, 1990). Depletion of such antioxidants 
must occur before the toxic effects of oxygen radicals can be mediated 
(Slater, 1984; Phillips et al, 1984; Rosenblum et al, 1989). Although 
antioxidant defences may be overwhelmed by high concentrations of oxygen 
radicals, there is some capacity for increasing their synthesis (Halliwell, 
1984).
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Superoxide anion radicals (O2'')  and HgOg are rendered harmless by 
the action of SOD and catalase (Phillips et al, 1984). SOD catalyses the 
dismutation of O2'* to H2O2 and O2 (Halliwell, 1984) and helps to prevent the 
Haber-Weiss reaction by removing the source of O2"’. Catalase converts 
HgOg to HgO and O2 and inhibits OH" formation by removing the source of
H2O2 (HalliweU, 1984; Fridovich, 1989).
Glutathione, in its reduced state, acts to protect the thiol groups of 
certain enzymes which have been oxidized by O2, by becoming oxidized 
preferentially; it may also be oxidized by HgOg (catalysed by glutathione per­
oxidase) to produce HgO (Halliwell, 1978; Halliwell, 1984; Fridovich, 1989). 
Glutathione reductases act with nicotinamide adenine dinucleotide 
phosphate (reduced) (NADPH) to regenerate reduced glutathione (Halliwell, 
1984).
Glutathione is known to be present in the Sertoli cells and germ cells 
of the testes of rat, mouse and hamster, being synthesized to a certain 
extent in the germ cells, with an important contribution from the Sertoli 
cells (den Boer et al, 1989; Grootegoed et al, 1989). Rat spermatids enjoyed 
a limited level of glutathione protection (den Boer et al, 1990). It is possible 
that this glutathione may protect against the action of CP (Trasler et al, 
1987) and 1,3-DNB (Cave & Foster, 1990).
The antifertility effects of gossypol may be due to its compromization 
of the antioxidant functions of the testis (Bender et al, 1988). The addition 
of antioxidants to Sertoli/germ cell cultures treated with gossypol could 
confirm this. The antioxidant defences of the cell are cytoplasmic enzymes 
(SOD, catalase, glutathione peroxidase) and hence spermatozoa have few of 
them (Aitken, 1989a). Extracellular antioxidant defences may contribute to 
the protection of sperm from the action of oxygen radicals (Aitken, 1989a).
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The addition of antioxidants to sperm prepared for in vitro fertilization could 
be used to investigate this contribution.
Various chemicals known to induce neural tube defects in rat embryos 
in vitro were shown to have different effects on glutathione content, 
indicating this is one of several alternative mechanisms by which this 
endpoint may occur (Harris et al, 1988). Glutathione and L-ascorbic acid 
protected against the embryotoxic effects of the metabolites of 2-acetylamino 
fluorene (Faustman-Watts et al, 1986). The damaging effect of acrolein, one 
of the principal metabolites of CP, on cultured rat embryos was prevented 
by glutathione (Slott & Hales, 1987). Glutathione at 10 mM acted to protect 
against the mutagenic and teratogenic effects of CP, possibly through 
conjugation of its metabolites, whereas the administration of lower 
concentrations (< 1 mM) to rats enhanced these effects (Hales, 1981). 
Glutathione can protect against xenobiotic action by conjugation catalysed 
by glutathione-S-transferases (Ketterer, 1986). Jenkinson et al (1986) 
demonstrated that glutathione and catalase, but not SOD, could protect 
cultured post-implantation rat embryos against the damaging effects of 
X/XO.
Repair
There is some capacity for DNA repair and for recovery in embryos 
at different stages. The alternative strategy of selection against abnormal 
forms may also be invoked.
Ageing is associated with various human disorders and there is a 
direct correlation between age and exposure to chemicals (environmental, 
occupational, therapeutic, eZc.) which could have a cumulative effect on 
reproductive processes. Fabricant & Parkening (1982) found an increase in 
the number of sperm with a morphological abnormality associated with
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increasing age in mice. However, repair processes are not thought to be 
compromised by age (Lehmann (1985) in Guli & Smyth, 1989). Guli & 
Smyth (1989) did not find an effect of maternal age on mouse oocyte DNA 
repair capacity (as measured by unscheduled DNA synthesis), although only 
young and old mice were tested and it is possible that animals at mid-range 
would have been different.
Mouse oocytes have DNA repair capacity and are thus able to repair 
DNA damage induced in sperm by X-rays or mitomycin C (Matsuda et al, 
1989b). Vogel et al (1989) showed repair of DNA damage caused by 
methylnitrosourea in pre-implantation embryos and Brent (1971) also 
concluded that the post-implantation embryo has a capacity for recovery, 
since lengthening of the time period over which a fixed X-ray dose is 
received by rat embryos in utero decreased the incidence of malformations.
Snow (1983) has described the process of restorative growth in post­
implantation embryos. This enables the embryo to compensate for growth 
inhibition induced by chemical insult but may induce malformations through 
its differential capacity in different cells. This capacity for recovery from 
toxic insult means that post-implantation embryos are of more relevance in 
studies of teratogenicity (New, 1983), since pre-implantation embryos are 
less sensitive.
Johnson et al (1990) concluded that ethylnitrosourea-induced sperm­
atogonial genetic damage, expressed in the offspring of mice mated 12 weeks 
after dosing, was repaired (or selected against) by 6 months after dosing, 
since no measurable effects on offspring could be detected at the later 
timepoint (Lovell eZ uZ, 1985). Since fractionation of X-ray doses given to 
mouse oocytes or spermatogonia reduced the frequency of tumours in 
offspring, it was concluded that these cells were capable of repairing such 
genetic damage, although post-meiotic germ cells were not (Nomura, 1982, 
1987).
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6.4 CONCLUSIONS
The work presented in this thesis allows several conclusions to be
made concerning;-
the advantages and disadvantages of in vitro and in vivo 
systems in investigations of reproductive toxicity;
the importance of male-mediated adverse effects on 
reproduction;
the potential for damage by reactive oxygen species in 
reproductive ^stem s.
The advantages and d isadvantages  
o f  in vitro and in vivo system s  
in  in vestiga tion s o f reproductive tox ic ity
Comparison of (i) in vitro and (ii) in vivo reproductive systems in 
toxicological investigations reveals the advantages and disadvantages 
inherent to each.
(i) In vitro systems
Advantages. The advantages of in vitro systems are:-
artificially enhanced sensitivity through the possibility of direct 
exposure to chemicals, removal of protective and physiological 
control mechanisms or as a result of manipulation during 
processing leading to reduced innate resistance;
separation of individual cell or tissue types for examination in 
a less complex environment;
availability of a battery of endpoints for measurement of
toxicity;
Zn uZfro assessments of toxicity can be extrapolated to the 
human situation through the use of human tissues where 
possible.
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The three in vitro reproductive systems described in this thesis were 
(a) post-implantation rat embryo culture, (b) in vitro fertilization using 
mouse gametes, and (c) culture of rat Sertoh/germ cells. Their advantages 
are discussed below.
(a) The assessment of neural suture abnormalities in cultured post­
implantation embryos provided a very sensitive index of the effects of 
reactive oxygen species and antioxidants (chapter 2). The in vitro system 
gave the opportunity to separate the maternal and embryonic components 
in embryotoxicity and protection, and to examine their relative roles. The 
use of an exogenous metabolizing system in vitro, to mimic that which is 
normally provided maternally, allows measurement of the embryonic 
contribution to the bioactivation of xenobiotics which leads to toxicity. The 
post-implantation embryo culture technique has a role in the investigation 
of teratogenic effects.
(b) Potentially, in vitro fertilization techniques (chapter 3) have a 
value in screening chemicals for their antifertihty effects since there is an 
opportunity for distinctly different aspects of the processes of fertilization 
and for the pre-implantation stages of embryonic development to be 
investigated. Human sperm is relatively easily obtainable and could be used 
to great effect for toxicity screening utilizing either human zonae pellucidae 
or zona-free golden hamster ova, as described in chapter 3. It is concluded 
that the application of in vitro fertilization techniques in reproductive 
toxicity screening would be best employed in this manner.
(c) Some of the endpoints of toxicity measured in cultured Sertoli 
cells were more sensitive than others (chapter 5) and in vitro systems were 
much more sensitive to toxic insult than the same cells in vivo (Gray & 
Beamand, 1984; Williams & Foster, 1988). Thus, it was important that 
various measures of toxicity were made in the Sertoh cell cultures. Human 
testicular material is difficult to obtain and, for this reason, its use must be
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restricted to research purposes, although it would provide a good model for 
toxicity testing.
Disadvantages. The disadvantages of in vitro systems are:- 
technical complexity;
limited timespan over which cultures can be maintained;
absence of metabolism, transport, distribution and some 
protective and physiological control mechanisms;
culture conditions themselves may disrupt normal structure 
and function, thereby influencing performance in vitro',
in vitro assessments of toxicity can be extrapolated to the 
human situation only after correlation of in vitro with in vivo 
effects.
Again, considering the different aspects of in vitro reproductive 
toxicology presented in this thesis, the following disadvantages were noted.
(a) Explantation and culture of post-implantation rat embryos 
(chapter 2) is a moderately difficult technical procedure, but it can be 
accomplished rapidly and methods for chemical exposure, culture and scoring 
require a small investment of time. Organogenesis is the most sensitive 
stage of embryogenesis with respect to toxicity (Brown, 1985) so that 
although embryos can only be cultured for 48 h, very useful information can 
be obtained.
Certain types of embryonic abnormality (those involving swellings) 
have more severe manifestations in vitro due to the removal of pressure 
exerted by the uterus. The removal of defences which are normally present 
in the maternal environment enhance the sensitivity of the embryo to 
toxicological action but, in so doing, enables the investigation of embryonic 
defence systems. Embryos may be more susceptible to chemical injury due 
to mechanical handling disadvantages.
(b) There is a high degree of technical complexity in the in vitro 
fertilization procedure (chapter 3) and, for this reason, few toxicological
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studies have actually utilized this technique. The correlation of sperm 
parameters, which are easier to measure, with fertilizing ability in 
experimental animals (as has been extensively investigated in humans) 
would justify their use instead for studying chemical toxicity.
The removal, for in vitro fertilization, of the female reproductive 
tract, probably the egg vestments and possibly the zona pellucida, which 
provide natural barriers to toxicity, may permit fertilization with sperm that 
would be incapable of fertilizing in vivo (Kot & Handel, 1987). Recognition 
of this artificially enhanced capability is essential before the technique can 
be used to precisely pinpoint the effects of chemicals through the use of a 
number of sperm parameters.
It has been demonstrated that the observed developmental retard­
ation of rabbit pre-implantation embryos in culture was mainly due to the 
comparatively imperfect environment (Carney & Foote, 1990). The mat­
ernal cytoplasm-mediated 2-cell block occurs in vitro and is also due to the 
nature of the culture medium (Chatot et al, 1989). Additional lactate is re­
quired in the culture medium of pre-implantation embryos in order for 
growth to take place (Gardner & Leese, 1990). Observation of pre-implant­
ation embryos in vitro is restricted to particular animal strains for the pur­
pose of toxicity screening, and it is concluded that the approach is somewhat 
limited. Thus, evaluation of toxicity through a series of in vitro 
measurements of fertility has a restricted application in research and cannot 
be routinely used for toxicity testing.
(c) The use of the dual-compartment system for the culture of 
Sertoli/germ cells in the presence of a metabolizing system (chapter 5) is a 
time-consuming procedure requiring a high degree of technical skill. 
However, metabolic activation is incorporated and the morphology of the 
Sertoli cells is improved over conventional dish cultures. Thus, a good
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model is provided for the comparison of effects of chemical toxic to the testis
and the development of male contraceptives.
That culture conditions influence the performance of cells in vitro is
shown in comparisons of Sertoli cell functions in dual-compartment systems
utilizing an extracellular matrix, and those in plastic dishes (Hadley et al,
1987). The correlation between in vitro and in vivo responses in rats to
chemicals known to be toxic to the testis (e.g. Gray & Beamand, 1984)
validates the system and, again, it can be used in order to select chemicals
for further testing. Thus, the dual compartment system chosen in the
studies presented in this thesis provides a good model for toxicological
investigation, although the complete system is functional only for a short
period of time and spermatogenesis does not proceed in vitro.
The advantages and disadvantages of the three in vitro reproductive
systems described in this thesis, lead to the following conclusions:-
a qualitative, if not quantitative, assessment of reproductive 
toxicity can be made through the use of in vitro systems;
identification of target sites for toxicity, metabolic capability 
and chemical vulnerability can be made through the separation 
of particular tissue types and examination of their function in 
vitro',
it is essential that the limitations of any system used for such 
risk assessment are fully appreciated before decisions on 
human exposure are taken;
in vitro systems cannot be expected to replace completely in 
vivo assessments of toxicity but they may be employed to 
predict and clarify responses to toxicity;
the observed similarities between the various in vitro systems 
used in these studies and their in vivo counterparts justify 
their use in toxicological investigations;
culture conditions themselves may be improved by making 
compensation for overriding deleterious factors.
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(ii) In vivo systems
Advantages. The advantages of in vivo systems are:-
physiologically more meaningful;
in vivo assessment of chemical toxicity can be extrapolated to 
humans because whole organisms are used.
Two of the studies described in this thesis involved the in vivo 
treatment of animals with toxic chemicals (ethanol and CP) and in both 
studies, metabolism, distribution and transport processes were present. In 
the first study an in vitro endpoint, namely fertilizing ability, was measured 
(chapter 3) enabling examination of individual aspects of the fertilization 
process. In the second, the endpoints were measured as abnormalities in 
the Fj population, indicating events that had occurred in the germ cells of 
the Fo population.
Since examination of heritable mutations must necessarily be carried 
out in vivo, epidemiological studies remain the only option in humans. 
Whilst such studies may detect correlations between levels of exposure to 
chemicals and reproductive consequences, they need always to be explained 
with respect to possible biological mechanisms and causal relationships in 
order to be credible. Animal studies provide the means for seeking out such 
explanations. It is concluded that in vivo studies of this type are justified, 
despite the use of a large number of animals, on the grounds that no wholly 
adequate in vitro model is currently available.
Disadvantages. The disadvantages of in vivo systems are:-
complexity leading to difficulty in elucidating mechanisms
measurement of toxicity endpoints which may sometimes be masked 
for specific functions of interest, by other endogenous factors;
length of time taken to conduct such studies;
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pressure to reduce the number of animals used and to alleviate 
animal distress.
in vivo assessment of toxicity can be extrapolated to humans 
only if physiological differences between species are taken into 
account.
The reduced number of offspring from male rats treated with CP was
the final outcome and, in that sense, the physiologically relevant result of
both germ cell- and embryotoxicity. Measurement of this endpoint alone
provided no indication of which specific function of interest had been
affected. The complexity of the intervening processes, and the limited scope
of the study, in terms of the additional resources required in order to
conduct a more detailed examination of endpoints, meant that further
studies would be required in order to elucidate the extent and precise
mechanism of genotoxic action.
The advantages and disadvantages of the two in vivo reproductive
systems described in this thesis, lead to the following conclusions:-
it is essential that the limitations of any system used for such 
risk assessment are fully appreciated before decisions on 
human exposure are taken;
whilst it is definitely the case that in vitro conditions are 
‘artificial’ the converse is not necessarily true, since animals 
may be manipulated {e.g. removal of testis) in order to monitor 
specific responses (Russell & Steinberger, 1989).
The im portance o f m ale-m ediated  adverse  
effects  on  reproduction
The effects of chemicals on the male reproductive system are
important because;-
human males are potentially exposed to a wide range of 
chemicals;
changes may occur which affect subsequent generations.
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Three studies of male reproductive toxicology have been performed 
in the work presented in this thesis: (a) in vitro fertilizing ability after 
ethanol treatm ent of male mice in vivo or treatment of the sperm in vitro,
(b) the induction of abnormalities in the generation after CP treatment 
of male rats in vivo, and (c) the use of rat Sertoh/germ cell cultures in 
investigations of testicular toxins.
Infertility is a serious consequence of exposure to chemicals and in­
vestigation into its mechanism through the use of in vitro systems, such as 
in vitro fertilization (chapter 3) and Sertoh cell culture (chapter 5), provide 
valuable information for its prevention. The studies presented in this thesis 
have shown that ethanol does not have an adverse effect on male fertihty 
that can be detected by in vitro fertilization techniques, thus implicating 
another aspect of the reproductive process. In addition, it has been shown 
that various chemicals (including reactive oxygen species) act on Sertoh cells, 
but may require metabolism in a different part of the body before an 
adverse effect becomes apparent.
The effects on offspring of paternal exposure to chemicals may be 
mediated via mutation or through non-genetic mechanisms (Johnson et al,
1990). In terms of recommending avoidance of such exposure in the human 
population, the mechanism of the deleterious effect on offspring is, perhaps, 
less important (Johnson et al, 1990). Further, since only a minority of the 
many human genetic disorders have an obvious pattern of inheritance, 
further investigation of the impact of chemically-induced germ cell 
mutations on adult offspring, rather than embryos, is warranted (Nomura, 
1987). Work such as that presented in chapter 4, indicates that the 
offspring of chemically-exposed males can potentially suffer adverse effects, 
both genetic and non-genetic in origin, as a result of such exposure.
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In conclusion:-
despite the fact that few experiments have shown unequivocal 
and strong evidence for paternally-mediated adverse effects on 
offspring (chapter 4; Abel & Lee, 1988; Brown, 1985; Cohen, 
1986; Joffe, 1979), the imphcations are such that caution in hu­
man male exposure is advisable.
The p o ten tia l for dam age by reactive  oxygen  
sp ecies in  reproductive system s
The role of reactive oxygen species in reproductive toxicology is
important because:-
various chemicals toxic to the reproductive system are known 
to have the capacity to generate reactive oxygen species;
reactive oxygen species may be generated through metabolism 
in situ .
Enzymically-generated reactive oxygen species and the possible 
protective role of the antioxidant vitamins L-ascorbic acid and DL-a- 
tocopherol have been investigated in two of the in vitro reproductive 
systems, namely cultured post-implantation embryos and cultured 
Sertoli/germ cells.
The generation of reactive oxygen species through the embryonic 
metabolism of certain xenobiotics is a feasible mechanism of embryotoxicity 
(see chapter 1). The culture of post-implantation rat embryos with X/XO 
has shown that reactive oxygen species may give rise to malformations 
(chapter 2). Moreover, the inclusion of the antioxidant vitamins L-ascorbic 
acid and DL-a-tocopherol in the culture medium abolished or decreased the 
incidence of these malformations.
Similarly, it has been suggested that testicular metabolism can also 
generate reactive oxygen species in situ (Cave & Foster, 1990; Georgellis et 
al, 1988). Again, the culture of Sertoli/germ cells with X/XO has shown 
that these reactive oxygen species may lead to Sertoli cell toxicity
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manifested in the form of germ cell detachment, and that L-ascorbic acid can 
ameliorate the effect (chapter 5).
Both chemicals (ethanol and CP) used in the in vivo studies presented 
in this thesis may mediate their effects through the action of reactive 
oxygen species. The SCE-inducing effects of CP were decreased by the 
action of L-ascorbic acid (Vogel et al, 1989), and ethanol has been shown to 
modulate the metabolism of L-ascorbic acid (Mochizuki & Yoshida, 1989). 
The effects of antioxidants on chemically-induced germ cell mutations or 
infertility have yet to be investigated.
In conclusion:-
antioxidants could afford protection against chemically-induced 
reproductive toxicity.
O verall con clu sions and  
fu ture p ossib ilities
The in vitro systems used have provided an insight into the 
mechanisms of toxic action in reproductive systems and have allowed control 
over the environment such that precise pinpointing of toxic action is 
possible. It is concluded that all three systems used have a useful role as 
research tools in reproductive toxicology but that none can replace in vivo 
testing systems at present.
The use of a metabolizing system with cultured Sertoh cells has 
enhanced the potential of this in vitro model and would merit further 
investigation. This might include the use of S-9 under controlled conditions 
or co-culture with other testicular cell types (e.g. Ley dig cells). Such an 
approach could also be a useful addition to the embryo culture system. Both 
systems have potential future uses as relatively quick and inexpensive initial 
screens for selecting chemicals requiring further toxicological evaluation.
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There is scope for expanding the use of the in vitro fertilization 
system in toxicology, although the technique is too technically-demanding 
to be used in any but the most detailed investigations into antifertility 
agents. The development of methods which allow treatment of the sperm 
with chemicals at different stages of the fertilization process would increase 
the probability of detecting a toxic effect. Comparison with other endpoints 
of toxicity using a range of antifertility agents would be useful.
Chronic exposure of the male to chemicals can cause abnormalities in 
the offspring which persist into adulthood. It has also been shown that 
genetic damage induced in this way may be heritable. Further studies in 
this area are warranted, since the impact on human populations could be 
very serious. A more detailed examination of the offspring would greatly 
increase the chance of detecting a chemically-induced abnormality.
The antioxidant vitamin L-ascorbic acid afforded protection against 
the toxic effects of enzymically-generated reactive oxygen species in both 
cultured post-implantation rat embryos and cultured rat Sertoli cells. DL-a- 
tocopherol could also afford protection, but to a lesser extent, and in the 
embryo culture system only. The results obtained in chapter 2 indicate that 
vitamin supplementation during pregnancy would be beneficial and 
emphasize the need for further studies, possibly in humans. It would be 
interesting to investigate whether these vitamins, or other antioxidants, 
protect against the damaging effects of toxic chemical such as ethanol, 
gossypol and 1,3-DNB, and also to pursue these studies in other in vitro 
systems, such as in vitro fertilization.
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Summary
Abnormalities of the neural suture were observed in cultured rat embryos exposed to oxygen radicals
generated by xanthine and xanthine oxidase. The distribution of the severity of these abnormalities was 
altered by the addition of L-ascorbic acid (AA) or DL-a-tocopherol (AT). The antioxidant effect of AA and 
AT were probably responsible for the protection of the embryos from the damaging effects of oxygen 
radicals.
Enzymically-generated oxygen radicals have 
been shown to be toxic a n d /o r  mutagenic in a
variety of in vitro test systems, e.g. in cultured rat 
lenses (Varma et al., 1986), in human lymphocyte 
chromosome breakage and sister-chromatid ex- 
change (SCE) tests (Emerit et al., 1982), in Chinese 
hamster ovary (CHO) cell SCE studies (Phillips et 
al., 1984; Weitberg and Weitzman, 1985) and in 
cultured rat embryos (Anderson et al., 1986; 
Jenkinson et al., 1986). It is known that L-ascorbic 
acid (vitamin C) and DL-a-tocopherol (vitamin E) 
can modify responses in such systems.
Vitamin C acts under different conditions as 
either a radical scavenger or as a pro-oxidant,
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producing hydrogen peroxide and free radicals by 
autoxidation (Shamberger, 1984). Thus, some 
workers have reported a protective effect against 
enzymically-generated oxygen radicals (Varma et 
al., 1986; Weitberg et al., 1985) while others have 
observed a mutagenic or toxic effect (Rosin et al., 
1985; Weitberg, 1987).
Vitamin E acts as a biological antioxidant. 
Consumed in the diet in oils and fats, its role in 
the body is to protect membranes from the action 
of free radicals (Cottrell, 1984). It has been shown 
to prevent the death of cultured embryos (Steele et 
al., 1974) and to reduce carcinogen-induced chro­
mosome breaks in cultured human lymphocytes 
(Shamberger et al., 1973). Weitberg and co-workers 
(1985) found that vitamin E protected CHO cells 
from hypoxanthine/ xanthine oxidase-induced 
SCEs only if added to the culture 72 h before 
exposure to the oxidising system.
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Malformations and growth reduction have been 
observed in whole embryo cultures in this labora­
tory after treatment with the oxygen radical-gener­
ating system of xanthine/xanthine oxidase (Jen­
kinson et al., 1986). Using this system the effects 
of AA and AT have now been investigated.
Materials and methods
Chemicals
Eagle’s Minimal Essential Medium (EMEM) 
(Gibco, Paisley, U.K.) was supplemented with 
penicilhn and streptomycin, 20 units/ml (Gibco, 
Paisley, U.K.) and L-glutamine 2 mM (Gibco, 
Paisley, U.K.). Xanthine oxidase (grade III from 
buttermilk) (Sigma, Poole, U.K.) was used at 25 or 
40 mU per ml EMEM. Xanthine (Sigma, Poole, 
U.K.) was 1 m g/m l in 0.5% sodium carbonate and 
L-ascorbic acid (Sigma, Poole, UK) was 10 mM in 
Dulbecco’s phosphate-buffered saline solution A, 
pH 7 .3  (PBS(A)). D L -a-Tocopherol (Sigma, Poole, 
U.K.) was suspended at 0.95 m g/m l in PBS(A) by 
sonication for 5-10 min and used within 2 h. 
Oxygen/carbon dioxide/  nitrogen mixtures were 
obtained from the British Oxygen Company, 
London, U.K.
Serum was prepared from Sprague-Dawley rats 
(Charles River, Margate, U.K.). Blood was im- 
mediately centrifuged (1800 g, 5 min) and left to 
stand for 30 min before discarding red cells and 
fibrin clots. The serum was heat inactivated at 
55 ° C for 30 min, sterilised by filtration and stored 
at — 20 ° C prior to use.
and treated for 1 h before transfer in groups 3 -6
to 50-ml pyrex bottles containing 3 ml rat serum 
and 1 ml EMEM. Cultures were incubated for 
approx. 44 h at 37° C rotating at 40 rpm. Bottles 
were gassed for 5 min with Og/CO^/N^ mixture 
at 0 h (5 :5 :9 0 ), 18 h (20 :5 :7 5 ) and 24 h 
(40 :5 :5 5 ).
After 44 h, embryos with a healthy, well-formed 
yolk-sac and blood circulation were assessed for
growth: yolk-sac diameter, crown-rump length and 
head length were measured and the number of 
somites was counted. Embryos were also ex­
amined for abnormalities of the neural suture and 
graded according to severity: no abnormality =  0; 
mild abnormality (small deviation from the nor­
mal straight line) = 1; moderate abnormahty (one 
or more sharp kinks) = 2; severe abnormality 
(incomplete closure of the neural suture at the 
sites of sharp kinks) = 3; and turning failure 
(incomplete change from dorsal to ventral concave 
flexure which should occur at 10.5 days) = 4. Total 
protein content was determined by reaction of 
sonicated embryos with Coomassie Brilliant Blue 
G-250 (Sigma, Poole, U.K.) protein reagent and 
measurement of absorbance at 595 nm in a spec- 
trophotometer (Cecil, Cambridge, U.K.) (Brad- 
ford, 1976). Embryos with no circulation and 
showing poor growth and development of both 
yolk-sac and embryo were noted (abnormality 
score =  5) but growth parameters could not be 
measured as development had not continued for 
the full 44 h. Assessments were done without 
knowledge of treatment.
Embryo culture
The embryo culture technique was essentially 
that of New (1978) and has been described previ­
ously by Jenkinson et al. (1986). Briefly, female 
Sprague-Dawley rats were caged individually with 
sexually mature male rats. Matings were con- 
firmed by the presence of vaginal plugs beneath 
the cages and the day plugs were found was 
designated day 0 of gestation. Embryos were ex­
planted on day 9 (9.5 days old) and the outermost 
membrane layer removed. The intact embryos, 
consisting of yolk-sac, amnion and ectoplacental 
cone, were checked for damage. Undamaged em­
bryos were assigned to the different treatment 
groups in equal proportions from different females
Treatments
All treatments were for 1 h in 10 ml EMEM in
60-mm petri dishes at 37 ° C CO^ .
Statistics
Growth parameters were tested for differences 
between treatments by analysis of variance and, if 
significant, by the Least Significant Difference 
(LSD) test having first ensured that Bartletts sta- 
tistic for homogeneity of variance was not signifi­
cant. The distribution of the severity of neural 
sutiue abnormahties was tested for differences 
between treatments by the Cochran Armitage trend 
test (Snedecor and Cochran, 1 9 6 8 ).
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Results
The effect o f  L-ascorbic acid  on neural suture  
abnorm alities
Treatment with xanth ine/ xanthine oxidase 
(X /X O ) altered the distribution of neural suture 
abnormalities, causing a significant linear trend 
( p  < 0.001) towards increasingly severe abnormal- 
ities when compared with control (xanthine (X) 
only) (Table 1). Low concentrations of AA (10 or 
100 juM) added to cultures containing X /X O , did 
not abolish this trend which remained non-signifi- 
cantly different from cultures without AA. How- 
ever, X/XO/KXX) juM AA caused a significant 
linear trend towards decreasingly severe abnor­
malities when compared with X /X O . The linear 
trend for distribution of abnormalities was not 
significantly different from X control.
10, 100 or 1000 /xM AA added to X control 
cultures caused a linear trend in severity of
abnormality which was not significantly different
from control.
c /  L-xiycorhfc uc/W OM growt/z paramerer.y
Growth parameters (yolk-sac diameter, crown- 
rump length, head length, somite number and 
protein content) were not found to be significantly 
different from X control in any of the treated 
embryos except for an increased yolk-sac diameter 
i p  < 0.05) and protein content (/? < 0.001) in em­
bryos treated with X /1 0  p m  AA (Table 2).
Yolk-sac diameter and crown-rump length were 
found to be lower in embryos treated with X /X O  
than in all other treatment and control groups 
with the one exception of embryos treated with 
X /100 p m  A A  where yolk-sac diameter was 
slightly lower still. The LSD test showed some of 
these differences to be significant as shown in 
Table 2. Protein contents were not significantly 
different from X /X O -treated embryos, with the
TABLE 1
EFFECTS OF L-ASCORBIC ACID ON NEURAL SUTURE ABNORMALITIES INDUCED IN CULTURED RAT EMBRYOS 
TREATED WITH XANTHINE OR XANTHINE/XANTHINE OXIDASE
Treatment Neural suture abnormalities CA trend test
None
0
Mild
1
Moderate
2
Severe
3
Turning failure 
4
vs. X v& X /X O
X 13 9 4 0 0 0
x"=14.1
X /X O 22 3 5 5 7 2
X^ —14.1
-
X /X O
10 /iM AA 13 3 3 1 2 4
X  ^= 9A
ns
X /X O  
lOOpM AA 10 0 4 3 1 2
x 4 = 1 2 3 x^ = o ^  
ns
X /X O  
lOOO^rM AA 10 7 3 0 0 0
X^  =  OB 
ns
X"=11.8
X
lOfiM  AA 12 9 1 2 0 0 ns
X '= l l . 3
X
100 juM AA 14 8 4 1 1 0
X ^ = 1 4
ns
x '  =  9 j
X
1 0 0 0 /fM AA 10 7 3 0 0 0
X' = 0^
ns
X' = 11.8
CA trend lest, Cochran Armitage Trend Test; x", chi-squared. X. xanthine 129 fiM; XO, xanthine oxidase 25 m U/m l; AA. 
L-ascorbic acid. ns. not significant; **. significantly different < 0.01; significantly different < O.OOL
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TABLE3
EFFECTS OF DL-a-TOCOPHEROL ON NEURAL SUTURE ABNORMALITIES INDUCED IN CULTURED RAT EMBRYOS 
TREATED WITH XANTHINE OR XANTH INE/XANTH INE OXIDASE
Treatment Neural suture abnormalities CA trend test
None
0
Mild
1
Moderate
2
Severe
3
Turning failure 
4
vs. X v & X / X O
X 18 13 4 0 0 1 -
x " - 1 9 . 7
X / X O 16 1 2 1 2 10 -
X / X O
95 /ig /m l AT 1 4 2 1 1 1 9
x "  =  OT
ns
X / X O
1 9 0  f i g / m l  AT 8 3 0 2 2 1
x '  =  5 7 X ^ =  4 A
X / X O
285 / i g / m l  AT 7 3 0 0 0 4
X ' =  7 J X ^ = 1 3
ns
X
28 5  f i g / m l  AT 10 7 3 0 0 0
X^ =  O J
ns
X^ =16.2
CA trend test, Cochran Armitage Trend Test: x^, chi-squared. X, xanthine 129 gM ; XO, xanthine oxidase 25 m U /m l; AT, 
DL-a-tocopherol. ns, not significant; *, significantly different p  < 0.05; **, significantly different p  < 0.01; * * * , significantly 
different p < 0.001.
TABLE4
EFFECTS OF DL-a-TOPOPHEROL ON NEURAL SUTURE ABNORMALITIES INDUCED IN CULTURED RAT EMBRYOS 
TREATED WITH XANTHINE AND HIGH LEVEL XANTHINE OXIDASE
Treatment Neural suture abnormalities CA trend test
None Mild M oderate Severe Turning
failure
Poor
development
vs. X vs. X /X O
0 1 2 3 4 5
X 18 16 1 0 0 1 0 -
X '  =  30.3
X /X O 18 0 1 1 0 0 16
X ^  = 30.3
-
X /X O
95 /ig /m l AT 19 0 1 0 0 6 12
X -  = 30.9 X^  = 0.16 
ns
X /X O
190 fig/m l AT 12 0 3 0 2 2 5
X ^ = 1 8 . 5 X ^  = 4 J
X /X O
285 fig/m l AT 8 2 0 0 2 2 2
x" = 1 2 . 6 X -  =  5 j
CA trend test, Cochran Armitage Trend Test; x^, chi-squared. X, xanthine, 129 juM; XO, xanthine oxidase 40 m U/m l; AT, 
DL-a-tocopherol. ns, not significant; *, significantly different p < 0 .0 5 ; * * * , significantly different 0.001.
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exception of a highly significant increase ( f  <
0.001) in protein content in embryos treated with 
X /1 0  jum AA.
TTze DL-oc-mcqp/zero/ o/z nez/m/ .ynmre
abn orm alities
As in the AA series of experiments, X /X O
caused a significant linear trend (p  < 0.001) to­
wards increasingly severe neural suture abnormali­
ties when compared with X control (Table 3). In 
comparison with X control embryos X /X O  cul­
tures with 95 /ig/m l of AT still showed a signifi­
cant linear trend towards increasingly severe 
abnormalities. However, higher concentrations of 
AT reduced the significance of this trend, 190 
jLLg/ml being slightly more effective than 285 
/ig/m l. This is a weaker effect than that seen with 
AA where the highest level used completely 
abolished the effect of X /X O  on abnormality 
distribution returning it to the control pattern.
In comparison with X/XO-treated embryos, 
cultures with AT added at 190 /ig /m l showed a 
significant linear trend ( p < 0.05) towards de­
creasingly severe abnormahties, and although a 
similar effect was seen in cultures with AT at 285 
/ig /m l, this was not significant. AT at 95 /ig /m l 
had no effect.
285 /ig /m l AT added to X control cultures 
caused a linear trend in severity of abnormality 
which was not significantly different from control.
Table 4 shows the distribution of neural suture 
abnormalities in embryos from the series of ex­
periments in which XO was used at nearly double 
that of the previous studies (40 m U/m l). Embryos 
treated with X and XO at 40 m U /m l showed very 
poor growth and development which resulted in a 
significant linear trend ( /?< 0.001) towards in­
creasingly severe abnormalities when compared 
with control.
In comparison with X control embryos the 
addition of AT to cultures containing X /X O  did 
reduce this trend in a dose-dependent manner (i.e.
decreased) but it was still significant in all 
groups at the 1% level.
In comparison with X /XO-treated embryos the 
addition of 95 /ig /m l AT to cultures containing 
X /X O  did not cause any significant difference in 
linear trend of severity of abnormality, higher
levels (190 or 285 /rg /m l) did cause a significant 
decrease ( f  < 0.05).
TTze q / DL-a-mcqp/zero/ on growl/z
In most comparisons, growth parameters were
not found to be significantly different from X 
control or X /X O -treated embryos (Table 5); yolk- 
sac diameters in embryos treated with X /285 
jug/ml AT was significantly greater at the 5% and
1% level respectively.
Equivalent results for the series of experiments 
in which 40 m U /m l XO was used are not pre­
sented, since growth parameters could not be 
meaningfully measured in embryos which had not 
developed for the full 44 h culture time.
Discussion
It has been shown previously (Jenkinson et al.,
1986) that teratogenic effects are observed in cul- 
tured rat embryos treated with X and XO and that 
these effects can be abolished by the addition of 
catalase or high concentrations of glutathione. The 
results of the present study confirm that neural 
suture abnormalities can be induced in cultured 
rat embryos by X and XO and show that the 
antioxidants AA and AT can abolish or reduce 
such effects respectively.
The assessment of neural suture abnormalities 
provided a very sensitive index of the teratogenic 
potential of each of the different treatments in this 
system. In the AA series of experiments, and in 
both series of AT experiments, a highly significant 
difference was observed between control embryos 
and those incubated with the oxygen radical gen­
erating system.
The growth parameters measured in the em­
bryos (yolk-sac diameter, crown-rump length, head 
length, somite number and protein content) did 
not show any consistent significant differences 
between embryos from treated and control groups 
and thus did not provide a very sensitive index of 
the extent of teratogenic effect. The results indi- 
cate that the addition of 10 /iM AA to control 
cultures enhanced yolk-sac size and protein con­
tent of embryos significantly and the addition of 
285 /ig /m l AT increased yolk-sac size.
AA at ICKX) /iM was observed to have a strongly 
protective effect, completely abolishing the neural
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suture abnormalities caused by X /X O . This effect 
was not seen at lower concentrations (10 or 100 
pM). AA did not damage control embryos at any 
of the three concentrations used. This correlates
well with the findings of Varma et al. (1986) who 
found that 1 mM Na-ascorbate protected cultured 
rat lenses from the action of hypoxanthine/XO, 
presumably by reaction with hydrogen peroxide, 
and that Na-ascorbate alone did not have a 
damaging effect. Faustman-Watts et al. (1986) 
also found AA at 1 mM to be protective against 
radical-induced defects from reactive metabolites 
of 2-acetylaminofluorene in cultured embryos.
However, Weitberg (1987) reported that in CHO 
cells, concentrations of AA of 100 ju,M and above 
potentiated the SCE-inducing effect of hypo- 
xanthine/XO. Weitberg and Weitzman (1985) had 
previously shown that AA added to CHO cultures 
alone at 10-1000 juM induced SCEs. When added 
with hypoxanthine/XO, AA protected at 10 ju.M 
or below, reducing, but not abolishing, the in- 
crease in SCEs caused by the oxygen radicals. At 
100-1000 JU.M AA either protected against (to a 
lesser extent than lower concentrations) or poten- 
tiated the effect of hypoxanthine/XO, and at 
10-100 mM caused cell death.
Na-ascorbate at 100 pM  and above was found 
to decrease cell survival in CHO cultures and at 
500 juM induced mutations at the HGPRT locus 
(Rosin et al., 1980). Very high concentration of 
AA (3 mM) was found to be mutagenic in the 
Ames test but only in the presence of Cu^^ 
(Norkus et ah, 1983).
In the present study AT was observed to have 
only a weakly protective effect against X-XO-in- 
duced damage, reducing but not abolishing the 
neural suture abnormalities caused by X /X O . AT 
at 285 p g /m l did not damage control embryos.
The reason for the limited antioxidant effect of 
the AT could be explained by its preparation as a 
suspension by sonication in PBS. This may have 
left a large proportion of AT as a micellar suspen- 
sion and biologically unavailable (Steele et ah, 
1974). However this was thought to be com­
pensated for by the high concentrations used in 
the present study which compare favourably with 
in vivo levels of 5 jug/ml reported by Steele et ah 
(1974). Our results suggest that AT increased yolk 
sac size in control cultures. In a similar embryo
culture system, Steele et ah (1974) found that 95 
jug/ml AT in the culture medium increased the 
survival time of the embryos, and that a dietary
deficiency of AT in female rats led to retarded 
embryonic development.
Weitberg et ah (1984) failed to observe an acute 
protective effect of AT-succinate at concentrations 
of up to 10 juM, in a system which measured the 
induction of SCEs in CHO cells by hypo­
xanthine/XO. They did, however, find a protec­
tive effect if cultures were pre-incubated with AT 
for 72 h. Cultured human leukocytes can be pro- 
tected from the chromosome-breaking action of 
carcinogens by 10 /iM Na-ascorbates or 10 /zM 
AT present in the culture medium for 15 h (Sham- 
berger et ah, 1973). Thus, a return to control 
distribution of abnormalities might have been 
achieved in the cultures treated with AT and the 
oxygen-radical generating system, had a system 
been developed in which greater time had been 
allowed for the vitamin to become associated with 
membranes.
In conclusion, AA and AT have an antioxidant 
effect in embryo cultures treated with the oxygen- 
radical generating system of X and XO.
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Tumours and malformations in the adult offspring 
of cyclophosphamide-treated and control male rats — 
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Summary
Adult offspring aged 52-104 weeks, from male Sprague-Dawley rats treated chronically with 
cyclophosphamide (CP) were examined for tumours and gross abnormalities. Litter size at birth and at 
weaning was found to be greatly reduced as a result of paternal CP treatment. No unusual abnormalities 
were found at post-mortem examination but there was an increase in the incidence of hydronephrosis in 
offspring from CP-treated males compared with offspring from control males. This increase could have 
been indirectly caused by CP-treatment through reduced litter size.
Histological examination of 26 tumours showed a variety of tumour types in the offspring of CP-treated 
and control males. Two of the four uterine tumours in offspring from CP-treated males were examined 
histologically; one was a sarcoma and the other an adenocarcinoma. Although no uterine tumours were 
found in offspring from control males, it is not clear whether this difference in frequency was treatment-re­
lated. The most common tumour site in female offspring from both CP-treated and control males was the 
mammary gland, and all six of these tumours which were examined histologically were adenofibromas.
Abnormal karyotypes were observed in 2 out of 21 offspring showing abnormalities from CP-treated 
males and none out of 2 offspring with abnormalities from control males. These were not associated with 
tumours.
It was concluded from this limited study that there was no clear evidence of increased tumour incidence 
in the offspring from CP-treated males. There was an indication that abnormal karyotypes may have been
caused by the paternal CP treatment and these abnormalities persisted into adulthood.
The paper, in this issue, by Jenkinson et al. chronically with cyclophosphamide (CP). Many of
describes the foetal abnormalities found in off- the malformed foetuses from CP-treated males
spring from male Sprague-Dawley rats treated carried chromosome deletions (Jenkinson et al ).
It is known that some human cancer syndromes
(e.g. Wilm’s tumour (Francke et al., 1979); reti-
%---------- .  ^ _ TT. r, . .. i .4 , 1 D noblastoma (Yunis and Ramsay, 1978)) are associ-Correspondence: Anne J. Francis, The Bntish Industnal Bio- -, i , , , - ,
logical Research Association, Woodmansterne Road, Carshal- ated With chromoSOme deletions. Rowley (1983)
ton, Surrey SM5 4DS (Great Britain). has described the association between the location
0027-5107/90/$03.50 0  1990 Elsevier Science Publishers B.V. (Biomedical Division)
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of human oncogenes and chromosomal aberra-
tions. Heritable tumours and malformations can 
be induced by mutations in the germ cells of male 
mice caused by X-rays (Kirk and Lyon, 1984) or
following treatment with chemicals such as 
urethane (Nomura, 1982), ethyl nitrosourea (ENU) 
(Tomatis et al., 1981) and CP (Trasler et al., 1985, 
1987). In addition, behavioural abnormalities have 
been found in adult offspring from male rats 
treated with CP (Adams et al., 1981).
The present study has examined adult offspring 
(aged 52, 66, 79, 91 and 104 weeks) from CP- 
treated and control males for gross tumours and 
other gross malformations. Some of the tumours 
were examined histologically. Ideally, all organs of 
all offspring would have been examined histologi- 
cally for evidence of tumour onset, but in this 
limited study only tumours evident macroscopi- 
cally have been recorded. Thus, an underestimate 
of actual tumour incidence has probably been 
made.
Karyotypes from normal offspring are cur-
rently under investigation. For this preliminary 
communication, those from some abnormal off-
spring have been analysed.
Materials and methods
Anim als and treatment
Adult male and female Sprague-Dawley rats 
(8-10 weeks) were obtained from Harlan Olac 
Ltd. (Bicester, Oxon) and treated as described by 
Jenkinson et al. In brief, males were randomly 
assigned to CP-treated or control groups following 
10 days acclimatization. The control animals were 
dosed daily with 10 m l/kg  of 0.85% sahne by 
gavage (n = 6) while the treated group received 
CP (Sigma, Poole, Dorset) in saline (n = 18). These 
E^  group sizes were chosen in order to provide 
around 100 individuals in each group. The dose 
level of CP was 3.5 m g/kg for the first 4 weeks 
and 5.1 m g/kg subsequently; dosing was daily for 
the first 12 weeks and then on 5 consecutive days 
per week until treatment was discontinued at 33 
weeks.
Manhg
Males were caged with 2 virgin females 30 
weeks after the beginning of treatment. Females
were allowed to litter and wean pups. The pups 
were counted and weighed as a litter at birth and 
at weaning.
Offspring from each litter were randomly as­
signed to the 5 groups for post-mortem examina­
tion (PM) at 52, 66, 79, 91 and 104 weeks of age. 
Animals that died or were killed in extremis were 
subject to a full PM and formed part of the 
analysis. A description of all gross abnormalities 
was made and a sample of tissue fixed in 10% 
buffered formalin for histological examination.
Samples from a number of tumours were 
processed, embedded in paraffin wax and 5-/zm 
sections cut and stained with haematoxyhn and 
eosin.
Mean pup weights and litter sizes at birth and 
at weaning were compared using a two-sided 
pooled two-sample r-test (Snedecor and Cochran, 
1968) and a two-sided M ann-W hitney test (Siegel, 
1956) respectively. Pregnancy rate and pre-wean­
ing mortality were compared using a chi-squared 
test (Siegel, 1956).
The frequency of gross abnormalities in off­
spring from CP-treated and control males were 
compared by the methods described by Peto et al. 
(1980) taking into account the week of death. 
Lesions were either classified as fatal, and a fatal 
analysis was performed, or an incidental analysis 
was carried out in which all lesions were assumed 
to have been observed in an incidental context. 
No attempt was made to separate tumours by 
histological class.
4 h before being humanely killed, animals were 
given 3 m l/kg  of 1 m g/m l colchicine (Sigma) by 
intra-peritoneal injection. At PM, bone marrow 
was aspirated from the femur into Hanks’ Bal­
anced Salt Solution containing 100 /zg/ml col­
chicine and 100 /zg/ml lithium heparin (Sigma). 
Cells were swelled in 0.075 M KCI with 0.1 /zg/ml 
demecolcine (Sigma) and fixed in 3 :1  metha­
nol : acetic acid. Chromosome spreads were pre-
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TABLE 2a
TUMOURS AND HYDRONEPHROSIS IDENTIFIED MACROSCOPICALLY AT PM IN FEMALE OFFSPRING FROM 
CYCLOPHOSPHAMIDE-TREATED AND CONTROL MALE RATS *
Abnormalities 
identified 
macroscopically 
at post mortem
Histological
findings
Paternal
treatment
Age at post mortem (weeks)
U pk)
53
54-
66
6.7-
79
80-
91
92-
104
Total
Hydronephrosis - CP 2 * 2 c » * Id » 2 # # # 2 e » » 10
Control 1 0 1 l b * la 4
Liver tumour Fibrosarcoma CP 0 0 0 0 0 0
Control 0 0 0 0 la 1
Lung tumour Fibrosarcoma CP 0 0 0 0 0 0
Control 0 0 0 0 la 1
Pituitary Adenoma CP 0 0 0 0 2e # 2
tumour Control 0 1 0 lb la 3
Lymph node Adenofibroma CP 0 0 0 0 0 0
tumour Control 0 0 1 » 0 0 1
Vaginal tumour Fibrosarcoma CP 0 1 0 0 0 1
Control 0 0 0 1 0 1
Ovarian tumour Fibrosarcoma CP 0 0 0 0 0 0
Control 0 0 0 0 la 1
Mammary tumour Total CP 1 5 5 4 4 19
(including Control 1 2 8 8 4 23
tumours not
examined)
Adenofibroma CP - 1 1 1 3
Control - - - I 2 3
Uterine tumour Total CP 0 1 Id 1 1 » 4
(including Control 0 0 0 0 0 0
tumours not
examined)
Sarcoma CP 0 Ic - 0 1
Control 0 0 0 0 0 0
Carcinoma CP 0 0 1 » 1
Control 0 0 0 0 0 0
Total number of female offspring CP 10 14 8 9 6 47
Control 9 19 18 14 7 67
Some tumours were examined histologically, and the findings are shown in the table.
Indicates each animal from which a karyotype was analysed (note that some animals had more than one macroscopic abnormality; 
see a -e  below).
all these abnormalities found in one animal; similarly, *''=4=; CP, cyclophosphamide; - ,  not examined histologically.
pared by the air-drying technique and stained with 
Giemsa. Photographs were taken of all the 
metaphases which were of sufficient quality and 
karyotypes were prepared. In this preliminary
com m unication karyotypes have only been 
analysed from animals with hydronephroses, pitui­
tary adenomas, lymph node tumours, vaginal 
fibrosarcomas, uterine tumours and (in males only)
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TABLE 2b
TUMOURS AND HYDRONEPHROSIS IDENTIFIED MACROSCOPICALLY AT PM IN MALE OFFSPRING FROM  
CYCLOPHOSPHAMIDE-TREATED A N D  CONTROL MALE RATS *
Abnormalities 
identified 
macroscopically 
at post mortem
Histological
findings
Paternal
treatment
Age at post mortem (weeks)
U p m
53
54-
66
67-
79
80-
91
9 2-
104
Total
Hydronephrosis - CP 0 0 1 » 2 7
Control 0 0 0 0 1 1
Pituitary tumour Adenoma CP 0 0 0 1 » 1 » 2
Control 0 0 0 0 la 1
Lymph node Total CP 1 0 1 0 0 2
tumour Control 0 0 0 0 0 0
Lipoma CP 0 0 1 = 0 0 1
Control 0 0 0 0 0 0
Fibrosarcoma CP 1 » 0 0 0 0 1
Control 0 0 0 0 0 0
Mammary tumour Total CP 0 1 0 0 1 2
(including Control 0 0 0 0 la 1
tumours not
examined
Lipoma CP 0 1 = 0 0 0 1
Control 0 0 0 0 - -
Fibrom a CP 0 0 0 0 I 1
Control 0 0 0 0 - -
Total number of male offspring CP 9 7 8 8 7 39
Control 14 9 10 10 6 49
Some tumours were examined histologically, and the findings are shown in the table.
■ Indicates each animal from which a karyotype was analysed.
both these abnormalities found in one animal; CP, cyclophosphamide; - ,  not examined histologically.
mammary tumours. Those from macroscopically 
normal animals are currently being prepared.
Results
Data on the litters from CP-treated and control 
males are shown in Table 1. The pregnancy rate 
was slightly higher for females mated with CP- 
treated males (90%) than for females mated with 
control males (83%) but this difference was not 
significant. The number of offspring per litter at 
birth was significantly lower {p < 0.001) for CP- 
treated (4.7) than for control males (12.6) and this 
difference was greater at weaning (3.6 vs. 11.6; 
p <  0.001) due to significantly higher (p < 0 .0 1 )  
pre-weaning mortality (23% vs. 8%). The mean
weight of pups from CP-treated males (7.1 g) was 
significantly higher {p < 0.01) than for pups from 
control males (6.2 g) at birth and this difference 
was greater at weaning (72.7 g vs. 57.9 g; p < 
0.001) presumably due to the smaller number of 
pups per litter which were thus able to grow 
larger.
Most of the anomalies observed at PM were 
those commonly found in Sprague-Dawley rats of 
this age. They were of a minor nature and found 
in offspring from both CP-treated and control 
males (e.g. red areas on lung, cysts on kidney; 
data not shown).
The incidence of hydronephrosis and of gross 
tumours together with details of the histological 
analysis are shown in Tables 2a (female offspring)
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and 2b (male offspring). Hydronephrosis was seen 
in the offspring of CP-treated males more com­
monly than in the offspring of control males. For 
female offspring the incidence was 8 from CP- 
treated vs. 1 from control and for male offspring 
10 vs. 4 (/)< 0 .0 1  by both fatal and incidental 
analyses). Four uterine tumours were found in 
female offspring from CP-treated males compared 
with none in those from control males {p  < 0.05). 
These tumours appeared as solid masses, 4 -8  mm 
diameter, attached to the uterine wall. Histological 
examination of 2 of these 4 uterine tumours 
showed one to be a sarcoma and the other an 
adenocarcinoma.
The most common tumour site in female off­
spring from both CP-treated and control groups 
was the mammary gland. Six of these mammary 
tumours were examined histologically and all were 
adenofibromas. The frequency of this tumour type
was similar in female offspring from both control 
and CP-treated males and therefore was not af­
fected by CP-treatment.
One female offspring from a control male 
showed multiple abnormalities at PM. This re­
sulted from the growth of a fibrosarcoma with 
multiple metastatic sites.
Karyotypes were successfully prepared from 23 
of the 36 selected animals, 21 from CP-treated 
males and 2 from controls. Metaphases from the 
other 13 abnormal animals (6 from CP-treated 
and 7 from control) were of insufficient quahty 
for analysis. No gross chromosome abnormalities 
were observed in any of the female offspring ex­
amined. Abnormal karyotypes were found in 2 of 
the male offspring from CP-treated males. Both 
had hydronephrosis but did not have tumours. 
One karyotype (Fig. la) had an additional minute 
chromosome (centric fragment) which was present
D A A / N  A  l \ A  A A < v o n X - '
1 2 3 4 5 6 1 2 3 4 ' 5 6
A  H 4  * # '% W S, vS" # >'wV.
7 8 9 10 11 12
7 8 9 10 : i r 12
W % #  k m % A A »  S  ■
13
*0 A,
14 15 16 17 18
A  ,
13 14 15 16. 17 18
19 20 X Y
19 20 X Y
... *
a # u
Fig. 1. Karyotypes for 2 male offspring with hydronephrosis from CP-treated males; A, an additional minute chromosome (centric 
fragment) present in every metaphase (i.e. n =  43); B, centrometric fusion of chromosomes 5 and 6.
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in every metaphase (i.e. n = 43) and the other 
(Fig. lb) had a centromeric fusion of chro­
mosomes 5 and 6. No other chromosome 
abnormalities were seen in the male offspring ex­
amined.
Discussion
Data are presented on observations made peri- 
natally and at PM between 52 and 104 weeks of 
age. A greatly reduced number of offspring were 
bom  to females mated with CP-treated males 
compared with those mated with control males. 
Many pups from the CP-group died during the 
first few days post-partum and it is probable that 
at the time of counting, some of the pups in each 
litter had already been cannibalised by the mother. 
Thus, Jenkinson et al. who examined foetuses on 
day 20 of pregnancy from a separate set of females 
mated to these males, found 5.5 live foetuses per 
litter whilst in the present study only 4.7 pups per 
litter were counted at birth and 3.6 pups per litter 
were weaned.
The majority of both the gross and pathological 
findings were not associated with treatment. They 
represented the background pathology that is ex­
pected in animals of this stock and age. The 
incidence of hydronephrosis and of uterine 
tumours showed a statistically significant increase 
in the offspring of CP-treated males compared 
with offspring from control males, although the 
biological importance of these findings is unclear. 
Hydronephrosis is not uncommon in animals of 
this stock and shows an increased incidence with 
increased dietary intake and bodyweight. CP 
produced a reduction in litter size which probably 
resulted in increased dietary intake. 2 of the 4 
uterine tumours were examined microscopically 
and found to be of different histological type. In 
an population an association with treatment 
would be difficult to make. In an Fj population, 
however, it is not known whether tumours result­
ing from treatment of the parent would be of the 
same histological type. It is conceivable that 
tumours arising from induced mutation in the 
germ cells could predispose the F, animals to 
different tumour types.
Only 2 offspring from CP-treated males had 
abnormal karyotypes out of 21 examined with
macroscopic abnormalities. This is a smaller per­
centage (9.5%) than that seen by Jenkinson et al. 
(31%). The most severe chromosomal abnormali­
ties probably caused the death of the offspring 
either in utero or during the first few days of life. 
No abnormal karyotypes were observed in the 2 
offspring with macroscopic abnormalities from 
control males which produced metaphases of suf­
ficient quality for analysis. The karyotypes pre­
pared were unbanded, so that a relatively insensi­
tive analysis has been performed in which chro­
mosomal abnormalities, such as terminal deletions 
and inversions, would not be detected. The back- 
ground level of karyotype abnormahties is ex­
tremely low, being found rarely in in vivo cyto- 
genetic studies in rats (e.g. Anderson and Richard­
son, 1981). Thus, the incidence of 9.5% found in 
the offspring of CP-treated males may be of bio­
logical importance particularly since this genetic 
damage has been induced in germ cells and has 
not been eliminated during meiosis or other stages 
of germ cell maturation.
An increased incidence of tumours in the off­
spring of males treated with FNU has been found 
by Tomatis et al. (1981). The tumours of the 
nervous tissue found in these offspring were simi- 
lar to those found in the treated males themselves 
and were also found at low incidence in offspring 
from control males. Paternal treatment with MNU 
has been shown to cause foetal abnormalities 
(Nagao, 1987).
Fpidemiological studies in humans have pro­
vided equivocal results relating paternal occupa­
tion to childhood cancer (Brown, 1985). One pos­
sible association is that between paternal hydro­
carbon exposure and Prader-Willi syndrome in 
children which is sometimes associated with a 
chromosome deletion (Strakowski and Butler,
1987).
In conclusion, the present study shows no clear 
association between tumour development and CP 
exposure. This limited study, however, would have 
detected only an alteration in gross but not subtle 
abnormalities. To detect more subtle changes 
would necessitate a more extensive histological, 
pathological and possibly biochemical examina­
tion of all animals. No correlation between gross 
chromosomal abnormalities and tumour develop­
ment can be made because the two animals that
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showed gross chromosomal changes, while having 
hydronephrosis, did not bear a tumour. Neverthe­
less, karyotype abnormalities have been found 
which have persisted into adulthood presumably 
after being induced in parental germ cells by the 
CP treatment but this remains to be verified.
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